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ABSTRACT
In the first project, a simple, rapid, and reversible fluorescent DNA INHIBIT 
logic gate has been developed for sensing mercury (Hg2+) and iodide (I-) ions based on 
a molecular beacon (MB). In this logic gate, a mercury ion was introduced as the first 
input into the MB logic gate system to assist in the hybridization of the MB with an 
assistant DNA probe through the thymine–Hg2+–thymine interaction, which eventually 
restored the fluorescence of MB as the output. With this signal-on process, mercury 
ions can be detected with a limit of detection as low as 7.9 nM. Furthermore, when 
iodide ions were added to the Hg2+/MB system as the second input, the fluorescence 
intensity decreased because Hg2+ in the thymine–Hg2+–thymine complex was grabbed 
by I- due to a stronger binding force. Iodide ions can be detected with a limit of detection 
of 42 nM. Meanwhile, we studied the feasibility and basic performance of the DNA 
INHIBIT logic gate, optimized the logic gate conditions, and investigated its sensitivity 
and selectivity. The results showed that the MB based logic gate is highly selective and 
sensitive for the detection of Hg2+ and I- over other interfering cations and anions.  
In the second project, an ultrasensitive and rapid turn-on fluorescence assay 
has been developed for the detection of 3’-5’ exonuclease activity of exonuclease III 
(Exo III) using molecular beacons (MBs). This method has a linear detection range 
from 0.04 to 8.00 U mL-1 with a limit of detection of 0.01 U mL-1. In order to improve 
the selectivity of the method, a dual-MB system has been developed to distinguish 
between different exonucleases. With the introduction of two differently designed MBs 
which respond to different exonucleases, the T5 exonuclease, Exo III and RecJf 
exonucleases can be easily distinguished from each other. Furthermore, fetal bovine 
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serum and fresh mouse serum were used as complex samples to investigate the 
feasibility of the dual-MB system for the detection of the enzymatic activity of Exo III. 
As a result, the dual-MB system showed a similar calibration curve for the detection of 
Exo III as in the ideal buffer solution. The designed MB probe could be a potential 
sensor for the detection of Exo III in biological samples. 
In the third project, A sensitive label-free fluorescence assay for monitoring 
T4 polynucleotide kinase (T4 PNK) activity and inhibition was developed based on a 
coupled λ exonuclease cleavage reaction and SYBR Green I. In this assay, a double-
stranded DNA (dsDNA) was stained with SYBR Green I and used as a substrate for T4 
PNK. After the 5 -´hydroxyl termini of the dsDNA was phosphorylated by the T4 PNK, 
the coupled λ exonuclease began to digest the dsDNA to form mononucletides and 
single-stranded DNA (ssDNA). At this moment, the fluorescence intensity of the SYBR 
Green I decreased because less affinity with ssDNA than dsDNA. The decrease extent 
was proportional to the concentration of the T4 PNK. After optimization of the 
detection conditions, including the concentration of ATP, amount of λ exonuclease and 
reaction time, the activity of T4 PNK was monitored by the fluorescence measurement, 
with the limit of detection of 0.11 U/mL and good linear correlation between 0.25-1.00 
U/mL (R2=0.9896). In this assay, no label was needed for the fluorescence detection. 
Moreover, the inhibition behaviours of the T4 PNK’s inhibitors were evaluated by this 
assay. The result indicated a potential of using this assay for monitoring of 
phosphorylation-related process. 
In the fourth project, a facile bottom-up method for the synthesis of highly 
fluorescent graphene quantum dots (GQDs) has been developed using a one-step 
pyrolysis of a natural amino acid, L-glutamic acid, with the assistance of a simple 
heating mantle device. The developed GQDs showed strong blue, green and red 
 xix 
 
luminescence under irradiation with ultra-violet, blue and green light, respectively. 
Moreover, the GQDs emitted near-infrared (NIR) fluorescence in the range 800–850 
nm with an excitation-dependent manner. This NIR fluorescence has a large Stokes 
shift of 455 nm, providing a significant advantage for the sensitive determination and 
imaging of biological targets. The fluorescence properties of the GQDs, such as the 
quantum yields, fluorescence life times, and photostability, were measured and the 
fluorescence quantum yield was as high as 54.5%. The morphology and composites of 
the GQDs were characterized using TEM, SEM, EDS, and FT-IR. The feasibility of 
using the GQDs as a fluorescent biomarker was investigated through in vitro and in 
vivo fluorescence imaging. The results showed that the GQDs could be a promising 
candidate for bioimaging. Most importantly, compared to the traditional quantum dots 
(QDs), the GQDs are chemically inert. Thus, the potential toxicity of the intrinsic heavy 
metal in the traditional QDs would not be a concern for GQDs. In addition, the GQDs 
possessed an intrinsic peroxidase-like catalytic activity that was similar to graphene 
sheets and carbon nanotubes. Coupled with 2,20-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) (ABTS), the GQDs can be used for the sensitive detection of hydrogen 
peroxide with a limit of detection of 20 mM.  
In the fifth project, a general, environmental-friendly, one-pot method for the 
fabrication of reduced graphene oxide (RGO)/metal (oxide) (e.g. RGO/Au, RGO/Cu2O, 
and RGO/Ag) nanocomposties was developed using glucose as the reducing agent and 
stabilizer. The RGO/metal (oxide) nanocomposites were characterized using STEM, 
FE-SEM, EDS, UV-vis absorption spectroscopy, XRD, FT-IR and Raman spectroscopy. 
The reducing agent, glucose, not only reduced GO effectively to RGO, but it also 
reduced the metal precursors to form metal (oxide) nanoparticles on the surface of RGO. 
Moreover, the RGO/metal (oxide) nanocomposites were stabilized by gluconic acid on 
 xx 
 
the surface of RGO. Finally, the developed nanomaterials were successfully applied to 
simultaneous electrochemical analysis of L-ascorbic acid (L-AA), dopamine (DA) and 
uric acid sing RGO/Au nanocomposite as an electrode catalyst.  
In the sixth project, a reduced graphene oxide/silver nanoparticle (RGO/Ag) 
nanocomposite using glucose as the environmental-friendly reducing agent was 
developed. The antibacterial activity of RGO/Ag nanocomposite was carefully 
investigated using Escherichia coli (E. coli) and Klebsiella pneumoniae (Kp) as 
bacterial models. We found that, compared with AgNPs, graphene oxide (GO) and 
RGO, RGO/Ag nanocomposite had higher antibacterial efficiency. Furthermore, under 
the near-infrared (NIR) irradiation, RGO/Ag nanocomposite demonstrated enhanced 
synergetic antibacterial activity through the photothermal effect. Almost 100 % of E. 
coli and Kp were killed by the treatment of 15 µg/mL and 20 µg/mL, respectively, with 
NIR irradiation. Moreover, the membrane integrity assay and ROS species assay 
demonstrated that RGO/Ag nanocomposite under NIR irradiation caused the cell 
membranes disruption and generation of ROS species, providing other possible 
mechanisms for their high antibacterial activity besides photothermal effect. 
In the seventh project, a rigid distance spacer, silica shell, was used between 
GO and dyes in this work to elucidate the quenching ability of GO. First, an organic 
dye was doped in silica nanoparticles, followed by the modification of another layer of 
silica shell with a different thickness. Due to the electrostatic interaction between GO 
and positively charged silica nanoparticles, GO wrapped the silica nanoparticles when 
they were mixed together. Therefore, the distance between GO and organic dyes was 
adjusted by the thickness of the silica shell. The quenching efficiency of GO to two 
different organic dyes, including Tetramethylrhodamine (TAMRA) and 
Tris(bipyridine)ruthenium(II) chloride (Rubpy), was measured at various distances. 
 xxi 
 
This quenching ability investigation of GO to dyes with distance-dependent manner 
would provide a guideline for the design of the fluorescent functional composite using 
GO in the future. 
In the eighth project, we characterized the antibacterial activity of GO in both 
cell culture and animal models. Klebsiella pneumoniae (Kp) is one of the most common 
multidrug resistant (MDR) pathogens in causing persistent nosocomial infections and 
is very difficult to eradicate once established in the host. First, we demonstrated that 
GO exerted direct killing of Kp in agar dishes and afforded the protection of alveolar 
macrophages (AM) from Kp infection in culture. We then evaluated the mortality, tissue 
damage, polymorphonuclear neutrophil (PMN) penetration, and bacterial 
dissemination in Kp-infected mice. Our results revealed that GO can counteract the 
invasive ability of Kp in vivo, resulting in lessened tissue injury, significant but subdued 
inflammatory response, and prolonged mouse survival. These findings indicate that GO 
may be an alternative agent for controlling MDR pathogens in clinics.
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CHAPTER I 
A REVERSIBLE FLUORESCENT LOGIC GATE FOR SENSING MERCURY AND 
IODIDE IONS BASED ON A MOLECULAR BEACON  
1. Introduction 
Molecular Boolean logic gates are advanced microdevices that can perform various 
logical operations based on molecules.1 The basic types of Boolean logic gates include 
AND, OR, NOT, INHIBIT, NOR, NAND, XOR, and XNOR. The advanced logical 
calculation could be performed through combination of these types of logic gates. 
Therefore, Boolean logic gate is  promising in the fabrication of molecular 
computation,2-4 becoming a potential substitute for the traditional silicon-based 
computation.5 Among the molecular Boolean logic gates, DNA-based logic gates have 
attracted great attention because of the easy manipulation of DNAs. They could be 
fabricated based on various behaviors of DNAs such as hybridization, cleavage and 
allosteric regulation.6  A number of DNA based logic gates, including the methods 
coupled with graphene oxide as the quencher,7, 8 DNAzyme,3, 9, 10 and aptamers11 were 
reported recently. Compared with other molecular logic gates, such as an enzyme-
inhibitor12 and a small super-molecule system,13 a DNA logic gate shows a number of 
advantages. The most significant benefits include low cost, specific genetic information 
recognition, simplicity, various input species (e.g., metal ions,14-18 DNA sequences,19-21 
small biomolecules,22  and proteins23) and different types of output signals.4, 15, 18, 24 
Meanwhile, the excellent selectivity of a DNA probe for its target inputs provides a 
promising platform for biosensing applications. For instance, the specific binding of 
the thymine-Hg2+-thymine (T-Hg2+-T) and cytosine-Ag+-cytosine (C-Ag+-C) were
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widely used for the multi-ions detection with fluorescence25 and colorimetric 
methods.26 However, most of the fluorescence output-based DNA logic gates were 
fabricated through coupling with fluorescence nano-quenchers. For example, graphene 
oxides were widely used to fabricate different types of logic gates.16, 22 The 
nanomaterials bring complicity to DNA logic gates. In contrast, molecular beacon-
based self-quenched DNA logic gates are more feasible.  
A molecular beacon (MB) is a designed hairpin-structured DNA strand labeled with 
a fluorophore and a quencher at both ends. MBs have been widely used for the 
fabrication of different biosensors.27 The high selectivity and sensitivity of the MB-
based biosensors are benefitted from its loop-stem structure and low background signal. 
Recently, a MB has been used for the fabrication of different types of Boolean logic 
gates.28 For example, Park et al. constructed several types of Boolean logic gates using 
DNA sequences as inputs.19 The developed logic gates could be operated reversibly and 
reset to the original state. Yang et al. developed a half-adder and half-subtractor through 
combining a MB-based AND gate and a XOR gate, an INHIBIT gate and a XOR gate, 
respectively.29 However, all of these MB based logic gates used DNA sequences as 
inputs, which limited their applications. 
Herein, a reversible INHIBIT logic gate based on a MB was developed with two 
ions as inputs and fluorescence as output for the detection of Hg2+ and I-. Hg2+ is 
considered as one of the most hazardous pollutants for human health and environmental 
protection.30, 31 The US Environmental Protection Agency (EPA) has a standard 
maximum allowable level for Hg2+ of 10 nM in drinking water. Iodide ion is an essential 
nutrient for humans. The lack of I- would lead to serious health problems.32, 33 Recently, 
several papers reported the sensitive sensing systems for the detection of Hg2+ using 
DNA probes. Liu et. al used a thrombin-binding aptamer labeled with a fluorophore and 
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a quencher at its 5’ and 3’ termini to detect Pb2+ and Hg2+ with the detection limit of 
300 pM and 5.0 nM, respectively.34 However, this is a turn-off method for the sensing, 
which might increase the background signal. Also, several nanomaterials, such as gold 
nanoparticles,35 quantum dots,17 carbon nanotubes36 and graphene oxides,7 have been 
used for the fabrication of Hg2+ and other ions sensors. These methods have some 
limitations, including complicated synthesis of the modified nanomaterials, high cost, 
and low stability for the long-time sensing. Therefore, the development of a novel 
system for the detection of these two ions is important for human health and 
environmental protection.  
2. Experimental Section 
 
2.1. Chemicals and Instruments. 
DNA sequences used in this work were purchased form Fisher Scientific. The 
sequences for MB was: 5’-FAM-CCA CCA GTT TTT TAG CTG AGG GTG G-BHQ1 
-3’; and the sequences for an assistant probe was 5’-CCCT CAG CTT AAT AACT-3’. 
NiCl2, CaCl2, ZnCl2, CuCl2, MnCl2, CoCl2, Pb(NO3)2, FeCl2 and HgCl2 were purchased 
from Sigma-Aldrich (reagent-grade). All experiments were performed in a pH7.4 buffer 
solution made of 10 mM Tris-HCl, 50 mM NaCl, and 10 mM MgCl2. The DI water 
(18.3 MΩ•cm) was produced from the Millipore water purification system. 
All fluorescence experiments were carried out using a Fluorolog-3 
Spectrofluorometer with a 450 W xenon lamp (Jonin Yvon-Spex, Instruments S.A., 
Edison, NJ). Both excitation and emission slit widths were set to be 5.0 nm. FAM was 
excited at 480 nm with a fluorescence emission range of 500 - 600 nm.  
2.2. Investigation of Feasibility of the Logic Gates. 
A 1.0 μL aliquot of 1.0 μM MB and 0.2 μL of 100.0 μM assistant MB probe 
were mixed in 100.0 μL buffer solution that was incubated at 32 ℃ for 5 min. The final 
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concentrations of MB and the assistant MB probe were 10.0 nM and 200.0 nM, 
respectively. Afterwards, 0.2 μL of 100.0 μM Hg2+ was added to the reaction system. 
After 5 min of reaction, aliquot of I- was added to the solution to react for 2 min. The 
final concentration of I- was 12.8 μM. Fluorescence intensity at 518 nm was monitored 
via the function of time. 
2.3. Investigation of Reversibility of the Logic Gate. 
A 1.0 μL aliquot of 1.0 μM MB, 0.2 μL of 100.0 μM assistant MB probe and 
0.2 μL of 100.0 μM Hg2+ were mixed in a 100.0 μL reaction buffer at 32 ℃ for 5 min, 
and then the fluorescence intensity was detected. Then, 0.2 μL of 200.0 μM I- was added 
and the fluorescence intensity was monitored within 2 min. Afterwards, 0.2 μL of 100.0 
μM Hg2+ was injected again to measure the fluorescence intensity in 5 min. This process 
was repeated for two times. 
2.4. Detection of Hg2+. 
A 1.0 μL aliquot of 1.0 μM MB and 0.2 μL of 100.0 μM assistant MB probe 
were added in a 100.0 μL reaction buffer at 32 ℃ for 5 min and recorded the 
fluorescence intensity. Different concentrations of Hg2+ were added into the solution. 
The Hg2+concentrations were 0, 10, 50, 100, 200, 500 and 1000 nM. After 5 min of the 
reaction, the fluorescence intensity of the solution was detected.  
The investigation of the selectivity of the MB logic gate over other interfered 
metal ions was conducted in a similar way. A 1.0 μL aliquot of 1.0 μM MB and 0.2 μL 
of 100.0 μM assistant MB probe were mixed in a 100.0 μL reaction buffer at 32 ℃ for 
5 min and the fluorescence intensity was measured. Afterwards, different ions, 
including Ni2+, Zn2+, Cu2+, Mn2+, Co2+, and Fe2+, were added into the solution and were 
incubated for 5 min. The final concentration of these ions was 1.0 μM. Finally, the 
fluorescence intensity of each solution was detected. 
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2.5. Detection of I-. 
A 1.0 μL aliquot of 1.0 μM MB, 0.2 μL of 100.0 μM assistant MB probe and 
0.2 μL of 100.0 μM Hg2+ were added in a 100.0 μL reaction buffer at 32 ℃ for 5 min 
followed by fluorescence intensity measurement. Afterwards, different concentrations 
of I- were added to the reaction solution. The concentrations of I- were 0, 0.05, 0.10, 
0.20, 0.40, 0.80, 1.60, 3.20, 6.40 and 12.80 μM. After 2 min of the reaction, the 
fluorescence intensity was measured. 
The investigation of the selectivity of the MB logic gate over other interfered 
anions was conducted in a similar way. A 1.0 μL aliquot of 1.0 μM MB, 0.2 μL of 100.0 
μM assistant MB probe and 0.2 μL of 100.0 μM Hg2+ were added in a 100.0 μL reaction 
buffer at 32 ℃ for 5 min and the fluorescence intensity was recorded. Afterwards, 
different anions, including Cl-, Br-, F-, SO4
2-, ClO3
-, HCO3
-, HPO4
-, NO3
-, IO3
- and I-, 
were added. The final concentration of these ions was 6.40 μM. After 2 min of 
incubation the fluorescence intensity of each solution was detected. 
3. Results and Discussion 
3.1. Design of the Logic Gate. 
In this work, we have fabricated a DNA INHIBIT logic gate based on a 
molecular beacon (MB) using Hg2+ and I- as inputs and the fluorescence signal as an 
output.  This logic gate could be used to detect trace amount of Hg2+ and I- as shown 
in Scheme 1.  A MB has a hairpin structure that induces fluorescence resonance energy 
transfer (FRET) between the modified dye and the quencher at each end, showing 
fluorescence “off” state. An assistant DNA probe was employed, which had two T-T 
mismatch bases when it hybridized with MB. Due to the T-T mismatch, the 
hybridization between the MB and the assistant probe was limited. Therefore, the loop 
of the MB could not be open, keeping fluorescence “off” status (Scheme 1 A).  
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Scheme 1. A schematic illustration of the MB-based INHIBIT logic gate for the sensing 
of the Hg2+ and I-. 
It has been demonstrated that Hg2+ could conjugate two mismatched thymines 
(T) in DNA sequences to form T–Hg2+–T complex.17 The binding constant between T 
and Hg2+ is about 106.37 Based on this principle, in our design Hg2+ was chosen as the 
first input. In the presence of Hg2+, the mismatched assistant DNA probe could easily 
hybridize with MB, formingT-Hg2+-T in the DNA duplex. At this moment the 
fluorescence of the MB was restored as an output, resulting in the fluorescence “on” 
state (Scheme 1 B). The fluorescence intensity would be proportional to the 
concentration of Hg2+. Therefore, the Hg2+ could be detected based on the fluorescence 
measurement. This is the first cycle of the logic gate. 
 The second cycle of the logic gate can be used to detect I-. At this cycle, I- 
could be functional as the second input. The principle is based on the strong binding 
affinity between I- and Hg2+.Their binding constant is 1029 that is much larger than that 
of the T–Hg2+–T complex.16 As a result, with the addition of I-, the T–Hg2+–T complex 
was disrupted by the formation of HgI2. At this moment, due to the loss of Hg
2+ between 
the MB and the assistant probe, the MB would reform to the original hairpin structure, 
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leading to the quenching of the fluorescence, again displaying the fluorescence “off” 
state (Scheme 1 A). The extent of the fluorescence decrease would be proportional to 
the concentration of I-. Therefore, by measuring the fluorescence intensity changes, the 
concentration of I- could be detected. In this cycle the fluorescence decrease was an 
output.  
Figure 1. (A) Fluorescence intensities of the MB logic gate at 518 nm in the presence 
of different inputs. (B) Truth table for the INHIBIT logic gate. 
Hg2+ and I- were defined as the two inputs for our logic gate, and fluorescence 
intensity change at 518 nm was defined as an output. For input, the presence of Hg2+ 
and I- was defined as 1, and their absence was defined as 0. For output, the original 
fluorescence intensity of MB was considered as 0, and the enhanced fluorescence was 
defined as 1 (Figure 1A). The four possible input combinations were (0, 0), (1, 0), (0, 
1) and (1, 1), as shown in the truth table (Figure 1B). With no input, or with I- input 
alone, the output was 0. With Hg2+ input alone the output signal was 1. When the two 
inputs were introduced together into the system, the strong binding force between Hg2+ 
and I- released the Hg2+ from the T–Hg2+–T complex and the fluorescence output signal 
was 0. 
3.1.1. Feasibility of the DNA INHIBIT logic gate for the detection of Hg 2+ and I-. 
 
A B 
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The feasibility of the designed fluorescent MB logic gate for the detection of 
Hg2+ and I- was investigated by monitoring the fluorescence intensity changes as a 
function of the reaction time. The result is shown in Figure 2. First, the fluorescence of 
the logic gate increased as the injection of 200 nM Hg2+, and it plateaued at 300 s.  
Figure 2. Real-time fluorescence intensities of the MB logic gate with the addition of 
Hg2+ (200 nM) and I- (12.80 μM). 𝜆ex = 480 nm, 𝜆em = 518 nm. 
This process demonstrated that the MB logic gate could be triggered to “on” state when 
the input Hg2+ was present. At the plateaued moment, 12.80 μM I- was added to the 
system for turning off the logic gate. The result demonstrated that the fluorescence 
intensity decreased immediately after the addition of I-. After 120 s the fluorescence 
signal returned to the original level where the Hg2+ input was not added. Clearly, the 
second input of I- quickly led to the fluorescence logic gate “off”.  Ultimately, this 
fluorescence MB logic gate could be used for sensing both Hg2+ and I- by measuring 
the fluorescence intensity changes. 
3.1.2. Performance of the DNA INHIBIT logic gate. 
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The performance of the logic gate was tested as shown in Figure 3. At no input 
(Figure 3, curve a) and I- input alone (Figure 3, curve b), the output of fluorescence 
intensity changes showed 0. When the Hg2+ input was added, the Hg2+ mediated MB 
hybridization with the assistant probe and led to the open structure of MB and the 
fluorescence intensity of MB increased dramatically, giving an output signal of 1 
(Figure 3 curve c). Finally, the two inputs with the concentrations of 200 nM and 6.40 
μM of Hg2+ and I- were introduced together into the system. As designed, the 
fluorescence output signal was 0 (Figure3, curve d). The whole digital behavior could 
be finished within 7 min.  The INHIBIT gate process was performed in the aqueous 
solution, showing convenience of the logic gate.  
Figure 3. Fluorescence emission spectra of the MB logic gate to different inputs: a) I- 
(0 μM) + Hg2+ (0 nM); b) I- (6.40 μM) + Hg2+ (0 nM); c) I- (0 μM) + Hg2+ (200 nM); d) 
I- (6.40 μM) + Hg2+ (200 nM). 
The operation reversibility of this logic gate was investigated by alternating 
the addition of Hg2+ and I-. As shown in Figure 4, the on/off switching behavior of the 
logic gate was reversible although after a cyclic treatment the fluorescence intensity 
was slightly decreased at the “on” state and increased at the “off” state. The slight 
decreases at the “on” state might result from the dilution because the total volume 
increased by alternating addition of Hg2+ and I-. And the slight increases at the “off” 
state might be due to the presence of extra Hg2+ in the complex. Overall, the results 
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indicated that the operation of the logic gate was reversible, providing its application 
potential. 
Figure 4. Reversible fluorescence signal changes of the MB logic gate with cyclic 
treatment of Hg2+ (200 nM) and I- (0.40 μM). 
3.2. Optimization of the Logic Gate Conditions. 
In order to obtain optimal results, some reaction conditions that would affect 
the MB hybridization and fluorescence intensity were investigated. 
3.2.1. Concentration of the assistant MB probe. 
The function of the assistant MB probe was to hybridize MB. The 
concentration of this probe would significantly affect the function of the logic gate. As 
a result, the optimal concentration of the assistant probe was investigated. A 1.0 μL 
aliquot of 1.0 μM MB and 0.3 μL, 100.0 μM Hg2+ were mixed in a 100.0 μL reaction 
buffer. Afterwards, various concentrations of assistant probe from 100 nM to 350 nM 
were added into the solution. The fluorescence intensity of the solutions with and 
without Hg2+ was detected under different assistant probe concentrations.  
As shown in Figure 5A, at a high concentration of the assistant probe, the MB 
was easily opened without Hg2+, resulting in a high background signal (column 1). 
However, at a low concentration of the assistant probe, it was difficult to open the MB 
even in the presence of Hg2+ (column 2), resulting in a decreased fluorescence signal 
for the detection of Hg2+. Both situations would decrease the detection sensitivity. The 
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effect of the assistant probe concentration on the fluorescence enhancement of the MB 
logic gate was further calculated as shown in Figure 5 B.  The optimal concentration 
of the DNA assistant probe was 200 nM that gave the highest signal-to-noise ratio. In 
the following experiments, a concentration of 200 nM assistant probe was chosen as 
the optimal concentration. 
Figure 5. (A) Fluorescence intensity of the logic gate at different concentrations of 
assistant probe. 1: without Hg2+; 2: 300 nM Hg2+. (B) The fluorescence intensity ratio 
of the logic gate with 300 nM Hg2+ to that without 300 nM Hg2+ changed with the 
concentration of the assistant probe. MB: 10 nM; temperature: 32℃; 𝜆ex= 480 nm, 𝜆em= 
518 nm. (C) Fluorescence intensity of the sensor at different temperatures. F: 
fluorescence intensity of the sensor in the presence of the 300 nM Hg2+; F0: fluorescence 
intensity of the sensor in the absence of the Hg2+. MB: 10 nM; assistant probe: 200 nM. 
𝜆ex = 480 nm, 𝜆em = 518 nm. 
3.2.2. Temperature effect. 
Temperature of the reaction solution affected the hybridization of the MB with 
the assistant probe, and further impacted the fluorescence intensity of the MB logic gate. 
Over a certain range, the higher the temperature, the easier the double-stranded DNA 
dehybridization. Therefore, the effect of temperature on the fluorescence enhancement 
of the logic gate was investigated. Based on the DNA hybridization reaction 
temperature range, we choose 22 – 36℃ for investigation of the temperature effect on 
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the signal-to-noise ratio. For different temperatures, the fluorescence intensity of the 
system with and without Hg2+ was measured as shown in Figure 5B. The signal-to-
noise ratio increased with the increase of temperature in the range of 22 - 32℃, and 
then decreased after 32℃. Therefore, 32 ℃ was chosen as the optimal temperature for 
the assay. 
3.3. Hg2+ Detection. 
3.3.1. Sensitivity study. 
To test the sensitivity of the designed  MB based logic gate for the Hg2+ 
detection, the MB logic gate system was mixed with various concentrations of Hg2+ and 
the fluorescence intensities of the system were detected under the optimal conditions. 
As shown in Figure 6A, upon increasing the Hg2+ concentration, the peak value of the 
fluorescence spectra increased, indicating a more efficient hybridization process 
between the assistant probe and MB and leading to the opening of MB and the 
restoration of the fluorescence intensity. The fluorescence enhancement of the MB logic 
gate system was sensitive to Hg2+ in a concentration-dependent manner (Figure 6B).  
The linear relationship between the fluorescence intensity and the Hg2+ concentration 
was in the range of 10 - 200 nM (R2 = 0.9834). The limit of detection (LOD) was 7.9 
nM based on 3 times of signal-to-noise ratio.  The result was lower than US EPA 
defined toxicity level of Hg2+ in drinking water (10 nM). 
3.3.2. Selectivity study. 
To validate the selectivity of this assay for Hg2+ detection, competing metal 
ions, including Ni2+, Zn2+, Cu2+, Mn2+, Co2+, and Fe2+, were tested under the same 
condition  with a concentration of  5 times higher than that of Hg2+. As shown in 
Figure 7, the fluorescence intensity of the MB logic gate system showed little changes 
in the presence of the majority of the interference metal ions. The Mn2+ gave a higher 
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signal than other ions. However, it was only 14.2 % of the fluorescence intensity of 
Hg2+ ions. The results showed the excellent selectivity for the Hg2+ detection over other 
metal ions. 
Figure 6. (A) Fluorescence response of the MB logic gate to Hg2+. The fluorescence 
emission spectra are shown for different Hg2+ concentrations from 0, 10, 50, 100, 200, 
500 to 1000 nM. (B) Changes of the fluorescence intensity at 518 nm of the MB based 
logic gate with different concentrations of Hg2+. The inset is the calibration curve of the 
MB based logic gate to the detection of Hg2+. 
Figure 7. Interference test of different metal ions for the logica gate. Concentration of 
Hg2+: 200 nM; concentration of other metal ions: 1000 nM. 
 
 14 
 
3.4. Iodide Ion Detection. 
 
3.4.1. Sensitivity study. 
As discussed previously, I- as a second input will turn off the logic gate. The 
change of the fluorescence intensity will be related to the amount of I-. To investigate 
the sensitivity for I- detection, different concentrations of I- were added into the 200 nM 
Hg2+, 10 nM MB system to monitoring the fluorescence intensity. As shown in Figure 
8A, with the increase of I- concentration, a gradual decrease of the fluorescence was 
observed. This demonstrated the competition between I- and thymine for Hg2+. Figure 
8B showed that the fluorescence decrease was dependent on the concentration of I-. 
Linear relationship (R2 = 0.9983) between the fluorescence decrease and the I- 
concentration was obtained when the concentration of I- varied from 0 to 0.40 μM (inset 
of Figure 8B). The LOD for I- was calculated to be 42 nM that was lower than the 
reported colorimetric method of 6 μM37 and the graphene oxide based fluorescence 
method of 100 nM.16 In addition, the process for the detection of I- using Hg2+/MB 
system was faster than the reported methods. Compared to the graphene oxide based 
fluorescence method for the iodide detection, this reaction time was 6 times shorter 
(Figure 2).16 
3.3.2. Selectivity study. 
The selectivity of this assay for the detection of I- was investigated by testing 
some common competing anions, including Cl-, Br-, F-, SO4
2-, ClO3
-, HCO3
-, HPO4
- , 
NO3
- and IO3
-, at a concentration of 6.40 μM under the same condition. The results 
showed that only I- decreased the fluorescence intensity dramatically (Figure 9), 
showing a 71.7% decrease of the original value. While, other anions showed 
insignificantly changes on the fluorescence signals of the Hg2+/MB system. Among 
them, the largest decrease was from Br-, showing an 8.6% decrease on the fluorescence 
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intensity. This was 8.3 times lower than that with I-. The student t test (p < 0.01) showed 
that there was significant difference between the addition of I- and Br-. Overall, the 
sensitivity and selectivity investigation for the I- detection demonstrated that this 
Hg2+/MB system was suitable for the detection of I- against other competing anions. 
Figure 8. (A) Fluorescence response of the MB logic gate to I- ions. The fluorescence 
emission spectra are shown for different I- concentrations from 0, 0.05, 0.10, 0.20, 0.40, 
0.80, 1.60, 3.20, 6.40 to 12.80 μM. (B) Changes of the fluorescence intensity at 518 nm 
of the MB based logic gate with different concentrations of I-. The inset is the 
calibration curve of the MB based logic gate for the detection of I-. 
Figure 9. Interference study of different anions to the MB-based logic gate. The 
concentration of all the ions: 6.40 μM. 
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3.5. Real Sample Detection. 
Table 1. Detection of Hg2+ and I- in tap water samples (n=3). 
Target Added  Found  Recovery 
Hg2+ 100 nM 108 ± 15 nM 108% 
150 nM 145 ± 16 nM 97% 
I- 0.10 µM 0.10 ± 0.03 µM 100% 
0.30 µM 0.31 ± 0.06 µM 103% 
To demonstrate the real application of the developed sensing system, we 
detected tap water using the logic gate. Different amounts of Hg2+ and I- were spiked 
into the tap water samples. All samples were first filtered with a 0.2 µm membrane. 
Afterwards, the concentration of Hg2+ and I- in the samples were analyzed. The results 
are shown in Table 1. The recoveries ranged from 97% to 108%. This result indicated 
that the present logic gate would be applicable for the detection of Hg2+ and I-. 
 
4. Conclusions 
   In conclusion, a simple, rapid and sensitive logic gate based on a MB was 
developed for sensing Hg2+ and I-. The fluorescence of MB logic gate increased with 
the assistant of Hg2+ in a concentration-dependent manner. With this assay, the LOD of 
Hg2+ was achieved as low as 7.9 nM. Furthermore, the fluorescence intensity of the 
Hg2+/MB system decreased with the addition of I- because of a stronger binding force 
between the Hg2+ and I-. The LOD of I- was calculated to be 42 nM which was lower 
than other reports. Based on the fluorescence change of the MB logic gate system with 
the addition of Hg2+ or/and I-, a DNA INHIBIT logic gate was constructed. To the best 
of our knowledge, this was the first molecular MB based logic gate to detect Hg2+ and 
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I-, which expanded the applications of the MB in the fabrication of the chemical 
Boolean logic gates. 
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CHAPTER II 
ULTRASENSITIVE DETECTION OF 3 -´5  ´EXONUCLEASE ENZYMATIC 
ACTIVITY USING MOLECULAR BEACONS  
1. Introduction 
DNA exonucleases are enzymes that digest DNA sequences from 3 -´
termini or 5 -´termini. Within the exonuclease family, the enzymatic activity of 
3'- 5' exonuclease plays a key role for several important cellular and 
physiological processes, such as promoting genetic recombination reactions,38 
keeping fidelity of DNA replication39 and repairing DNA double-strand breaks.40 
Both overexpression and lack of 3'- 5' exonuclease enzymatic activity will cause 
serious diseases and lead to more susceptible to cancers and other diseases under 
stress conditions.41, 42 For example, a major 3'- 5' exonuclease named TREX1 
could inhibit the innate immune response to HIV.43, 44 Therefore, the detection of 
the 3'- 5' exonuclease activity could be used for the diagnoses and therapies for 
several diseases. 
Traditional approaches for the detection of 3’-5’ exonuclease activity 
are based on radioisotope labeled DNA,45 which are cost-prohibitive, time-
consuming, and could cause safety concerns.46 Therefore, it is urgent and useful 
to develop an efficient, sensitive and easily-operated method for evaluating the 
3'- 5' exonuclease activity. Recently, fluorescence-based methods have been 
developed for the detection of different enzymes, 
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such as polymerases, ligases, and endocleases.47-50 However, only a few studies 
were published for the detection of 3'- 5' exonuclease activity with the 
fluorescence-based assay.51, 52 For example, Leung et al. developed a label free 
fluorescence assay for the detection of 3'- 5' exonuclease activity based on the G-
quadruplex-binding probe.53 This assay showed great advantages over the 
traditional methods. However, its limit of detection was 5 U/mL only. Recently, 
Su et al. used the single-labelled DNA probe to detect the activity of Exo III with 
the limit of detection of 0.04 U/mL. However, a phosphorothioated base in the 
3’ terminal should be modified in order to achieve the selectivity to the Exo III, 
which increased the cost and complexity of the detection system.54 To overcome 
these limitations of these methods, we developed a fast, sensitive and cost-
effective method to detect the activity of 3'- 5' exonuclease based on the 
traditional molecular beacon (MB).  
A MB is a single-stranded DNA sequence that can form a hairpin 
structure modified with a fluorophore and a quencher on the 5' - and 3'-ends, 
respectively. MBs have been developed rapidly for biosensor applications in the 
last few decades.55, 56 Because of the low background fluorescence signal and 
excellent selectivity of MBs, a high signal-to-background ratio can be achieved 
using MBs for detection of DNA, mRNA, proteins, metal ions, and small 
molecules.10, 27, 57-61 Moreover, MBs have been used for the detection of 
enzymatic activities, such as the activity of the endonuclease,47 polymerase,48 
ligase49 and other enzymes which can change the nucleic acid conformation.62 
However, so far, the traditional MBs have not been applied for the detection of 
exonuclease activities. Therefore, an ultrasensitive and ultra-rapid fluorescence 
assay for the detection of 3'- 5' exonuclease activity based on MBs was developed 
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in this work. Exo III was used as a model that contains the activities of 3'- 5' 
exonucleases to illustrate the proof-of-concept of our method. Surely, Exo III 
does not exist in human body. However, other enzymes containing the 3'- 5' 
exonucleases activities in human are expected to be detected by this method 
because they contain the same enzymatic activity. The dual-MB system 
developed in this work can detect the 3'- 5' exonucleases activities with limit of 
detection of 0.01 U/mL in buffer and 0.04 U/mL in 10 times serum sample. This 
implied that the dual-MB system has the potential for evaluating the 3'- 5' 
exonucleases activities in order to investigate the disease generating process, 
diagnosis and therapy strategies. 
2. Experimental Section 
2.1. Chemicals and Materials 
DNA sequences used in this work were purchased form Fisher Scientific. The 
sequences for molecular beacons (MBs) were: 5'-
FAMCCACCAGTTTTTTAGCTGAGGGTGG-BHQ1-3' (FAM-MB) and 5'-Cy5-
CCTCGAGTTTTTTAGCTGATCGAGGTTGTG-BHQ2-3' (Cy5-MB), respectively. 
All the exonuclease enzymes (Exo III, Exo I, T7 Exo, T5 Exo, Exo T and RecJf) and 
10X NEBuffer 4 (20 mM Tris-acetate, 50 mM potassium acetate, 10 mM Magnesium 
Acetate and 1 mM Dithiothreitol pH 7.9 @ 25 °C) were purchased from New England 
Biolabs, Inc. The deionized water (18.3 MΩ •cm) was produced from the Millipore 
water purification system. 
2.2. Apparatus 
Fluorescence experiments were all performed using a Fluorolog-3 
Spectrofluorometer with a 450 W xenon lamp (Jonin Yvon-Spex, Instruments S.A., 
Edison, NJ). For the FAM fluorescence detection, the excitation wavelength was 480 
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nm with an emission range of 500-600 nm. The fluorescence intensity at 518 nm was 
used to evaluate the performance of the proposed assay. For the detection of Cy5, the 
excitation was 645 nm with an emission range of 655-750 nm. The fluorescence 
intensity at 660 nm was used to evaluate the performance of the proposed assay. Both 
the excitation and emission slit widths were set to 5.0 nm. All the experiments were 
carried out at 37 °C for 200 s. 
2.3. Exo III Detection Based on FAM-MB 
A 10 nM FAM-MB sample was incubated in 50 µL 1X NEBuffer 4 at 37 °C. 
A 0.20 U Exo III aliquot was then added into the solution to incubate for 200s. Finally, 
the fluorescence of the solution was detected. In contrast, no Exo III was added to the 
control solution and the fluorescence intensity was monitored for 200 s. 
To investigate the sensitivity of the assay for Exo III, FAM-MB (10 nM) was 
mixed with different concentrations of Exo III varying from 0.04 U/mL to 4.00 U/mL. 
The fluorescence intensity of FAM at 518 nm was recorded after 200s. The calibration 
curve was obtained by plotting the relative fluorescence intensity vs the concentrations 
of the Exo III. The selectivity of the assay for the detection of Exo III was investigated 
by incubating FAM-MB (10 nM) with different exonucleases including T7 Exo, Exo I 
and RecJf at the concentration of 4.00 U/mL. The fluorescence intensity was also 
measured at 200 s for each exonulease. 
The effects of pH on the enzymatic activity of Exo III were investigated by 
incubating 10 nM FAM-MB in 50 µL 1X NEBuffer 4 at 37 °C, with the addition of  
0.20 U Exo for 200 s. The pH varied from 5.5 to 9.5. For the investigation of effect of 
divalent ions, 10 nM FAM-MB was incubated in 50 µL 1X NEBuffer 4 at 37 °C with 
addition of 0.3 mM Cu2+, Ca2+ and Mn2+, respectively. Then, 0.20 U Exo III was added 
into each solution to incubate for 200 s. 
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2.4. Distinguishing Exonucleases Based on Dual-MB System 
FAM-MB (10 nM) and Cy5-MB (10 nM) were incubated in 50 µL 1X 
NEBuffer 4 at 37 °C. 0.20 U Exo III, T5 Exo and RecJf were then added to the solution 
to incubate for 200 s. Finally, the fluorescence of FAM and Cy5 were detected. 
Properties and expected responses of the exonucleases in dual-MB system are 
summarized in Table 1. 
3. Results and Discussion 
3.1. Detection of Exo III with MB 
As shown in Figure. 10A, a 6-carboxyfluorescein (FAM) modified MB (FAM-
MB) with blunt 3'-termini was used as the probe. Because of the hairpin structure of the 
MB, FAM was close to the quencher (Black Hole Quencher-1, BHQ1) modified on the 
3'-termini. The fluorescence of the FAM was quenched by BHQ1 through effective 
Förster resonance energy transfer (FRET). However, in the presence of Exo III, whose 
substrate is blunt or recessed 3'-termini, the FAM-MB would be digested by Exo III 
from the 3'-termini. Because the quencher was modified on the last mononucleotide of 
the 3'-termini, with the removal of the last mononucleotide, the quencher was also 
removed from the MB by Exo III. As a result, the fluorescence of the FAM was restored. 
As shown in Figure. 1B, the fluorescence intensity of FAM-MB solution increased by 
about 18 times after the reaction with 4.00 U/mL Exo III for 200 seconds (Figure. 10B, 
curve a) compared to the control that has no Exo III (Figure. 10B, curve c), 
demonstrating that the designed FAM-MB could be an ultrasensitive fluorescence 
probe to detect 3'- 5’ exonuclease activity of Exo III. In order to further confirm that 
the fluorescence increase is due to the addition of active Exo III, a heat-inactivated Exo 
III was used as the second control. The Exo III was heated at 80 °C for 30 min to be 
inactivated before incubation with the FAM-MB. The result showed that the 
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fluorescence intensity of FAM-MB was significantly diminished (Figure. 10B, curve 
b). 
In the investigation of sensitivity of the assay, a 10 nM FAM-MB solution was 
incubated with various concentrations of Exo III (0-8.00 U/mL) at 37 °C in 50 µL 1X 
NEBuffer 4. The FAM’s fluorescence intensity increased as the concentration of Exo 
III increased (Figure. 11A). The signal-to-background ratio reached 27 when the 
concentration of Exo III was 8.00 U/mL. The total detection time is less than 200 s 
because the fluorescence intensity reached a plateau at 200 s after the addition of Exo 
III. In the following experiments, the incubation time of 200 s was chosen. 
 
Figure 10. (A) The working principle of the detection of Exo III enzymatic activity 
based on FAM-MB. (B) Fluorescence emission spectra of 10 nM FAM-MB in 50 μL 
1X NEBuffer 4. (a) 4.00 U/mL Exo III; (b) 4.00 U/mL heat-inactivated Exo III; (c) no 
Exo III.  λex= 480 nm. 
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Figure 11. The detection of Exo III based on FAM-MB. (A) Time-dependent 
fluorescence responses in the presence of different concentrations of Exo III. From 
bottom to top: 0, 0.04, 0.10, 0.20, 0.40, 1.00, 2.00, 4.00, 8.00 U/mL of Exo III in 1× 
NEBuffer 4. (B) The plot of the fluorescence enhancement of different concentrations 
of Exo III. Reactions were performed in 50 µL of 1× NEBuffer 4 with 10 nM FAM-
MB at 37 °C for 200 s. Inset: the two calibration curves in different concentration ranges. 
(C) Selectivity of the assay for Exo III over other exonucleases. Fluorescence 
enhancement of the FAM-MB system responded to 4.00 U/mL exonucleases. 
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The fluorescence enhancement of the FAM-MB system was proportional to 
the concentration of Exo III. The dynamic range was from 0.04 U/mL to 8.00 U/mL. 
There were two linear ranges for the calibration curve. The first one was in the low 
concentration range (0.04 U/mL-0.40 U/mL); the calibration curve in the first linear 
range is showed in the top inset of Figure 11B. The regression equation was Y = 
18.029X +1.6564 with a correlation coefficient of 0.9766. The second linear range was 
from 0.40 U/mL to 8.00 U/mL whose calibration curve was showed in the bottom inset 
of Figure. 11B. The regression equation was Y = 2.5011X +7.5561 with a correlation 
coefficient of 0.9989. Y and X represented the relative fluorescence and the 
concentration of Exo III in the unit of U/mL, respectively. The limit of detection (LOD) 
was 0.01 U/mL based on three times of the signal-to-noise level. This was 500 times 
lower than that of the G-quadruplex-binding label-free fluorescence method.16  
Next, we investigated whether this FAM-MB assay could selectively detect 
Exo III from other types of exonucleases. According to the property of Exo III, any 
exonucleases containing a duplex DNA substrate may interfere with the detection of 
Exo III. T7 exonuclease is such an exonuclease, which acts on duplex DNA in the 5'- 
3' direction. In addition, Exo I and RecJf belong to the similar exonuclease family with 
Exo III. Exo I can catalyze the removal of nucleotides from single-stranded DNA in the 
3'- 5' direction, and RecJf can catalyze the removal of deoxynucleotide monophosphates 
from single-stranded DNA in the 5'- 3' direction. Therefore, these three exonucleases 
were chosen to investigate the assay selectivity. Encouragingly, the T7 exonuclease did 
not induce dramatic fluorescence enhancement with the same concentration of the Exo 
III (Figure. 11C). This result may have benefited from the rapid detection of the 
fluorescence within 200 s of reaction time. Similarly, the fluorescence enhancement 
from Exo I and RedJf were limited as well (Figure. 11C). 
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3.2. The Stability and Effect of Ions 
The stability of the probe was also investigated. Generally, the pH not only would 
affect the hybridization of the MB, but could also affect the activity of the exonuclease. 
Thus, the pH value should play a crucial role in the stability of the MB probe. We chose 
five buffer solutions with different pH values in the range of 5.5 to 9.5 to test the 
fluorescence intensity of the MB probe. The results are shown in Figure. 12A. The 
highest signal-to-background ratio was gained when the pH was 7.5. Both the acid and 
alkali conditions led to the decrease of the signal-to-background ratio. Apparently, the 
pH value significantly affects the stability of the MB probe. 
Figure 12. The stability investigation of the MB system for the detection of Exo III. (A) 
The effect of pH on the reaction rate of the MB system to Exo III. (B) The effect of 
divalent ions on the Exo III activity of the MB system to Exo III. 
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Furthermore, we investigated the effects of metal ions on the activity of 
exonucleases. It was reported that some divalent ions would inhibit the activity of the 
exonucleases to cleave DNA phosphodiester bonds.63 Thus, the effects of three common 
divalent ions, including Cu2+, Ca2+ and Mn2+, on the activity of the Exo III were 
investigated. These cations might be present in complex samples including serum or 
cells. As shown in Figure. 12B, the addition of any of these ions would dramatically 
affect the activity of Exo III compared to the control. Under the same concentration, 
the Cu2+ reduced the MB probe signal over 95 %. Therefore, the designed MB probe 
has fairly good selectivity to the Exo III over both other types of exonucleases and metal 
ions. 
Figure 13. The fluorescence intensity responded to 10 nM FAM-MB (a), added with 
4.00 U/mL T5 exoclease (b) or 4.00 U/mL Exo III (c). 
3.3. Design of Dual-MB System 
However, even though the T7 exonuclease did not affect the detection of 
Exo III, other similar exonucleases may give a false signal if they could react fast with 
the MBs. We found that the T5 exonuclease, an exonucleas that has 5'- 3' exonuclease 
activity, degraded DNA in the 5'- 3' direction in both single-stranded and double-
stranded DNAs. When the T5 exonuclease was incubated with the FAM-MB system 
for 200 s, the fluorescence of the FAM increased as the addition of Exo III (Figure 13). 
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In order to overcome this interference, a dual-MB system was developed, containing 
not only FAM-MB, but also a Cy5-MB with a 3 e´xtention terminus.  
As shown in Figure 14A, in the dual-MB system, the Exo III could only catalyze 
the digestion of the duplex DNA with blunt or recession 3'-termini to induce the 
fluorescence enhancement of the FAM, but not the Cy5. In contrast, the T5 exonuclease 
could catalyze both single-stranded DNA and double-stranded DNA from 5'-termini; 
as a result, it would induce the fluorescence enhancement of both FAM and Cy5. RecJf 
exonuclease, which can only catalyze the removal of deoxynucleotide monophosphates 
from a single-stranded DNA in the 5'- 3' direction, would not induce any fluorescence 
enhancement. The properties of the three exonucleases and anticipating fluorescence 
responses were summarized in the Table 2. 
Figure 14. (A) Schematic illustration of the dual-MB system for distinguishing different 
exonucleases. (B) Fluorescence enhancement patterns of the dual-MB system with 4.00 
U/mL Exo III, T5 exonuclease and RecJf. The dual-MBs system 20 contained 10 nM 
FAM-MB and 10 nM Cy5-MB in 50 GL of 1× NEBuffer 4, incubated at 37 °C for 200 
s to detect the fluorescence intensity. λex (FAM)=480 nm, λem (FAM)= 518 nm. λex 
(Cy5)= 645 nm, λem (Cy5)= 660 nm. 
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Table 2. The properties of different exonucleases. “+” indicates fluorescence 
enhancement; “-” indicates constant fluorescence. 
Exonuclease Substrate Direction FAM-MB Cy5-MB 
Exo III dsDNA 3'- 5' + - 
T5 Exo dsDNA,ssDNA 5'- 3' + - 
RecJf ssDNA 5'- 3' - - 
Using this dual-MB system, three exonucleases at the concentration of 4.00 
U/mL were detected (Figure 14B). As the negative control, the RecJf exonuclease 
showed no fluorescence enhancement of FAM and Cy5, which meant that both FAM-
MB and Cy5-MB were not digested by the RecJf exonuclease. When Exo III was added 
into the solution, the fluorescence of FAM increased by 16.6 times, while the 
fluorescence of the Cy5 did not change because this 3' extention Cy5-MB was not the 
substrate of Exo III. However, when T5 exonuclease was added into the solution, the 
fluorescence intensity of FAM increased by 12.8 times and the fluorescence intensity 
of Cy5 increased by 6.3 times. If the fluorescence enhancement for each dye was 
defined as 1, and no fluorescence enhancement defined as 0, the responses of the dual-
MB system in the manner of (FAM, Cy5) for Exo III, T5 exonuclese, and RecJf were 
(1, 0), (1, 1) and (0, 0), respectively. From these different response patterns, Exo III, T5 
exonuclease, and RecJf could be distinguished from each other. 
3.4. Complex Samples Investigation 
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Figure 15. The fluorescence enhancements of FAM-MB in different solutions. The 
concentrations of Exo III were 4.00 U/mL. 
To test the feasibility of the designed MB probe for the detection of Exo 
III we applied the probe to complex samples, including cell culture medium and 
fetal bovine serum. As shown in Figure 15, with the same concentration of Exo 
III, the fluorescence enhancements of FAM in the 10 times diluted RPMI 1640 
medium and fetal bovine serum were lower than that of the ideal buffer solution. 
The lower fluorescence enhancements of FAM in the complex samples compared 
with the ideal buffer might be due to the high background signal of these two 
matrixes when they were excited at 488 nm irradiation. In order to show how 
much the other exonucleases would interfere the detection of Exo III, T5 
exonuclease and RecJf were added into the dual-MB systemin the complex 
sample. As shown in Figure 16A, T5 exonuclease induced the fluorescence 
enhancement of both FAM and Cy5 in the serum sample. In contrast, RecJf 
exonuclease did not cause any fluorescence enhancement for these two dyes. The 
fluorescence intensity of FAM increased with the addition of Exo III. In contrast, 
the fluorescence intensity of Cy5 kept constant (Figure 16A), which was 
consistent with the results in the buffer solution. Therefore, this dual-MB system 
could eliminate the interference of other exonuclease for the detection of the 3'- 
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5' exonuclease enzymatic activity in complex sample by the different 
fluorescence enhancement combinations.   
Because the fluorescence enhancements in these two complex samples were 
not consistent with that in the ideal buffer, a new calibration curve had to be prepared 
for the detection of the Exo III in the complex samples. The fetal bovine serum was 
chosen as the example of the complex sample for the preparation of the calibration 
curve. As shown in Figure. 16B, the complex time fluorescence enhancements of FAM 
in the dual-MB system with addition of different concentrations of Exo III were 
monitored in 10 times diluted fetal bovine serum. Figure. 16C demonstrated the 
calibration curve of the dual-MB system for the detection of Exo III in the 10 times 
diluted fetal bovine serum. A similar curve at the concentration from 0 to 8.00 U/mL 
was exhibited as that in the ideal buffer except the corresponding relative fluorescence 
intensity was lower than those in the ideal buffer. Two linear ranges from 0 to 0.40 
U/mL and 0.40 to 8.00 U/mL were observed in the complex sample, respectively. In 
order to further investigate the feasibility of this method for the detection of 
Exonuclease III activity in complex biological sample, fresh mice serum was used as 
another complex sample. As shown in Figure 17, the detection range was from 0 to 8 
U/mL with similar two different linear ranges, including 0 to 0.4 and 0.4 to 8 U/mL. 
The limit of detection in this sample was 0.03 U/mL according based on three times of 
the signal-to-noise level. This is 3 times higher than that in ideal buffer, which might 
be caused by the complexity of the mice serum. However, all the results indicated that 
this dual-MB system might be used in complicated samples for the real-time detection 
of the enzymatic activity of Exo III.  
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As shown in Figure 11B and Figure 16C, the Exo III calibration curves in buffer 
and 10 times-diluted fetal bovine serum demonstrated an initially high slope up to Exo 
III concentration of 0.4 U/mL followed by a decrease in slope. This might be due to the 
fixed substrate’s concentration. Theoretically, the calibration curve should  
Figure 16. (A) The fluorescence enhancements of FAM-MB and Cy5-MB in 10 times 
diluted fetal bovine serum with the addition of 4 U/mL Exo III, T5 Exo and RecJf Exo. 
(B) Time-dependent fluorescence responses in the presence of different concentrations 
of Exo III. From bottom to top: 0, 0.04, 0.20, 0.40, 2.00, 4.00, 8.00 U/mL of Exo III in 
10 times diluted fetal bovine serum. (C) The plot of the fluorescence enhancement of 
different concentrations of Exo III. Reactions were performed in 50 µL of 10 times 
diluted fetal bovine serum with 10 nM FAM-MB and 10 nm Cy5-MB at 37 °C for 200 
s. Inset: the two calibration curves in different concentration ranges. 
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Figure 17. (A) Time-dependent fluorescence responses in the presence of different 
concentrations of Exo III. From bottom to top: 0, 0.08, 0.20, 0.40, 0.80, 2.00, 4.00, 8.00 
U/mL of Exo III in 10 times diluted fresh mice serum. (C) The plot of the fluorescence 
enhancement of different concentrations of Exo III. Reactions were performed in 50 µL 
of 10 times diluted fresh mice serum with 10 nM FAM-MB and 10 nm Cy5-MB at 
37 °C for 200 s. Inset: the two calibration curves in different concentration ranges. 
be off from the linear range when the concentration is higher than the saturated 
concentration. The reason for the second linear range might be from the excess residue 
intact the MB, which could be slowly digested by higher concentration of Exo III 
beyond the theoretical linear concentration limit. In this case, Exo III with a 
concentration of 0.40 U/mL was enough to digest most of the FAM-MB in the system. 
This triggered a larger slope of the calibration curve in the low concentration range. 
However, when the concentration of Exo III was higher than the turning point of 0.40 
U/mL, even most of the FAM-MB was digested by the Exo III, the excess Exo III would 
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no longer have enough substrate to digest. As a result, the slope of the calibration cure 
in the higher concentration range decreased.  
4. Conclusions 
In conclusion, an ultrasensitive, rapid and simple fluorescence method has 
been developed for the detection of Exo III. The dynamic range of the assay was 0.04 
U/mL to 8.00 U/mL with the detection limit of 0.01 U/mL. The total incubation time 
for the assay was 200 s which was about 10 times faster than the label-free fluorescence 
method. The assay showed good selectivity over T7 exonuclease, Exo I and RecJf 
exonuclease. Even the T5 exonuclease would interfere the detection of Exo III, the dual-
MB system was successful for eliminating the interference of other exonucleases. 
Finally, the designed dual-MB probe was applied to the monitoring of the enzymatic 
activity of Exo III in complex samples. The results suggested a great potential of the 
dual-MB probe for the detection of Exo III levels in complex samples. The proposed 
fluorescence assay is expected to be used for disease diagnosis and therapy related to 
the overexpression or loss of 3 -´5 e´xonucleases and to expand the application of MBs 
in the enzymatic analysis. 
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CHAPTER III 
LABEL-FREE FLUORESCENCE ASSAY COUPLED EXONUCLEASE 
REACTION AND SYBR GREEN I FOR THE DETECTION OF T4 
POLYNUCLEOTIDE KINASE ACTIVITY 
1. Introduction 
Phosphorylation, a transferring of γ -phosphate residues of adenosine 
triphosphate (ATP) to 5  ´-hydroxyl terminus of polynucleotides, plays an important role 
in DNA replication, DNA repair and recombination64, 65. In these normal cellular 
processes, several factors, such as chemical substances, ionizing radiation66 and 
nucleases67, would cause nucleic acid lesions that contain 5’-hydroxyl termini. This 5’-
hydroxyl termini may lead to failure of 5’-phosphate terminal dependent repair 
processes for nucleic acids, resulting in severe gene damage and diseases68, 69. 
Therefore, it is highly desirable to monitor the polynucleotide kinase activity and 
inhibition for further understanding phosphorylation and related biological processes. 
Normally, methods used to study the phosphorylation of nucleic acids 
included radical isotope 32P-labeling, polyacrylamide gel electrophoresis (PAGE) and 
autoradiography69-71. However, these methods have safety concerns (radio labelling), 
and are time-consuming and complex. Recently, several electrochemical and 
fluorescence sensors for monitoring kinase activities were developed72-76. The 
replacement of radio labelling using fluorescence labelling in these assays eliminated 
safety concerns; however, labelling fluorophores to nucleic acids increased the cost of 
the assay. For example, Tang et al. reported a fluorescence 
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assay for monitoring phosphorylation process using a dual-label molecular beacon77, 
and Song et al. developed a real-time method for the kinase activity detection using a 
singly labelled molecular beacon75. By using graphene oxide as a quencher platform, 
Lin et al. developed a novel method for the kinase activity and inhibition monitoring 
with a FAM modified dsDNA76. These methods provided high sensitivity for detections 
in spite of labelling requirements. The development of labelling-free methods for the 
detection of phosphorylation kinase activities and inhibition is still a challenge. 
Integrated DNA dyes, such as SYBR Green I (SG), are very powerful tools 
for fabricating DNA sensors based on their different affinities to the ssDNA and 
dsDNA78, 79. They have been wildly used for the detection of DNAs80, metal ions81-83, 
proteins and small molecules84 with high sensitivity and low cost. Therefore, SG could 
provide a low-cost alternative for label-free detection of phosphorylation kinase 
activities and inhibition. λ exonuclease (λ exo) is an enzyme that catalyzes efficiently 
cleavage of dsDNA from 5’-phosphate termini to generate ssDNA and 
mononucleotides. However, the cleavage efficiency of the λ exo is greatly reduced if 
the 5’-termini of dsDNA is hydroxyl. In this work, we developed a simple, label-free 
sensitive method for kinase activity and inhibition analysis based on the coupled λ exo 
cleavage reaction and the SYBR Green I. The label-free method developed in this work 
can detect phosphorylation kinase activities in the linear range of 0.25 to 1.00 U/mL 
with a limit of detection of 0.11 U/mL. 
2. Experimental 
2.1. Materials and Apparatus 
DNA sequences were purchased from Eurofins MWG Operon (Alabama, 
USA). The sequences for hair-pin probe were:  5’-TGC CTA CGA CCA ATT CCA 
CCT CAG CTA CCA GCA ACA GT-3’ and 5’- ACT GTT GCT GGT AGC T-3’. The 
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exonuclease enzymes (T4 polynucleotide kinase and λ exo) and 10X NEBuffer 4 (50 
mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate and 1 mM DTT, 
pH 7.9.) were purchased from New England Biolabs, Inc (NEB, U.K.). SYBR Green I 
was purchased from Fisher Scientific (Pennsylvania, USA). The deionized water (18.3 
MΩ•cm) was produced from the Millpore water purification system. Fluorescence 
experiments were performed using a Fluorolog-3 Spectrofluorometer with a 450 W 
xenon lamp (Jonin Yvon-Spex, Instruments S.A., Edison, NJ). 
2.2. T4 PNK Detection and Optimization 
In a typical phosphorylation and cleavage assay, 0.1 μL 10x SG, 20 nM 
dsDNA probe, 0.1 mM ATP, 0.25 units of λ exo, and a series of different concentrations 
of T4 PNK were added to 100 μL of 1x NEBuffer 4. After 30 min incubation at 37°C, 
the fluorescence spectra were recorded with the excitation wavelength of 490 nm and 
emission from 505 nm to 650 nm. The fluorescence intensity at 518 nm was used as the 
detection signal. The optimal values of phosphorylation time, concentrations of λ exo 
and ATP were investigated. 
2.3.  T4 PNK Inhibitor Evaluation 
To investigate effects of the T4 PNK inhibitors on the phosphorylation 
process, the reactions were performed at various concentrations of inhibitors, including 
(NH4)2SO4 (0-120 mM), and Na2HPO4 (0-90 mM). All mixtures contained 0.1 μL 10x 
SG, 20 nM dsDNA probe, 0.1 mM ATP, 0.25 units of λ exo, and 10 U/mL T4 PNK.  
3. Results and Discussion 
3.1. Scheme of the T4 PNK Activity Detection 
Based on the high affinity of SG to dsDNA and the unique property of λ exo, 
a label-free method was designed for the detection of T4 PNK activity. The proposed 
scheme for the PNK activity detection was illustrated in Figure 18. A double-stranded 
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DNA with one duplex 5’-hydroxyl termini was used as the label-free DNA probe. An 
integrating dye molecule, SG, was selected as the fluorescence signal source. The 
dsDNA coupled with SG would generate strong fluorescence intensity. With the 
addition of the T4 PNK, the 5’-hydroxyl termini of the dsDNA would be transferred to 
5’-phosphate termini in the presence of ATP (Figure 18, step A). In the following step, 
the dsDNA probe was digested by the λ exo from the duplex 5’-phosphate termini to 
generate mononucletides and ssDNA (Figure 18, step B). The binding force between 
the ssDNA and SG decreased dramatically, which led to a reduction of the fluorescence 
intensity. The extent of the fluorescence decrease was proportional to the concentration 
of T4 PNK. As a control, in the absence of T4 PNK, the λ exo digestion of the 5’-
hydroxyl termini dsDNA was limited due to the lack of preferred substrate. As a result, 
the fluorescence intensity of the SG would have little change. With this strategy, no 
fluorescence label was needed to perform the detection of T4 PNK activity.  
Figure 18. Schematic diagram of monitoring the T4 PNK activity by a label-free DNA 
probe coupled with SG and λ exo. 
The phosphorylation process of T4 PNK could be monitored by measuring 
fluorescence changes of the system using SG as the integrating dye. As shown in Figure 
19, when the dsDNA probe was treated with λ exo only, it exhibited high fluorescence 
intensity in the presence of SG (Figure 19 curve a). However, when the T4 PNK was 
added to phosphorylate the 5’-termini of the dsDNA probe followed by the digestion 
of the λ exo, much lower fluorescence intensity was observed (Figure 19, curve b). Up 
to 90% fluorescence emission disappeared upon the addition of the 20 U/mL T4 PNK. 
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The main reason was that the phosphorylated 5’-termini dsDNA was the preferred 
substrate of λ exo. It was reported that the reaction rate of the λ exo for dsDNA with 
5’-phosphoral was over 300 times faster than that with 5’-hydroxyl termini85. As a 
result, the dsDNA probe phosphorylated by the T4 PNK was digested much more 
rapidly than that without T4 PNK treatment by λ exo. The generated mononucleotides 
and ssDNA had low affinity to the SG, resulting in low fluorescence emission signal. 
The dsDNA probe without T4 PNK treatment remained the double-stranded structure 
which emitted high fluorescence signal with the interaction of the SG. The following 
experimental results showed that the fluorescence decrease was proportional to the 
activity and concentration of the T4 PNK, which demonstrated that this label-free 
system could be used for the detection of the T4 PNK activity.  
Figure 19. Fluorescence spectra of the dsDNA system without T4 PNK (a) and with 20 
U/mL T4 PNK (b). Reactions were performed in 100 µL of 1x NEBuffer 4 (pH = 7.9) 
with 20 nM dsDNA at 37°C for 30 min. The concentrations of ATP and λ exo were 0.1 
mM and 0.25 units, respectively. λex = 480 nm.  
3.2. Optimization of SG Concentration 
SG played a crucial role in this designed assay. Therefore, the optimal 
concentration to distinguish ssDNA and dsDNA had to be investigated to obtain the 
highest sensitivity of the assay. In the presence of ssDNA, a very limited fluorescence 
signal was appeared (Figure 20A, curve a). However, the fluorescence intensity of SG 
enhanced several times when a dsDNA was added to the solution (Figure 20 A, curve 
b). The dramatic difference between curve a and curve b was the basis for distinguishing 
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ssDNA and dsDNA. To obtain the optimum detection ability, the concentration of SG 
must be optimized since it would affect the signal-to-background ratio of the detection. 
As shown in Figure. 3B, with the increase of the concentration of SG, both the 
fluorescence intensities of dsDNA and ssDNA solutions increased. To obtain the 
highest difference between dsDNA and ssDNA, the fluorescence intensity of dsDNA-
to-ssDNA ratio was plotted against the SG concentration as shown in Figure 20C. The 
highest fluorescence dsDNA-to-ssDNA ratio was reached at the concentration of 20 
nM. Therefore, 20 nM SG was chosen as the optimal concentration for the following 
experiments.  
Figure 20. (A) Fluorescence spectra of 40 nM SG incubated with 20 nM ssDNA (Curve 
a) and dsDNA (Curve b). (B) Fluorescence intensity of dsDNA and ssDNA with the 
change of the concentration of SG. (C) The fluorescence intensity ratio of dsDNA to 
ssDNA with the change of the concentration of SG. Fluorescence intensity was 
measured in 100 µL of 1x NEBuffer 4 (pH = 7.9) with 20 nM ssDNA or dsDNA at 
37°C. λex = 480 nm. 
3.3. Optimization of the Detection Parameters  
500 525 550 575 600 625 650
0.0
200000.0
400000.0
600000.0
800000.0
20 nM ssDNA
20 nM dsDNA
Wavelength (nm)
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 (
C
P
S
)
10 20 40 80 12
0
0.0
200000.0
400000.0
600000.0
800000.0
1000000.0
1200000.0
1400000.0
ss DNA
ds DNA
Concentration of SG (nM)
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 (
C
P
S
)
0 20 40 60 80 100 120 140
0
2
4
6
8
10
12
14
16
Concentration of SG (nM)
F
d
s
D
N
A
/F
s
s
D
N
A
A B
C
 41 
 
In the phosphorylation process of DNA, there are several factors that will affect the 
catalysis efficiency. ATP is a co-factor for assisting in T4 PNK phosphorylation 
because it provides the phosphate group to be modified on the DNA strands. The 
concentration of ATP may affect the activity of the T4 PNK in the system. To gain 
better analytical performance, the effect of ATP concentration on the fluorescence 
intensity was studied as shown in Figure 21A. Because the fluorescence intensity of SG 
will decrease when the T4 PNK was present, we used the fluorescence intensity change 
as a measurement to evaluate the effect of ATP on the T4 PNK activity. 
Figure 21. (A) Optimization of ATP concentration. The concentrations of λ exo, 
dsDNA, and T4 PNK were 1 unit, 20 nM, and 20 U/mL, respectively. (B) Optimization 
of the reaction time. The concentrations of λ exo, dsDNA, ATP and T4 PNK were 0.25 
units, 20 nM, 0.1 mM and 20 U/mL, respectively. λex = 480 nm. (C) Optimization of 
the amount of λ exo.  (D) The relationship of signal-to-background ratio (S/B) with the 
amount of λ exo. The concentrations of dsDNA, ATP and T4 PNK were 20 nM, 0.1 
mM and 20 U/mL, respectively. 
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With the increase of the ATP concentration, the fluorescence intensity change 
reached the highest point as 93% fluorescence intensity disappeared when 100 µM ATP 
was introduced. As a result, 100 µM was chosen as the optimum concentration of ATP 
in the phosphorylation and cleavage processes. 
In this assay, λ exo was used as an enzyme to digest dsDNA after the 
phosphorylation by T4 PNK. The concentration of the λ exo should be a primary factor 
for affecting fluorescence intensity of the system. A higher concentration of λ exo 
would increase fluorescence background signal by digesting the dsDNA that without 
the phosphorylation by T4 PNK, which led to the lower signal-to-background ratio 
(S/B) ratio. In contrast, the lower amount of λ exo was not enough to digest the 
phospholated-dsDNA. Therefore, it is necessary to investigate the optimal 
concentration of λ exo. As shown in Figure 21C, with the increase of the λ exo 
concentration, the fluorescence intensity change of both solutions with T4 PNK or 
without T4 PNK increased. To get the optimum (S/B), the relationship of the S/B ratio 
with the amount of the λ exo was studied. It was shown that the highest S/B value was 
obtained in the presence of 0.25 units of λ exo (Figure 21 D). Therefore, 0.25 units of 
λ exo were used in the following experiments.  
The reaction time of the T4 PNK catalysed phosphorylation and the coupled 
λ exo digestion was the other crucial factor. As shown in Figure 21B, the fluorescence 
intensity of SG decreased dramatically through the incubation time. The results showed 
that the fluorescence intensity decreased with the increase of the incubation time to 30 
min. In the first 2 min, 87.5 % fluorescence was decreased, followed by the gradual 
decrease until 30 min. This is due to the rapid catalytic activity of λ exo when T4 PNK 
was added to phosphorylate the dsDNA. The stable fluorescence intensity after 30 min 
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suggested the complete phosphorylation and digestion. As a result, 30 min was chosen 
for the incubation time in the following experiments. 
3.4. Monitoring of the Phosphorylation Process of T4 PNK 
Under the optimized conditions, a series of concentrations of T4 PNK from 0 
to 20 U/mL was applied to quantify the kinase activity of the T4 PNK. As shown in 
Figure 22A, the fluorescence signals gradually decreased as the concentration of T4 
PNK increased. The relative fluorescence intensity reached the saturation when the T4 
PNK concentration reached 10 U/mL. The calibration curve between the fluorescence 
intensity change and T4 PNK concentration was shown in Figure. 5B. There was a good 
linear range between 0.25 to 1.00 U/mL (Figure 22B inset). The linear relationship can 
be demonstrated as Y = 2.5011X + 7.5561 with a correlation coefficient of 0.9896. Y 
and X represented the fluorescence intensity change and concentration of T4 PNK in 
units of U/mL, respectively. The limit of detection (LOD) was 0.11 U/mL according to 
the definition of 3s/slope. This result demonstrated the method as a potentially simple, 
quantitative and label-free strategy for polynucleotide kinase activity assay.  
Figure 22. Monitoring the T4 PNK activity. (A) Relative fluorescence intensity with 
different concentrations of T4 PNK (top to bottom, 0, 0.25, 0.50, 1.00, 5.00, 10.00, 
20.00 U/mL). (B) Concentration curve for T4 PNK. Inset indicated the linear 
relationship between fluorescence intensity change and the concentration of T4 PNK 
from 0 to 1.00 U/mL. Fluorescence intensity was measured in 100 µL of 1x NEBuffer 
4 (pH = 7.9) at 37°C after 30 min incubation. The concentrations of λ exo, dsDNA, and 
ATP were 0.25 units, 20 nM, and 0.1 mM, respectively. λex = 480 nm. 
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3.5. Inhibition Investigation 
Since phosphorylation plays important roles in several bio-processes, the 
inhibition to the T4 PNK activity was also important to evaluate. Therefore, the 
inhibition effects of the ammonium sulphate and sodium hydrogen phosphate on 
phosphorylation were also investigated through this label-free fluorescence assay. It 
was reported that these inhibitors had no effect on the activity of the λ exo76; thus, they 
can be used for the evaluation of the inhibition on the T4 PNK activity. As shown in 
Figure 23, the phosphorylation activity of T4 PNK was inhibited by both ammonium 
sulphate and sodium hydrogen phosphate depending on the concentration of the 
inhibitors. With the increase of the concentration of the inhibitors, the relative 
fluorescence intensity of the system increased which indicated that the phosphorylation 
process was inhibited by the high concentration inhibitors. The results showed that this 
assay could investigate the various effects on phosphorylation quantitatively.  
Figure 23. The effect of different concentrations of T4 PNK inhibitor. (A) Effect of 
(NH4)2SO4 (0-120 mM); (B) Effect of Na2HPO4 (0-90 mM). Fluorescence intensity was 
measured in 100 µL of 1x NEBuffer 4 (pH = 7.9) at 37°C after 30 min incubation. The 
concentrations of λ exo, dsDNA, ATP and T4 PNK were 0.25 units, 20 nM, 0.1 mM, 
and 10 U/mL respectively. λex = 480 nm. 
4. Conclusions 
In conclusion, we have developed a facial, quantitative, cost-effective and label-
free fluorescence assay for the detection of T4 PNK activity and inhibition coupled with 
λ exo and SG. In this sensing platform, the 5’-hydroxyl group of the dsDNA was 
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phosphorylated by T4 PNK in the presence of ATP, the resulting 5’-phosphoryl termini 
dsDNA was digested by the λ exo in the following step. As a result, the SG integrated 
in the dsDNA was released from the dsDNA which lead to the fluorescence intensity 
decrease of the system. This assay offered a new opportunity in the development of 
phosphorylation monitoring and related drug screening and clinical diagnostics. 
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CHAPTER IV 
FABRICATION OF HIGHLY FLUORESCENT GRAPHENE QUANTUM DOTS 
USING L-GLUTAMIC ACID FOR IN VITRO/IN VIVO IMAGING AND SENSING 
1. Introduction 
Recently, graphene and its derivative graphene oxide have attracted 
remarkable attention due to their extraordinary optical and electronic properties 
and biocompatibility.86-89 However, applications of graphene in the fields of 
bioimaging and optoelectronics are limited because graphene is a zero-bandgap 
semiconductor.90 To generate a bandgap in graphenes, a zero-dimensional 
derivative, graphene quantum dots (GQDs) have been developed.14, 91-95 GQDs 
have strong quantum confinement and edge effect when their sizes are in the 
range of 3-10 nm.96, 97 Compared to zero-bandgap graphene sheets, GQDs exhibit 
stronger photoluminescence for bioimaging,98 light-emitting diodes,99 and 
biosensors.92 The photoluminescence is not only attributed to the quantum 
confinement effect, but also to the edge effect of the small graphene quantum 
dots. Most importantly, compared to the traditional quantum dots (QDs),17, 100-104 
GQDs are chemically inert. Thus, the potential toxicity of the intrinsic heavy 
metal in traditional QDs would not be a concern for GQDs. Even though the 
mechanism of photoluminescence needs further investigation, a wide variety of 
applications of GQDs have been developed, such as photovoltaic devices,105 
biosensing,106 drug delivery,107 cellular imaging,97 and the interaction with 
biological systems.108 
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A number of methods have been developed for the synthesis of GQDs. 
Generally, the approaches can be divided into two groups: top-down and bottom-
up methods. The top-down methods are based on cutting large carbon materials, 
such as carbon nanotubes, graphene sheets and carbon fibers, to form small 
GQDs. For example, Pan et al. synthesized blue GQDs by a hydrothermal method 
using a pre-oxidized graphene sheet.10 Zhou et al. broke C-C bonds of a graphene 
oxide using the photo-Fenton reaction to produce GQDs.108 With controlling of 
the photo-Fenton reaction conditions, the nanoporous graphene sheets and GQDs 
were generated. Using microwave as an energy source, Li et al. synthesized 
greenish-yellow luminescent GQDs by cutting a graphene oxide under acid 
conditions.109 Furthermore, several other methods  were developed such as acid 
treatment coupled with the chemical exfoliation of carbon fibers,93 the 
electrochemical etching of a graphene electrode,110 and the ultrasonication 
breaking of graphene.110, 111 Although luminescent GQDs could be obtained from 
carbon sources by these top-down methods, the reaction conditions and 
purification processes were complicated and time-consuming.  
In contrast to the top-down approaches, bottom-up methods fabricate 
GQDs from small carbon precursors  including glucose,99 hexa-peri-
hexabenzocoronene,112 citric acid,92 etc.113 The bottom-up methods produced 
GQDs with controllable morphology and well-distributed sizes. However, harsh 
reaction conditions, such as using a strong acid or alkali, a long treatment period 
of time, and necessary separation processes, are limitations of the bottom-up 
methods. To overcome these limitations in this work, we have developed a 
simple and rapid bottom-up synthetic method by carbonizing a common amino 
acid, L-glutamic acid (Glu), using a heating mantle for pyrolysis. This is the first 
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report to use the L-glutamic acid for the synthesis of highly fluorescent nitrogen-
doped GQDs with a simple heating process. The obtained GQDs emitted various 
wavelengths of fluorescence including the near-infrared fluorescence (NIR).  In 
the NIR region, biological samples have low background fluorescence signals, 
providing high signal to noise ratio. Meanwhile, NIR radiation can penetrate into 
sample matrices deeply due to low light scattering. Thus, the GQDs are 
promising labeling reagents for sensitive determination and imaging of biological 
targets. The fluorescence quantum yield of the developed GQDs was about 5 
times higher than the GQDs from citric acids.92 We have demonstrated the 
feasibility of using the GQDs in the in vitro and in vivo fluorescence imaging. 
Besides the bioimaging applications, the GQDs showed a peroxidase-like 
catalytic activity that was used for the sensitive detection of H2O2.  
2. Experimental Section 
2.1. Materials.  
L-glutamic acid, Ludox SM-30 colloidal silica (30 wt. % suspension in water), 
hydrogen peroxide, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), 
fluorescein isothiocyanate (FITC) isomer I, rhodamine-101 and phosphate buffered 
saline (PBS) tablet were purchased from Sigma-Aldrich. The deionized water (18.3 
MΩ•cm) was produced from the Millpore water purification system.  
2.2. Synthesis of GQDs.  
The GQDs was synthesized by pyrolyzing L-glutamic acid. Briefly, 2.0 g L-
glutamic acid was added to a glass bottle and heated to 210 °C with a heating mantle. 
After the solid L-glutamic acid changed to liquid, the boiling colorless liquid turned to 
brown in 45 s, which indicated the formation of GQDs. Then, 10.0 mL water was added 
to the solution followed stirring for 30 min. When the solution temperature reached 
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room temperature, the solution was centrifuged at 10,000 g for 30 min and the 
supernatant was collected. The resultant GQD solution could be stored at the room 
temperature for at least 5 months without precipitation.  
2.3. Characteristics of GQDs.  
A JEOL JEM-2100 high-resolution transmission electron microscope 
(HRTEM) was used to characterize the GQDs at an operating voltage of 200 kV. The 
size distribution of the GQDs was measured and graphed using Image J. Fourier 
transform infrared (FTIR) spectra were obtained on a FT-IR spectrometer (Peking). The 
Energy-dispersive X-ray spectroscope (EDS) (Oxford), which was attached on the 
Hitachi SU8010 field emission scanning electron microscope (SEM) with an operating 
voltage of 5 kV, was used to analyze the relative contents of carbon, nitrogen and 
oxygen in L-glutamic acid and GQDs. X-ray diffraction (XRD) profiles were obtained 
with Bruker AXS D8 advanced powder x-ray diffraction system using Cu Kα radiation. 
Raman spectra were performed on an Aramis labRAM Raman spectrometer (Horiba 
JobinYvon) using the helium-neon laser at 542 nm. A Shimadzu UV-250 UV/vis 
spectrometer was used for the measurements of the UV/vis absorption of GQDs. The 
fluorescence spectra, lifetime, and quantum yields were measured using a Jobin-Yvon-
Horiba Fluorometer 3 Model (FL 3-11 spectrofluorometer). The zeta potential was 
detected using the Zetasizer (Marlwen, model of Nano-ZS) by adjusting the pH of the 
GQDs from 2.0 to 12.0 using PBS buffer. 
2.4. Detection of Quantum Yields.  
Fluorescein in 0.1 M NaOH (QY = 92 %) was chosen as a reference.114, 115 The 
quantum yield was calculated according to the following equation: 
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Where the subscripts ST and X denote standard and sample, respectively. Φ is 
the quantum yield. I represents the measured integrated fluorescence intensity. A is the 
absorbance at the excitation wavelength, and η is the refractive index of the solvent. 
The refractive index for the standard and sample are 1.33. The GQDs were excited at 
360 nm with an emission range of 380-650 nm. 
2.5. Detection of Fluorescence Lifetime.  
The fluorescence lifetime of GQDs was measured using time-correlated single 
photon counting (TCSPC) with the LED (370 nm) equipped on the Jobin-Yvon-Horiba 
Fluorometer 3. A Ludox SM-30 colloidal silica was used as the reference. The emission 
wavelength of GQDs changed from 455 to 505 and 650 nm. An emission wavelength 
of 815 nm was used for the NIR fluorescence lifetime measurement.  
2.6. In Vitro Fluorescence Imaging of Cells.  
The fluorescence imaging of cells treated with GQDs was conducted at various 
wavelengths (Zeiss LSM-510 Meta Confocal Microscope). Briefly, murine alveolar 
macrophage cells (MH-S) were cultured overnight at 37 °C on plates in RPMI 1640 
medium containing 10 % fetal bovine serum in a 5 % CO2 environment.  Then, the 
cultured cells were washed twice with PBS buffer (pH 7.4). Afterwards, a 2 mL aliquot 
of 10 mg/mL GQDs in PBS was added to the cell culture medium followed by 1 hour 
culture at 37 °C in a 5% CO2 environment. Finally, the MH-S cells were washed twice 
using the PBS buffer and imaged using the Zeiss LSM-510 Meta confocal microscope. 
2.7. In Vivo Fluorescence Imaging of Mice.  
The in vivo fluorescence imaging of mice treated with GQDs was carried out 
using the IVIS imaging system (IVIS Lumina XR, Caliper). The athymic BALB/c-nu 
mice with weight of 20-25 g were obtained from Charles River (Wilmington, MA), and 
Φ𝑋 = Φ𝑆𝑇  (
𝐴𝑆𝑇
𝐴𝑋
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maintained in the University of North Dakota animal center. All animal operations were 
in accord with the institutional animal use and care regulations, according to protocol 
No. 1204-4 and 1204-5. The feasibility of the GQDs for in vivo fluorescence imaging 
was investigated by subcutaneous and intramuscular injection. The mice were 
anesthetized and injected with 100 µL of 25 mg/mL GQD PBS solution (pH 7.4) 
subcutaneously on the back, and 100 µL of 25 mg/mL GQD intramuscularly in the right 
back leg. The fluorescence images of the mice were taken immediately with different 
excitation and emission filter combinations.  
2.8. Detection of H2O2 Based on the GQD’s Catalytic Activities.  
5.4 mg/mL GQDs was dissolved in 110 µL of 10 mM Tris-HCl buffer (pH = 
5.0), followed by the addition of 7.2 mM ABTS. The control samples were prepared 
using the same condition except for no GQDs or H2O2, respectively. The absorption 
spectra of these three samples were recorded after 2 min of the reaction. Then, the 
reaction conditions, such as pH, temperature, concentrations of ABTS, and 
concentrations of GQDs, were optimized. Different concentrations of H2O2 were added 
into the solution for the investigation of sensitivity. The absorbance at 416 nm against 
the reaction time of 120 s was measured.  
3. Results and discussion 
3.1. Design of the Highly Fluorescent GQDs.  
The objective of this work was to develop a simple bottom-up method 
for the synthesis of highly fluorescent GQDs. The key factor of our design was 
the usage of a green and natural L-glutamic acid as the precursor. Traditionally 
the “bottom up” methods for the preparation of GQDs used some special organic 
precursors, such as 3-iodo-4-bromoaniline,113 resulting in a complicated 
synthetic process. However, in the synthesis of carbon nanodots, some common 
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organic molecules, including citric acid,116 histidine117 and glucose,118 were used 
as the precursors with the assistance of microwave. These studies revealed a 
possibility of using common organic molecules to generate GQDs. Most 
recently, using a citric acid as the precursor, Chen et al. successfully developed 
fluorescent GQDs and graphene oxide.92 Inspired by this pioneer work, we 
considered using a natural amino acid as a precursor to synthesize N-doped 
GQDs based on the pyrolysis of the precursor. Our criteria for the selection of 
the precursor were non-toxic, common/natural materials, containing nitrogen 
groups for easy surface modification of the GQDs during their applications, and 
no further capping process is needed. Considering of these criteria, we selected 
L-glutamic acid. Our result demonstrated that the L-glutamic acid was an 
excellent precursor for making the GQDs. The formation of a GQD from the L-
glutamic acid was illustrated in Scheme 2. The solid L-glutamic acid was first 
directly heated to 210 °C using a heating mantle. This temperature is the boiling 
point of the L-glutamic acid. At this condition, the L-glutamic acid melted and 
boiled very soon. The colorless liquid changed to pale yellow and brown within 
45 s, indicating the carbonization of L-glutamic acid during the pyrolysis. At this 
moment, distilled water was added into the brown liquid to dissolve and disperse 
the GQDs under vigorous stirring to avoid aggregation. Unlike other methods, 
surface passivation agents or other inorganic additives were not needed for the 
generation of high quantum yield GQDs. The residue L-glutamic acid could act 
as a surface passivation agent, resulting in the extremely stable and highly 
fluorescent GQDs in solution. The GQDs were formed in one step of the 
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pyrolysis of the precursor. Moreover, the amino group on the L-glutamic acid 
surface provided active groups for surface modification of GQDs.  
Scheme 2. Schematic diagram of the formation of GQDs through pyrolysis of L-
glutamic acid. 
Figure 24. (A) The HRTEM image of GQDs with a scale bar of 5 nm. Inset: A typical 
single GQD with the lattice parameter of 0.246 nm. The scale bare was 1 nm; (B) The 
size distribution of GQDs calculated from more than 100 dots. 
3.2. Characterization of the Morphology and Composites of the GQDs. 
 The morphology of the obtained GQDs was first characterized using a 
high resolution TEM (Figure 24A).  The high crystallinity of the GQDs was 
shown as in the inset of Figure 24A. The GQDs’ lattice space was accurately 
measured to be 0.246 nm at the HRTEM image, which is comparable to that of 
graphitic.119 The average diameter of the GQDs was 4.66 ± 1.24 nm according to 
the statistic calculation of more than 100 dots (Figure 24B). The size distribution 
showed uniform dimension of the developed GQDs.  
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Figure 25. EDS spectra of L-glutamic acid (A) and GQDs (B), and the relative atomic 
percentage of L-glutamic acid and GQDs(C). 
The element content of the GQDs was analyzed using EDS. As a 
control, the relative atomic percentage of L-glutamic acid were 48.73% (C), 
9.54% (N), and 41.73% (O) (Figure 25A and C), which was similar to the 
theoretically relative atomic percentage of L-glutamic acid (50 % of C, 10 % of 
N and 40 % of O). After the pyrolysis of the L-glutamic acid, the GQDs were 
formed. Their carbon content increased from 48.73 % to 60.01 %. Meanwhile, 
the oxygen content decreased from 41.73 % to 34.60 %, and the nitrogen content 
decreased from 9.54 % to 5.39 % (Figure 25B and C). This result indicated that 
the L-glutamic acid was carbonized after pyrolysis. 
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Figure 26. (A) Raman spectra of GQDs. (B) XRD patterns of GQDs. 
To confirm the formation of GQDs XRD pattern and Raman spectroscopy 
were used to characterize the product. As shown in Figure 26A, the Raman 
spectrum of GQDs has two typical peaks at ca. 1355 cm-1 and 1580 cm-1. The G 
band (1580 cm-1) was related to the vibration of the sp2-bonded C atoms in the 
graphene materials; and the D band (1355 cm-1) corresponded to the destruction 
of the sp2 network by the sp3-bonded C atoms. Figure 26B showed a typical XRD 
profile of GQDs. It had a broad (002) peak centered at ca. 20.0°, which is similar 
to the GQDs synthesized by other methods.99 
Figure 27. (A) FT-IR spectra of L-glutamic acid (a) and GQDs (b). (B) The zeta 
potential of GQDs in different pH solutions. 
The structural change of the L-glutamic acid during the formation of the 
GQDs was further characterized using the FT-IR spectra (Figure 27A).  
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Compared curve a with b in Figure 27A, the C=C stretching of graphite was 
formed as indicated by the appearance of the 3000 cm-1 and 1500 cm-1 peaks, 
which demonstrated the formation of GQDs.120 The broad peak area from 2500 
– 2800 cm-1 was from the carboxylic acid O-H stretch. Meanwhile, the strong 
peak from 1600 to 1730 cm-1 resulted from the combination of carboxylic acid 
C=O stretch and amide C=O stretch in the GQDs. The carboxylic acid O-H 
stretching and C=O stretching peaks demonstrated the presence of the carboxyl 
groups. The amide C=O stretching and new formed amide N-H stretching peak 
(3700 – 3500 cm-1) indicated the formation of the amides between the amine 
group and the carboxyl group. The stretching vibrations of amine N-H (ca. 3360 
cm-1) in both curves indicated the presence of amine groups in the L-glutamic 
acid and GQDs. The oxygen-containing and nitrogen-containing groups 
promised the high water solubility and stability in solution.  
The zeta potential of the GQDs in different pH values was also 
investigated. As shown in Figure 27B, the zeta potential changed from positive 
6.81 mV to negative 23.2 mV by increasing the pH value from 2 to 12. This large 
change of the zeta potential with the pH was related to the presence of the amino 
and carboxyl groups in the GQDs. Because of the reaction activity of the amino 
and carboxyl groups, the biomolecules, such as antibodies and aptamers, could 
be easily conjugated onto GQDs for further applications.  
3.3. Fluorescence Properties of the GQDs.  
The significant feature of the developed GQDs relies on their 
fluorescence properties. We have investigated the fluorescence properties using  
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Figure 28. (A) The absorption (curve a), excitation (curve b) and emission spectra 
(curve c) of GQDs. Inset: from left to right are the GQDs solutions under bright light, 
violet, blue and green irradiation, respectively; (B) Fluorescence emission spectra of 
GQDs with different excitation wavelengths; (C) - (E) The confocal fluorescence 
images of the GQDs under different excitation wavelengths. (C) 359 nm excitation; 
DAPI channel; (D) 488 nm excitation, LP 505 nm; (E) 514 nm excitation, BP 530-600 
nm. 
both the spectroscopy and the microscopy. The obtained UV-vis absorption 
spectra and photoluminescence spectra were shown in Figure 28A. The GQDs 
showed two obvious absorption peaks at 238 nm and 335 nm, respectively 
(Figure 28A, curve a). The peak around 238 nm was attributed to π- π* transitions 
of C=C bonds. The apparent peak at 335 nm indicated the major uniform size of 
the sp2 clusters in the GQDs even though these sp2 clusters were doped in the sp3 
matrix. The color of GQDs in the aqueous solution was yellow (Inset of Figure 
28A). When the GQDs were excited at 360 nm (Figure 28A curve b), the GQDs 
showed a strong fluorescence peak at 440 nm (Figure 28A curve c). More 
importantly, the fluorescence is strong enough to be observed by naked eyes 
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(Inset of Figure 28A), which has promising applications for fluorescence 
imaging. In addition, the fluorescence emission spectra showed an excitation-
dependent manner. The emission peak of GQDs shifted from 415 nm (violet) to 
580 nm (red) when the excitation wavelength was changed from 320 nm to 540 
nm (Figure 28B).  
We then investigated the fluorescence property of GQDs using a 
fluorescence microscope. With the irradiation of the violet (330-385 nm), blue 
(460-500 nm) and green (535-585 nm) light, the GQDs emitted strong blue, green 
and red fluorescence, respectively (Figure 28C, D, E). It should be noted that the 
precursor of the GQDs showed no absorption in the violet region and no 
fluorescence in the range of violet to visible. Thus, all these fluorescence 
properties should come from the formation of GQDs.  
To further explore the fluorescence features of the developed GQDs, we 
measured their fluorescence quantum yield and lifetime. Using fluorescein as a 
reference dye the quantum yield of GQDs was measured to be 54.5 % under the 
excitation of 360 nm. This relative high quantum yield might be benefited from 
the protection of the residue L-glutamic acid as the surface passivation agent. 
The fluorescence lifetime of the GQDs was analyzed using the TCSPC method 
at different emission wavelengths with 370 nm excitation. All three fluorescence 
emissions exhibited well fitted triple-exponential function as shown in Figure 29. 
The observed lifetimes of GQDs at 445 nm, 505 nm, 650 nm and 815 nm were 
summarized in Table 3. Their average lifetime was in the range of 1.48 to 2.40 
ns. The nanosecond lifetime of GQDs demonstrated their potential for 
optoelectronic and biological applications.  
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Figure 29. Lifetime measurement curves for reference (a) and GQDs at different 
emission wavelengths with 370 nm LED irradiation. Emission wavelengths: (b) 445 
nm; (c) 505 nm; (d) 650 nm, and (e) 815 nm. 
Table 3.  Caption Fluorescence lifetime of GQDs at different emission wavelengths 
with 370 nm excitation. 
Ex (nm) Em (nm) τ1 (ns) τ2 (ns) τ 3 (ns) Av. τ (ns) Chi 
370 445 0.81 3.64 11.55 2.40 1.14 
370 505 3.78 0.80 12.04 2.22 1.27 
370 650 2.35 6.77 0.47 1.48 1.13 
370 815 3.23 0.47 8.70 1.91 0.97 
 
Compared to the traditional organic dyes, such as FITC, the GQDs not 
only could emit fluorescence at different wavelengths, but also showed much 
higher photostability. As shown in Figure 30, the fluorescence of FITC was 
bleached by 70 % under a confocal laser within 2 min (Figure 30A, C).  
However, the fluorescence of GQDs still showed strong intensity (47 % was 
bleached) even after 18 min of the same irradiation (Figure 30B, C). This 
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increased photostability provided the GQDs with a great potential for in vitro and 
in vivo fluorescence imaging.  
Figure 30. Comparison of the photostability of the GQDs with a fluorescent dye 
molecule FITC under the irradiation of a confocal laser. A, the confocal fluorescence 
images of FITC; B, the confocal fluorescence images of GQDs; C, the photostability of 
these two fluorescent materials; D, the effect of pH on the fluorescence intensity of the 
GQDs. 
We also investigated the stability of the GQDs at different pH values 
(Figure 30D). The results showed that at pH 7.0 the GQDs had the highest 
fluorescence intensity. In the range of pH 5.0-9.0, the changes of the fluorescence 
intensity were less than 1.4 %. This range covered the majority of pH values of 
living systems. When the pH value was below 5.0 or higher than 9.0, the 
fluorescence intensity of the GQDs was reduced by 32.3 %. The significant 
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stability of the GQDs over the broad pH range might come from the surface 
amino groups and carboxyl groups, which could resist the pH effect on the 
fluorescence intensity of GQDs.  
Figure 31. (A) Fluorescence emission spectrum of the GQDs in the visible-NIR region. 
(B) NIR fluorescence spectra of the GQDs under different excitation wavelengths. (C) 
The NIR fluorescence intensity vs. the concentration of GQDs. 
Besides the fluorescence emission in blue, green and red regions, the 
GQDs emitted relatively lower NIR fluorescence around 815 nm with the 
irradiation of 360 nm. The intensity ratio of 815 nm to 440 nm was 0.2 according 
to the fluorescence spectra (Figure 31A). The NIR peak was significantly higher 
than the 2 λ diffraction peak as shown in Figure 31B. Similar to the fluorescence 
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property in the visible region, the peak in the NIR region showed red shift if the 
excitation wavelength became longer (Figure 31B). Meanwhile, the fluorescence 
intensity of the GQDs in the NIR region was proportional to the concentration of 
the GQDs in the range of 0.468-15.000 mg/mL (Figure 31C). This relationship 
indicated that the NIR fluorescence must be attributed to the GQDs even though 
the mechanism was not clear yet. Notably, the Stokes shift of this NIR 
fluorescence was as large as 455 nm. The large Stokes shift provided the GQDs 
with significant advantages for fluorescence bioimaging and biosensing. The 
lifetime of the fluorescence at 815 nm with excitation of 370 nm was examined 
(Figure 29e). The result showed a similar value to that of the visible fluorescence. 
The short lifetime value eliminated the possibility of phosphorescence of the 815 
nm peak.  
3.4. In Vitro Fluorescence Imaging Using GQDs.  
Based on these excellent fluorescence properties, the bioimaging 
applications of the fluorescent GQDs were further investigated in vitro and in 
vivo. The in vitro fluorescence imaging using the developed GQDs was explored 
under different excitation wavelengths. After the GQDs were incubated with 
MH-S cells for 1 h, the fluorescence images of the cells were taken using a 
confocal microscope. As shown in Figure 32B, the MH-S cells incubated with 
GQDs in PBS buffer showed strong green (LP475) and red (LP 530) colors upon 
excitation at 458 nm and 514 nm, respectively. However, no apparent 
fluorescence was observed from the control group that was not incubated with 
the GQDs under the same conditions (Figure 32A). Our results demonstrated that 
the GQDs can emit strong fluorescence in the range of green to red for in vitro 
fluorescence imaging. The strong fluorescence on the MH-S cells incubated with 
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GQDs suggested that GQDs had penetrated into the cells and were able to label 
both the cell membrane and the cytoplasm of MH-S cells. The uptake of GQDs 
by MH-S cells would be similar to the pathway of nanoparticles, which is 
endocytosis.121 
Figure 32. Laser scanning confocal fluorescence microscopy images of MH-S cells. (A) 
Control MH-S cells without GQDs; (B) the MH-S cells treated with GQDs for 1 hour. 
All the scale bars was 20 µm. 
3.5. In Vivo Fluorescence Imaging Using GQDs.  
The feasibility of the GQDs for in vivo bioimaging was investigated in 
mice. A 100 μL aliquot of 25 mg/mL GQDs were injected subcutaneously into 
the back of nude mice and intramuscularly into the right back leg. The 
fluorescence images of the mice under different excitation and emission filters 
were captured. As shown in Figure 33, various excitations from blue to red 
centered at 430, 465, 500, 535 and 605 nm were applied for the in vivo 
fluorescence imaging. The emission bandpass filters for each excitation 
wavelength were illustrated on the top of each image in Figure 33. With the 
excitation wavelength increased, all the fluorescence intensity decreased. 
Moreover, the detectable fluorescence region had extended with the longer 
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excitation and emission wavelengths from the intramuscularly injection spot of 
the right back leg. This result demonstrated that the longer wavelengths had 
better penetration ability than the short wavelengths for the in vivo fluorescence 
imaging. Considering the decreased fluorescence intensity in the longer 
wavelengths, the optimal excitation and emission bandpass to obtain the highest 
signal-to-background ratio should be investigated in the future for further 
imaging applications. Overall, the in vivo fluorescence imaging in mice under 
subcutaneous and intramuscular injection indicated that the GQDs could be used 
as a fluorescent labeling agent for bioimaging in both visible and NIR regions.  
Figure 33. In vivo fluorescence imaging of mice injected GQDs subcutaneously (spot 
a) and intramuscularly (spot b). The images were taken under various excitation 
wavelengths and emission wavelengths indicated on the top of each image. A 100 µL 
aliquot of 25 mg/mL GQDs was injected into each spot. The following emission 
bandpass filters were used: GFP: 515-575 nm; DsRed: 575-650 nm; Cy5.5: 695-770 
nm. 
3.6. Colorimetric Detection of H2O2 Using GQDs.  
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Figure 34. UV-vis absorption spectra of the ABTS solution containg a) 9 mM 
H2O2; b) 2.7 mg/mL GQDs with 9 mM H2O2; and c) 2.7 mg/mL GQDs. Inset: 
The corresponding photographs of these three samples. 
To extend the application fields of the GQDs, in addition to the optical 
properties, we have investigated the catalytic ability of the GQDs. It was reported 
that the materials containing aromatic sp2 carbon clusters had the intrinsic 
peroxidase-like catalytic activity to produce a blue color reaction in the presence 
of H2O2 and peroxidase substrate, 3,3,5,5-tetramethylbenzidine (TMB). For 
example, both carbon nanotubes and graphene sheets were used for the label-free 
detection of glucose and single-nucleotide polymorphism through their intrinsic 
peroxidase-like catalytic activity.122, 123 Inspired by this work, we explored 
whether our GQDs could be used for label-free colorimetric sensing as a catalyst. 
With the addition of H2O2, the GQDs catalyzed the reduction of hydrogen 
peroxide indicated by the color change of the solution to green in the presence of 
the peroxidase substrate ABTS (Figure 34 inset). The absorbance change of 
ABTS at 416 nm could be used for monitoring the reaction rate and the 
peroxidase-like catalytic activity (Figure 34). Compared to the control groups 
including the solution without GQDs or H2O2, the signal-to-background ratio was 
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higher than 9. Thus, the peroxidase-like catalytic activity of the GQDs would be 
used for the detection of H2O2, an important reactive oxygen species in the 
biomedical context.  
We then optimized the detection conditions for catalyzing H2O2 reaction 
using the GQDs. The conditions included pH, reaction temperature, and 
concentrations of ABTS and GQDs. The pH value was a critical factor for the 
detection of H2O2. It was reported that the optimal pH for a carbon nanoparticle 
catalyzed H2O2 reaction was 4.0.
124 Our results showed that, in a low pH range 
(3.0-5.0), the reaction rate was very stable (Figure 35A). However, the reaction 
rate decreased above pH 5.0. Therefore, the pH 5.0 was chosen as the optimal 
pH. Meanwhile, the reaction temperature would affect the catalytic reaction rate. 
As shown in Figure 35B, high temperature would increase the reaction rate. 
Considering normal mammalian body temperature, 37 °C was selected as the 
standard condition for analyzing H2O2. Apparently, the ABTS as a substrate 
could affect the sensitivity of the colorimetric detection of H2O2. As shown in 
Figure 35C, the reaction rate increased as the concentration of ABTS increased 
until a concentration of 7.2 mM was reached. Therefore, 7.2 mM of ABTS was 
chosen as the optimal concentration. Moreover, the concentration of GQDs was 
proportional to the reaction rate (Figure 35D). However, a high concentration of 
GQDs would affect the absorption of the ABTS. Therefore, a concentration of 
5.40 mg/mL GQDs was chosen as the optimal concentration for the detection.  
Under the above optimal conditions, the detection of H2O2 was carried 
out using this GQDs-based label-free colorimetric system. As shown in Figure 
36A, with the increase of the concentrations of H2O2, the absorbance increased 
in a concentration-dependent manner. This assay provided rapid detection (2 
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min) of H2O2 with the linear range from 0.1 mM to 10 mM (Figure 36B). The 
limit of detection was 20 µM according to the calibration curve at a signal-to-
background ratio of 3. Thus, our studies suggest that the GQDs may have 
potential for applications in the biosensing field. 
Figure 35. Optimization of the reaction conditions for the detection of H2O2. (A) 
pH; (B) temperature; (C) concentration of ABTS; (D) concentration of GQDs. 
Figure 36. (A) The relationship of the absorption with the concentrations of H2O2 (from 
the bottom to the top: 0, 0.1, 0.2, 0.3, 0.4, 0.5, 1.0, 5.0 and 10.0 mM); (B) The 
calibration curve of the label-free colorimetric method for the detection of H2O2. 
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4. Conclusions 
In conclusion, GQDs with excellent fluorescence properties and peroxidase-
like activity were developed using a direct and simple pyrolysis of an amino acid, L-
glutamic acid. The GQDs not only showed a stable, strong excitation-dependent 
photoluminescence with high quantum yield (54.5 %) in the blue to red range but also 
provided an excitation-dependent NIR fluorescence emission around 815 nm. Even 
though the mechanism of this NIR fluorescence emission was not well understood, the 
application potential of the NIR fluorescence was significant. By using a strong visible 
irradiation, the GQDs showed the potential to be used for in vitro and in vivo 
fluorescence imaging. Furthermore, the GQDs possessed a peroxidase-like activity 
which could catalyze the reduction of H2O2 in the presence of the ABTS substrate. 
Using the labelling-free colorimetric method, the GQDs may have broad applications 
in detecting H2O2, an important reactive oxygen species in biomedical context.
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CHAPTER V 
ONE-POT SYNTHESIS OF REDUCED GRAPHENE OXIDE/METAL (OXIDE) 
NANOCOMPOSITES AND ITS APPLICATION FOR ELECTROCHEMICAL 
ANALYSIS 
1. Introduction 
Graphene, a two-dimensional carbon nanomaterial containing a monolayer of 
sp2 hybridized carbon atoms, has attracted increasing attention due to its useful 
electronic, thermal, and optical properties.125-131 Graphene is usually synthesized by the 
modified Hummer’s method, which forms graphene oxide (GO) from graphite with 
ultrasonication, afterwards oxygen-containing groups on the GO are treated to form 
reduced graphene oxide (RGO). The electrical and thermal conductivity of RGO 
exceeds those of GO even though they are still lower than pristine graphene.132-134 
However, the residual oxygen-containing groups in RGO (carboxyl, epoxy, carbonyl, 
and hydroxyl) provide active sites for further chemical modification and decoration 
with other nanomaterials, thereby allowing electronic and optoelectronic properties to 
be tailored.135, 136  When modified  with inorganic nanomaterials (e.g., Au, Cu, Ag, 
TiO2, Fe3O4, QDs, SiO2, and etc.), graphene has found numerous applications in fields 
such as solar energy storage,137 Li-ion battery fabrication,138-140 biosensors,141-144 and 
drug delivery.145-148 For instance, Xu et al. adsorbed metal nanoparticles (Au, Pt and 
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Pd nanoparticles) on the surface of GO followed by reduction of  GO to RGO 
using ethylene glycol.149 The resulting graphene-Pt composites showed promise in 
direct methanol fuel cells. Lightcap et al. anchored semiconductor and metal 
nanoparticles on RGO at separate sites.150 With UV irradiation, the photogenerated 
electrons from TiO2 were captured and transferred through RGO to reduce silver ions 
to silver nanoparticles apart from TiO2. This electron storage and shuttling ability of 
RGO demonstrated its potential use as a catalytic nanocomposite.  
In general, there are two different pathways to fabricate graphene-inorganic 
nanocomposites including ex situ hybridization and in situ decoration.131 In the process 
of ex situ hybridization, the inorganic nanoparticles are synthesized separately from 
graphene using traditional methods. Afterwards, the well-defined inorganic 
nanoparticles are adsorbed onto the surface of RGO through either covalent or non-
covalent binding. This method ensures better shape and size control of the inorganic 
nanoparticles. Meanwhile, surface modification of inorganic nanoparticles can be 
easily conducted prior to their hybridization with RGO. However, all the inorganic 
nanoparticles should be prepared in advance for ex situ hybridization, which 
complicates the preparation process. Also, loading efficiency of the inorganic 
nanoparticles on RGO is usually lower than in situ methods. Accordingly, in situ 
methods for the fabrication of RGO-inorganic nanocomposites have received 
increasing attention.151-153  
Several inorganic nanoparticles, especially metallic nanoparticles have been 
decorated on the surface of GO or RGO using in situ methods.154-156 Usually, the metal 
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precursors are added directly to the graphene materials for a one-pot synthetic method 
that dramatically simplifies the synthetic process. The oxygen-containing groups in GO 
and RGO provide nucleation sites for crystallization of the metal nanoparticles.135, 136 
Meanwhile, with the introduction of reducing agents, the metal precursors and GO 
could be simultaneously reduced in solution.157 However, two main limitations of these 
in situ methods are (i) the unstable dispersion of RGO in aqueous solutions due to the 
removal of oxygen-containing groups and (ii) the use of toxic reducing agents (e.g., 
hydrazine and sodium borohydride). To improve stability of the RGO-inorganic 
nanocomposites, surfactants and polymers can be adsorbed to the surface of RGO prior 
to the reducing process.158-160 To avoid toxic reducing agents, biocompatible reagents, 
such as ascorbic acid,157 glucose,161 sodium citrate162 and ethylene glycol,163 can be 
used to reduce GO and metal precursors. However, in most of these methods, an extra 
stabilizer is usually needed to disperse the resulting RGO-inorganic nanocomposites in 
solution. Therefore, a general simple in situ method to decorate RGO with inorganic 
nanocomposites is needed.  
The present work demonstrates a generalized, environmental-friendly in situ 
method for fabrication of RGO-metal (oxide) nanocomposite materials. The 
environmentally benign reagent, glucose, was found synthetic to be an especially 
effective reductant and solution stabilizer in the one-pot process. Moreover, the process 
was found to be adaptable for synthesizing a variety of RGO/metal (oxide) 
nanocomposites, including RGO/Au, RGO/Cu2O and RGO/Ag. Extensive 
characterizations were used to confirm the composition and morphology of the 
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designed nanocomposites. Furthermore, the electrocatalytic activity of the RGO/Au 
nanocomposite was demonstrated with the simultaneous analysis of L-ascorbic acid (L-
AA), dopamine (DA) and uric acid (UA) under physiological solution conditions. This 
result illustrated the potential of the developed nanocomposites for other biomolecule 
detection schemes.  
2. Experimental Section 
2.1. Materials.  
Graphene oxide was purchased from Cheap Tubes Inc., VT. Glucose (≥99.5%, 
GC grade), L-ascorbic acid (L-AA, ≥99.0%, crystalline), dopamine hydrochloride 
(DA), uric acid (UA, ≥99%, crystalline), chloroaunic acid tetrahydrate (+ 99.9%), 
copper(II) chloride dehydrate (ACS reagent, ≥99.0%), silver nitrate (ACS reagent, 
≥99.0% ) and ammonium hydroxide (ACS reagent, 28.0 %) were purchased from 
Sigma Aldrich Inc. Phosphate buffered saline tablets and fetal bovine serum were 
purchased from Fisher Scientific. Deionized (DI) water (Millipore Milli-Q grade) with 
resistivity of 18.2 MΩ•cm was used in all experiments. 
2.2. Preparation of RGO/Metal (Oxide) nanocomposites.  
The RGO/metal (oxide) nanocomposites were prepared using a one-pot 
reaction. In brief, 160.0 mg glucose was added to a stirred homogeneous GO solution 
(100.0 mL, 5.0 mg) and stirred for 30 min. An 80 µL aliquot of NH4OH (28.0 %) was 
added quickly to the solution and the flask was heated to boiling for 20 min. During 
this time, the color of the solution changed from brown-yellow to dark black, indicating 
the formation of RGO from GO. Afterwards, 1.0 mL of the metal precursor solution 
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(1.0 % HAuCl4, 1.0 % CuCl2 or 0.5 % AgNO3) was added drop wise and the mixture 
was boiled for 15 min. Finally, the cooled dispersed solution was centrifuged to separate 
the unattached metal nanoparticles that remained suspended in the supernatant during 
the centrifugation. The RGO/metal nanocomposite precipitate was redispersed into 
20.0 mL Milli-Q water with sonication for further usage.  
2.3. Characterization.  
The scanning transmission electron microscopy (STEM) and scanning 
electron microscopy (SEM) images of RGO/metal (oxide) nanocomposites were 
obtained with a Hitachi SU8010 field emission scanning electron microscope. 
Elemental analysis for different RGO/metal nanocomposites was performed by an 
energy-dispersive X-ray spectroscope (EDS) (Oxford, X-Max) installed in the Hitachi 
SU8010 SEM. X-ray diffraction (XRD) profiles were obtained with a Bruker AXS D8 
advanced powder X-ray diffraction system using Cu Kα radiation. Raman spectra were 
obtained with an Aramis labRAM Raman spectrometer (Horiba JobinYvon) using a 
helium-neon laser at 542 nm. Fourier transform infrared (FTIR) spectra were obtained 
with a FT-IR spectrometer (Spectrum 400, PekinElmer) and UV-vis absorption spectra 
were recorded with a Shimadzu UV-250 spectrometer. 
2.4. Electrochemical Measurement.  
All cyclic voltammetry (CV) and differential pulse voltammetry (DPV) were 
performed with an Autolab PGSTAT302 potentiostat using a standard three-electrode 
cell. The cell was configured in all experiments with a Ag/AgCl (saturated KCl) 
reference electrode, a platinum wire counter electrode, and a modified glassy carbon 
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electrode (GCE, 5 mm diameter, BASi). Prior to the medication, the GCE was cleaned 
by polishing with an aqueous suspension of 0.05 µm alumina powders (Buehler), 
rinsing with DI water under sonication and then electrochemical cycling in 1.0 M 
H2SO4 from - 0.4 V to 1.5 V until a stable CV was obtained. After rinsing and drying 
the cleaned electrode, a 20 μL aliquot of GO, RGO or RGO/Au nanocomposites was 
drop-cast onto the GCE surface and dried in a 60°C oven for 30 min.  
CV and DPV measurements of L-AA, DA and UA were performed at room 
temperature with a 0.01 M pH 7.0 PBS buffer and usually containing 10-times diluted 
serum to model physiological conditions. The DPV analysis was conducted with L-AA, 
DA and UA stock solutions spiked into the PBS buffer with diluted serum.  
3. Results and Discussion 
3.1. Design and Synthesis of the RGO/Metal (Oxide) Nanocomposites.  
The designed one-pot synthetic process for RGO/metal (oxide) nanocomposite 
was shown in scheme 3. This method has three main features. First, the reductant used 
in the synthetic process is environmental friendly, by being natural and non-toxic. 
Secondly, the reductant plays multiple roles in the synthetic process as a reducant for 
both GO and metal precursors and as a stabilizer for protection of the product from 
aggregation. Thirdly, this synthetic method is general enough to produce different types 
of RGO/metal (oxide) nanocomposites. The rational of selection of glucose as the 
reductant is based on its natural and nontoxic properties as well as its abundance and 
relatively gentle activity. Other natural substances, such as sucrose, fructose and L-
ascorbic acid, have also been used for the reduction process.161, 164 However, glucose 
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has already been proven to be useful for the reduction of GO.161 After reducing GO, 
glucose is oxidized to gluconic acid that has also been used as a stabilizer to remain 
RGO stable in aqueous solution.161 Meanwhile, glucose has been used for the synthesis 
of gold and silver nanoparticles.165 Inspired by these works, we developed the one-pot 
approach was developed for the synthesis of RGO/metal (oxide) nanocomposites using 
glucose as the multi-functional reducing agent and stabilizer precursor as shown in 
scheme 3. 
Scheme 3. Illustration of the synthetic process of RGO/metal (oxide) nanocomposites 
using glucose as the reducing agent. (A) GO was stirred with glucose without heating; 
(B) GO was reduced to form RGO by glucose with boiling for 20 min; (C) RGO/Au 
nanocomposite was formed through the injection of HAuCl4 in (B) for boiling another 
15 min.  
  In Scheme 3, the oxygen-containing groups on GO, such as carboxyl and 
hydroxyl groups, were removed under thermal treatment with an excess of glucose as 
the reducing agent. The color of the solution changed from brown-yellow (Scheme 3A) 
to dark black (Scheme 3B) indicated the formation of the RGO from GO. In literatures, 
RGO was reduced by other methods, including thermal treatment and chemical 
reduction, which suffered from unstable suspension because most of the oxygen-
 (1) 
(A) (B) (C) 
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containing groups were removed from GO and electrostatic repulsion between the RGO 
sheets decreased significantly. In contrast, RGO reduced by glucose was more stable in 
water suspension due to the protection of gluconic acid on the surface of RGO.161 
Moreover, the gluconic acid and residual oxygen groups on RGOs provided reactive 
sites for absorption and nucleation of different metal ions onto the surface of RGO, 
followed by reduction of metal ions to form the nanoparticles on these sites (Scheme 
3C). The color of the solution changed with the addition of metal precursors, indicating 
the formation of different metal (oxide) nanoparticles on the surface of RGOs. The 
resulted RGO/metal (oxide) nanocomposites required several centrifugation/washing 
cycles with DI water to ensure separation of dispersed metal nanoparticles from the 
nanoparticle-decorated RGOs.  
3.2. Characterization of Designed Nanocomposites.  
Nanocomposites were characterized with a number of methods including 
imaging, elemental analysis, and spectroscopies.  
3.2.1. Morphology and elemental analysis of the developed nanocomposites.  
Successful decoration of different metal (oxide) nanoparticles onto RGOs was 
demonstrated by STEM images (Figure 37, images of 1 series) and SEM images (Figure 
37, images of 2 series). First, before the reaction, the pure GO was imaged (A1 and A2). 
The both STEM and SEM images clearly showed GO sheet structures. After the 
reaction with glucose, little difference can be observed (B1 and B2) compared to A1 and 
A2, although spectroscopy results described in the next section confirmed the distinct 
oxidation state of RGO. When an addition of different metal precursors were added to 
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the RGO, the images clearly showed metal or metal oxide nanoparticles nanoparticles 
formed on the RGO surface (Figure 37 C-E). Specifically, an addition of HAuCl4 
yielded 45.3 ± 0.8 nm gold nanoparticles which fully coated RGO (Figure 37 C1 and 
C2). The energy dispersive X-ray (EDS) analysis of this sample in Figure 37C indicated 
that the nanoparticles were Au (Figure 38A). to test the universal potential of this 
phenomenon to other metal elements, an Ag precursor (AgNO3) was added to the RGO 
solution. As expected, the RGO surface was successfully decorated with Ag 
nanoparticles (Figure 37 D1 and D2), and the EDS spectra indicted the presence of 
element of Ag (Figure 38B). In addition to the formation of pure metal nanoparticles, 
some metal oxide nanoparticles could be produced on the RGO surface. We treated 
RGO solution with a copper precursor (CuCl2). The nanoparticles were also produced 
(Figure 37 E1 and E2). However, the elemental analysis (Figure 38 C) of the 
nanoparticles was significantly distinct from Au and Ag. In Figure 38C, the atomic ratio 
of oxygen to carbon was 2.33:1 in RGO/Cu2O nanocomposite, which was higher than 
the other two metals (2.11:1 and 2.05:1 for RGO/Au and RGO/Ag, respectively), 
indicating the possible formation of copper (I) oxide nanoparticles instead of copper 
nanoparticles.  
SEM images showed that metal and metal oxide nanoparticles on each side of 
RGO could be easily distinguished based on their different contrast. Wrinkles of the 
RGO could be recognized especially from the area with nanoparticles. It seems that the 
nanoparticles were trapped within the RGO sheet. Average diameters of these 
nanoparticles were statistically calculated from the measurements of multiple 
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nanoparticles (N > 50). The results were 45.3 ± 0.8 nm (Au), 53.4 ± 0.9 nm (Ag) and 
675.1± 9.2 nm (Cu2O). Overall, the above results demonstrated that different metal 
(oxide) nanoparticles could be decorated on the surface of RGO during the in situ 
reduction process using glucose as a reductant.  
Figure 37. The STEM (A1, B1, C1, D1 and E1) and FE-SEM (A2, B2, C2, C2, D2 and E2) 
images of GO (A1 and A2), RGO (B1 and B2), RGO/Au (C1 and C2), RGO/Ag (D1 and 
D2) and RGO/Cu2O (E1 and E2) nanocomposites. Reaction conditions: 100.0 mL GO 
solution (0.1 mg/mL), 160.0 mg of glucose, and 80 µL NH4OH were mixed to form a 
homogenous solution. The solution was boiled for 20 min followed by the addition of 
1.0 mL metal precursors for another 15 min of boiling.  
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Figure 38. EDS of RGO/Au (A), RGO/Ag (B) and RGO/ Cu2O (C) nanocomposites. 
Reaction conditions: 100.0 mL GO solution (0.1 mg/mL), 160.0 mg of glucose, and 80 
µL NH4OH were mixed to form a homogenous solution. The solution was boiled for 
20 min followed by the addition of 1.0 mL metal precursors for another 15 min of 
boiling. 
3.2.2. Spectroscopic characterizations.  
We further confirmed the developed nanocomposites using UV-vis spectra, 
FTIR, Raman spectra and XRD. First, we investigated their UV-vis spectra (Figure 
39A). UV-vis absorption spectrometry is a powerful tool to distinguish the GO from 
RGO since they were hard to be differentiated from the previous microscopic images. 
It should show a red shift on the absorption peak if GO becomes RGO according to the 
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literature.157 In our result, the pure GO showed a typical absorption peak at 230 nm 
(Figure 39A curve a). After 20 min of reaction with glucose, the 230 nm absorption 
peak was shifted to 260 nm (Figure 39A curve b). This peak shift was an indication of 
the change from GO to RGO. The formation of metal (oxide) nanoparticles on the RGO 
can also be confirmed from their UV-vis absorption spectra. After the reaction with the 
metal precursors, RGO remained its original absorption peak at 260 nm. Meanwhile, a 
second absorption peak appeared at 560 nm for Au (Figure 39A curve c), which was 
corresponded to the red color of the RGO/Au nanocomposite. Similar to the RGO/Au 
nanocomposite, an absorption peak at 425 nm was formed for Ag (Figure 39A curve 
e), which was assigned to the color of yellow. However, the copper-based 
nanocomposite showed no second absorption peak (Figure 39A curve d), although the 
resulted RGO/Cu2O nanocomposite appeared a light blue color in solution. which was 
probably due to the overlap of RGO absorption. The reduction of GO to RGO was 
further confirmed by other three spectroscopic methods below.  
We then performed FTIR spectrometry to further confirm the reduction of GO 
to RGO (Figure 39B). As a control, first, the pure glucose’s the FT-IR spectrum of 
glucose (Figure 39B curve a). Compared to the pure glucose, GO showed a strong 
infrared absorption band at 1725 cm-1 due to C=O stretching (Figure 39B curve b). 
When the GO was reduced by glucose, this peak decreased significantly while the C=C 
stretching peak at 1620 cm-1 appeared (Figure 39B curve c). The peak shift from C=O 
to C=C indicated the reduction of GO to RGO. Furthermore, we tested Au, Ag and 
Cu2O decorated RGO. As shown in Figure 39B curves d, e, and f, their FT-IR spectra 
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clearly showed C=C peak around 1620 cm-1 but the C=O peak at 1725 cm-1were not 
visible. The FT-IR spectrometry results supported the reduction of GO to RGO by 
glucose.  
Figure 39. (A) Absorption spectra, of GO (a), RGO (b), RGO/Au (c), RGO/Cu2O (d) 
and RGO/Ag (e) nanocomposites. (B) FT-IR spectra of glucose (a), GO (b), RGO (c), 
RGO/ Cu2O (d), RGO/Au (e) and RGO/Ag (f) nanocomposites. (C) Raman spectra of 
GO (a), RGO (b), RGO/Au (c), RGO/ Cu2O (d) and RGO/Ag  (e) nanocomposites.  
(D)  XRD  patterns of GO (a), RGO (b), RGO/Au (c), RGO/ Cu2O (d) and RGO/Ag  
(e) nanocomposites. Reaction conditions: 100.0 mL GO solution (0.1 mg/mL), 160.0 
mg of glucose, and 80 µL NH4OH were mixed to form a homogenous solution. The 
solution was boiled for 20 min followed by the addition of 1.0 mL metal precursors for 
another 15 min of boiling. 
Raman spectra further demonstrated different structural signatures between 
GO and its reduced products by glucose (Figure 39C). In general when GO is reduced 
to RGO, one of the typical structure changes is to form sp2 domain structure. The 
change could be evidenced by the increased intensity ratio of the D band at 1350 cm-1 
A B 
C D 
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to the G band at 1595 cm-1 (ID/IG). As shown in Figure 39C, the ratio of ID to IG was 
0.92 for the pure GO (Figure 39C curve a); however, the ratio was increased to 1.04 
after the glucose was used to reduce the GO (Figure 39C curve b). The 13% increase in 
the ratio of ID to IG indicated the formation of RGO. We then tested the Au, Cu2O and 
Ag nanoparticles decorated RGO (Figure 39C curve c, d and e). All these samples 
showed apparent D and G bands for which the ratios of ID to IG were 1.03, 1.08 and 
1.03, respectively. These results demonstrated that GO had been reduced by glucose 
and formed a more sp2-like ordered structure.  
Structures of GO, RGO, RGO/Au, RGO/Cu2O and RGO/Ag nanocomposites 
were further characterized using powder XRD (Figure 39D). GO showed a graphitic 
diffraction peak at 11.5° (curve a), corresponding to an interlayer d-spacing of 0.73 nm. 
Compared to 0.34 nm of d-spacing of pristine graphite (0.34 nm)161, the larger d-
spacing distance indicated that the oxygenated functional groups were introduced into 
the carbon sheet. The the peak at 11.5° disappeared and a bump around 20° formed for 
the newly formed RGO (Figure 39D curve b), which demonstrated the removal of the 
oxygen-containing groups from GO and exfoliation of the layered RGO. Once metal 
(oxide) nanoparticles were introduced on the surface of the RGO, their corresponding 
peaks were evident. For example, RGO/Au (Figure 39D curve c) showed the peaks at 
38.4°, 44.2°, and 64.7° which can be assigned to (111), (200) and (220) faces of the Au 
nanoparticles. RGO/Cu2O and RGO/Ag also showed characteristic peaks at 29.5°, 
36.3° and 38.1° 42.2°, 64.5°and 77.5°, respectively, (Figure 39D curve d and e), which 
were coincided to their XRD patterns in the literatures.166-168  
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The above characterization results have confirmed our design that the GO has 
been reduced to RGO and then different types of metal (oxide) nanoparticles decorated 
on the surface of the produced RGO. Afterwards, we optimized the synthetic conditions 
for making RGO/metal (oxide) nanocomposites. RGO/Au nanocomposite was chosen 
as an example for this optimization.  
3.3. Optimization of Nanocomposite Synthesis.  
Various experimental conditions would affect the formation of RGO/Au 
nanocomposites. Here, we investigated a few important conditions that may play crucial 
roles for the formation of the designed nanocomposites. 
3.3.1 Effect of glucose.  
As the solo reductant and stablizer, glucose played an important role in the 
synthesis. Therefore, we investigate the effect of glucose on the formation of 
nanocomposite. First, glucose acted as a reductant for the generation of both gold 
nanoparticles and RGO. Thereafter, glucose served as a stabilizer for RGO and 
RGO/Au nanocomposite. We repeated the synthetic process without addition of any 
glucose to observe the resulted product. It was found that the absorption peak of GO at 
230 nm still existed in either solution before (Figure 40A, curve a) and after (Figure 
40A, curve b) the addition of HAuCl4. However, there was no peak appeared at 260 nm 
which attributed to RGO. This implied that GO was not reduced without the addition 
of glucose. Interestingly, after the addition of HAuCl4, red colored gold nanoparticles 
was still formed, with the absorption peak at 538 nm (Figure 40A, curve b). SEM image 
showed that all the gold nanoparticles were anchored to the surface of GO (Figure 40B). 
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However, compared with Figure 37C1 and C2, less gold nanoparticles were coated on 
to the surface of GO, which might be due to the loss of glucose on GO.  
 
Figure 40. (A) Absorption spectra of GO (curve a) and GO/Au nanocomposite (curve 
b) without glucose addition. (B) SEM images of the GO/Au nanocomposites without 
addition of glucose. (C) Photographs of aqueous dispersions of 0.05 mg/mL GO (a), 
RGO reduced by glucose (b), RGO/Au nanocomposites (c) and RGO reduced by the 
hydrazine hydrate (d). Solution (a), (b) and (c) were stored for about 3 months. Solution 
(d) was stored for 1 day.  
We then studied the function of glucose as a stabilizer to protect RGO from 
aggregation. As shown in Figure 40C, GO, RGO and RGO/Au nanocomposite reduced 
by glucose were stable in aqueous solution for more than 3 months (Figure 40C, a, b 
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and c). Usually, GO was reduced by the strong reductant, such as hydrazine hydrate. 
However, the instability of RGO reduced by hydrazine hydrate limited their 
applications in analysis. Therefore, we synthesized RGO using hydrazine hydrate as a 
control. The result showed that the RGO reduced by hydrazine hydrate was not stable. 
It started aggregation quickly. As shown in Figure 40C (d), the RGO totally precipitated 
in one day. This is significantly different than that three month-stable RGO obtained 
using glucose as a stabilizer.  
3.3.2. Effect of glucose-to-HAuCl4 ratio.  
The amount of glucose and precursor added into the reaction will certainly 
affect the resulting product. To better investigate their effect, we choose to study the 
effect of glucose-to-HAuCl4 ratio instead of their absolute amount. With a fixed 
concentration of GO at 0.2 mg/mL, we adjusted the glucose-to-HAuCl4 mass/volume 
ratio from 1.60/1 g/mL, 0.32/1 g/mL, 0.16/1 g/mL, to 0.10/1 g/mL during the synthesis 
process. The concentration of the added HAuCl4 was 1.0%. After collecting the 
resulting products through centrifugation, each product was characterized with SEM.  
As shown in Figure 41, the size of gold nanoparticles on RGO was similar for each 
sample, which is around 45.3 ± 0.8 nm. However, the coverage on RGO surface 
increased with more HAuCl4 addition, which was illustrated by the increased numbers 
of bright spots on RGO in the SEM images from Figure 41A to C. The difference 
between Figure 41C and D was insignificant. Both images showed high coverage with 
almost every corner of RGO covered, indicating the saturation of the gold 
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nanoparticles.  In the following experiments, the 0.16/1 (g/mL) ratio of glucose-to-
HAuCl4 composition (Figure 41C) was chosen as the optimum condition.  
3.3.3. Effect of glucose-to-GO ratio.  
The effect of amount of glucose should also be considered from its relative 
amount to GO. With a fixed ratio of glucose-to-HAuCl4 as 0.16/1 (g/mL), the effect of 
glucose-to-GO ratio on the final RGO/Au nanocomposite was investigated (Figure 42). 
We changed the glucose-to-GO mass ratio from 32/1, 16/1, to 8/1. It was found on the 
SEM images that the diameter of the gold nanoparticles on RGO decreased from 45.3 
± 0.8 nm to 29.5 ± 4.7 nm and 25.5 ± 0.6 nm as the glucose-to-GO ratio was decreased 
from 32/1 to 16/1 mg and 8/1, respectively. By fixing the concentration of HAuCl4, 
increased amount of GO would provide more binding sites for gold ions to anchor. 
Therefore, this might decrease the diameter of single gold nanoparticles on RGO.  
Figure 41. SEM images of the RGO/Au nanocomposites with different glucose-to-
HAuCl4 ratios. (A) 1.60/1, g/mL; (B) 0.32/1, g/mL; (C) 0.16/1, g/mL; and (D) 0.10/1, 
g/mL. The concentration of  HAuCl4 was 1.0 %. The amount of GO was fixed at 20.0 
mg.   
 87 
 
Figure 42. SEM images of the RGO/Au nanocomposites with different glucose-to-GO 
ratios. (A) 32/1; (B) 16/1; (C) 8/1. The amount of 1.0 % HAuCl4 was fixed at 1.0 mL.  
3.4. Electrochemical Detection of L-AA, DA and UA using a RGO/Au-Modified GCE 
as a Catalyst.  
L-AA, DA and UA play important roles in physiological processes of the 
human metabolism.169, 170 Several disease states and disorders can be monitored by 
measuring the levels of these biomolecules under physiological conditions.171-173 
However, electrochemical detection through direct oxidation of these biomolecules is 
difficult with conventional carbon electrodes because of the sluggish and irreversible 
nature of these couples.  Moreover, oxidation peaks of these three biomolecules occur 
at similar potentials, often resulting in an undistinguishable overlap when they are 
detected simultaneously. Modification of carbon electrodes with nitrogen-doped 
graphene, chitosan, carbon nanotube and gold nanoparticles improves the 
electrochemical oxidation of these three biomolecules and has provided a reliable 
means for their simultaneous detection.174-178 This improved performance has been 
especially true for a variety of recently developed gold nanomaterials. However, by 
coupling RGO with gold nanoparticles, the electrochemical analytical performance 
might be improved because of the large surface area and high conductivity of RGO. 
Meanwhile, RGO could provide a platform for gold nanoparticles to anchor on the 
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surface of electrode without other assistant molecules, like chitosan. Accordingly, we 
have investigated the electrocatalytic activity of our RGO/Au nanocomposite toward 
oxidation of L-AA, DA and UA, followed by the simultaneous detection of these 
biomolecules under physiological conditions.  
3.4.1. Electrochemical activity of RGO/Au nanocomposites.  
RGO has been widely used for electrochemical sensing due to its improved 
conductivity after reduction. Meanwhile, metal (oxide) nanoparticles have shown some 
electrocatalytic activity for the detection of biomolecules. Therefore, we evaluated the 
application of RGO/Au nanocomposites for the electrochemical detection of 
biomolecules.  
3.4.2. L-AA detection.  
The electrochemical behavior of L-AA in 0.01 M PBS (pH 7.0) at a bare GCE, 
GO-GCE, RGO-GCE and RGO/Au-GCE was investigated using CV and DPV. As 
shown in Figure 43A, the L-AA oxidation was chemically irreversible with an anodic 
peak that changed significantly in shape and potential with different electrode 
modifiers. Bare GCE and GO-modified GCE yielded broad peaks at rather positive 
potentials (> +0.3 V) consistent with sluggish electron transfer. By comparison, the 
oxidation peaks with RGO- and RGO/Au-modified GCE were shifted to a much lower 
potential (ca. 0 V). The RGO/Au-modified GCE (Figure 43A, curve d) yielded a 
particularly narrow peak (Ep-Ep/2 ca. 70 mV) and enhanced peak current. These 
characteristics are consistent with electrocatalysis of the L-AA oxidation noted for other 
types of gold-modified electrodes.179 They also provide an enhanced signal for L-AA 
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detection. To evaluate the sensitivity of the RGO/Au-modifier for detection of L-AA, 
DPV was used for concentrations of L-AA ranging from 0.1 to 2.2 mM in 0.01 M PBS. 
As shown in Figure 37C, background-subtracted peak oxidation current (I’pa) was 
centered near 0 V and increased linearly below 1 mM with a sensitivity of 4.234 
µA/mM (R2 = 0.9973) L-AA (Figure 43D).  
 
Figure 43. (A) CVs of the bare-GCE (a), GO-GCE (b), RGO-GCE (c) and RGO/Au-
GCE (d) in 0.01 M PBS (pH 7.0) containing 1 mM L-AA. Scan rate: 50 mV/s; (B) Plot 
of oxidation peak of RGO/Au-GCE versus square root of the scan rate in  0.01 M PBS 
(pH 7.0) containing 1 mM L-AA; (C) DPV curves of RGO/Au-GCE in  0.01 M PBS 
(pH 7.0) containing different concentrations of L-AA (0.1, 0.2, 0.4, 0.6, 0.8 and 1.0 
mM); (D) Plot of oxidation currents versus different concentration of L-AA at -0.014 
V. I: oxidation peak current in the presence of L-AA; I0: oxidation peak current in the 
absence of L-AA. Inset shows: the calibration curve of oxidation peak current response 
versus concentration of L-AA in the linear range of 0.1 - 1.0 mM. 
3.4.3. DA detection.  
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The CV and DPV behaviors of the RGO/Au-GCE for the DA detection were 
also investigated. As shown in Figure 44A, RGO/Au-GCE showed the highest peak 
currents compared to bare GCE, GO-GCE, and RGO-GCE, which indicated that the 
RGO/Au-GCE had the better catalytic activity and higher surface area (Figure 44A, d). 
Different from the CV behavior of L-AA (Figure 43A) and UA (Figure 45A), the DA 
showed a more chemically reversible process on the surface of  
Figure 44. (A) CVs of the bare-GCE (a), GO-GCE (b), RGO-GCE (c) and RGO/Au-
GCE (d) in 0.01 M PBS (pH 7.0) containing 160 µM DA. Scan rate: 50 mV/s; (B) Plot 
of oxidation peak of RGO/Au-GCE versus square root of the scan rate in 0.01 M PBS 
(pH 7.0) containing 80 µM DA; (C) DPV curves of RGO/Au-GCE in 0.01 M PBS (pH 
7.0) containing different concentrations of L-AA (1.0, 2.5, 5.0, 10.0 and 20.0 µM); (D) 
Plot of oxidation currents versus different concentration of DA at 0.160 V. I: oxidation 
peak current in the presence of DA; I0: oxidation peak current in the absence of DA. 
Inset shows: the calibration curve of oxidation peak current response versus 
concentration of DA in the linear range of 1.0-20.0 µM. 
RGO/Au-GCE. The anodic and cathodic peak currents were related to the square root 
of scan rate (Figure 44B), which showed that the electrochemical reaction of DA on the 
RGO/Au-GCE was a diffusion-controlled process. The sensitivity for DA detection was 
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investigated with RGO/Au-GCE using DPV. As shown in Figure 44C and D, the 
current at ca. 0.16 V increased with the addition of DA in 0.01 M PBS. The oxidation 
peak current of DA was linear to the DA concentration at RGO/Au-GCE with a linear 
function (I-I0) = 0.6277 CDA + 0.1272 (R
2 = 0.9897) in the range of 1.0 to 20 µM.  
Figure 45. (A) CVs of the bare-GCE (a), GO-GCE (b), RGO-GCE (c) and RGO/Au-
GCE (d) in 0.01 M PBS (pH 7.0) containing 200 µM UA. Scan rate: 50 mV/s; (B) Plot 
of oxidation peak of RGO/Au-GCE versus square root of the scan rate in 0.01 M PBS 
(pH 7.0) containing 200 µM UA; (C) DPV curves of RGO/Au-GCE in 0.01 M PBS 
(pH 7.0) containing different concentrations of L-AA (5, 10, 20, 40, 80 and 120 µM); 
(D) Plot of oxidation currents versus different concentration of UA at 0.290 V. I: 
oxidation peak current in the presence of UA; I0: oxidation peak current in the absence 
of UA. Inset shows: the calibration curve of oxidation peak current response versus 
concentration of UA in the linear range of 5-120 µM. 
3.4.4. UA detection.  
The same process was carried out for the detection of UA using RGO/Au-GCE 
in 0.01 M PBS. As shown in Figure 45, UA showed an oxidation peak potential at ca. 
0.32 V, which is a more negative potential than that for bare GCE and GO-GCE, and 
with the highest peak current. Similar to the electrochemical behavior of L-AA and DA, 
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UA showed a linear relationship between the oxidation peak current and the square root 
of scan rate (Figure 45B). The DPV peak current of UA was linear to the UA 
concentration at RGO/Au-GCE with a linear function (I-I0) = 0.164 CUA + 0.1863 
(R2=0.9866) in the range of 5-80 µM (Figure 45C and D).  
3.4.5. Simultaneous determination of L-AA, DA and UA.  
Based on the above results for the detection of L-AA, DA and UA, the 
RGO/Au-GCE showed great potential for the simultaneous detection of these three 
biomolecules. The oxidation peak potential differences for L-AA/DA, DA/UA, and L-
AA/UA were 200 mV, 150 mV, and 350 mV, respectively. Peak separations of their 
magnitude are generally sufficient for simultaneous analysis. Therefore, we 
investigated the simultaneous oxidatin of the L-AA (2.2 mM), DA (160 µM) and UA  
(200 µM) using DPV with different electrodes. As shown in Figure 46A, bare GCE 
showed only one peak that was the overlap of DA and UA. GO-GCE showed two peaks 
for DA and UA, which are more positive than that from RGO-GCE and RGO/Au-GCE, 
but still no peak for L-AA was observed. RGO-GCE and RGO/Au-GCE were able to 
discriminate these three analytes. However, the peak currents for RGO/Au-GCE were 
higher than that of RGO-GCE, and the peak potential difference between DA and UA 
for RGO-GCE was smaller than that of RGO/Au-GCE. This result indicated that the 
Au nanoparticles and RGO all played important roles on the electrochemical catalytic 
activity for the simultaneous detection of L-AA, DA and UA. Two combinations of 
different concentrations of L-AA, DA and UA were also investigated with RGO/Au-
GCE using DPV. As shown in Figure 46B, the peak currents for each molecule 
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increased when the concentrations of these three analytes increased. Therefore, 
RGO/Au-GCE showed a great potential for the simultaneous detection of L-AA, DA 
and UA.  
 
Figure 46. (A) DPV curves at bare-GCE (a), GO-GCE (b), RGO-GCE (c) and RGO/Au-
GCE (d) in 0.01 M PBS (pH 7.0) containing 2.2 mM L-AA, 160 µM DA, and 200 µM 
UA; (B)DPVs curves at RGO/Au-GCE in 0.01 M PBS (pH 7.0) containing different 
concentrations of L-AA, DA and UA. (a) 0.6 mM L-AA, 10 µM DA, 20 µM UA; (b) 
1.2 mM L-AA, 20 µM DA, 40 µM UA. 
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Figure 47. (A) DPV curves of the RGO/Au modified GCE in 10-times diluted serum 
containingg individual concentration of AA, DA and UA mixture. [L-AA]: 0.2, 0.4, 
0.8, 1.2, and 1.6 mM. [DA]: 1.0, 2.0, 4.0, 6.0 and 8.0 µM. [UA]: 5.0, 10.0, 20.0, 40.0 
and 60.0 µM. The calibration curves for L-AA (B), DA (C) and UA (D) in the 10-times 
diluted serum.  
3.4.6. Reproducibility.  
Using L-AA as a model, a series of repetitive measurements were carried out 
in 1.0 mM L-AA solution to demonstrate the reproducibility of the RGO/Au-GCE. The 
results of nine measurements showed a relative standard deviation (RSD) of 3.41%, 
indicating excellent reproducibility for the RGO/Au-GCE.  
3.4.7. Complex sample analysis.  
To explore the use of a RGO/Au-GCE for practical application, the electrode 
was used to detect the three species in fetal bovine serum samples. The fetal bovine 
serum was diluted 10 times with 0.01 M PBS (pH 7.0) and then spiked with certain 
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amounts of L-AA, DA and UA. As shown in Figure 47A, the peak currents for each 
analyte increased with the increased concentrations. Compared to the plot for buffer 
alone, the peak potential for each analyte was shifted to more negative values, which 
might be due to the complex matrix of the serum samples. However, for all the analytes, 
the RGO/Au-GCE showed a response range and high performance linear range (Figure 
47B, C and D). The results indicated that the RGO/Au-GCE can be used for the 
sensitive simultaneous determinations of L-AA, DA and UA in the real samples.  
4. Conclusion 
A one-pot synthetic method was developed for the fabrication of RGO/metal 
(oxide) nanocomposites using glucose as a reducing agent for both GO and metal 
(oxide) nanoparticles. With this simple method, RGO/Au, RGO/Cu2O, and RGO/Ag 
nanocomposites were easily produced. Different characterization methods successfully 
demonstrated the formation of RGO/metal (oxide) nanocomposite. Using RGO/Au as 
a model, we found that the coverage and size of gold nanoparticles on RGO were 
affected by the glucose-to-HAuCl4 ratio and glucose-to-GO ratio, respectively. 
Furthermore, with the high electrochemical catalytic activity of RGO/Au 
nanocomposites, the electrochemical behaviors of L-AA, DA and UA were investigated 
using CV and DPV. Compared to the bare GCE, GO-GCE, and RGO-GCE, RGO/Au-
GCE showed higher peak currents and larger peak potential differences for the 
detection of L-AA, DA and UA. Finally, the simultaneous detection of these three 
different analytes with high sensitivity was achieved.  
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CHAPTER VI 
ENHANCED SYNERGETIC ANTIBACTERIAL PROPERTIES OF REDUCE 
GRAPHENE OXIDE/AG NANOCOMPOSITE 
1. Introduction. 
Since the emergence of drug-resistant bacterial strains, it is important to 
develop new antibacterial agents that show better treatment efficacy in clinic.180, 181 
Therefore, nanomaterials that possess excellent antibacterial activities provide a 
promising direction for combating bacterial infections.182-184 Several nanomaterials 
have been reported as antibacterial agents, such as silver nanoparticles (AgNPs),185-187 
carbon nanotubes,188 graphene and graphene-based nanomaterials.189-195 Among these 
antibacterial nanomaterials, the use of AgNPs has been deeply investigated and they 
are undergoing the process for clinic application.196, 197  
Graphene, the novel two-dimensional carbon nanomaterial discovered in 
2004, has attracted tremendous attention from both chemists and biologist for its 
excellent mechanical, optical, thermal and electronic properties.125-127, 146, 198, 199 
Meanwhile, the great biocompatibility of the carbon nanomaterials makes graphene and 
graphene-based nanomaterials excellent candidates for biomedical applications.200-202 
Therefore, graphene-based nanomaterials have been used for the biosensing,203, 204 
bioimaging,134, 205, 206 drug delivery145, 207-209 and construction of theranostic agents for 
different diseases.210-212 Especially, the photothermal property of  
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graphene can be used for targeting therapy with controlled laser irradiation.213 Because 
of their large surface area and absorbing ability, graphene-based nanomaterials have 
been widely used for cancer chemotherapy and photothermal therapy.207, 209, 214, 215 
Recently, graphene-based materials have been used as efficient potential antibacterial 
agents.190, 191 For example, Liu et al. investigated the antibacterial activity of four 
different types of graphene-based materials and found thatgraphene oxide (GO) showed 
the highest antibacterial activity, followed by reduced graphene oxide (RGO), graphite 
and graphite oxide.191 By using the photothermal effect of RGO under near-infrared 
(NIR) irradiation, Wu et al. developed magnetic nanoparticles modified RGO 
composite to capture and kill bacteria through photothermal effect.189   
To increase the antibacterial property, the AgNPs and graphene-based 
nanomaterials were coupled together to form graphene/silver nanocomposite using 
several different methods.192, 216-219 The resultant products showed enhanced 
antibacterial activity due to their combination. Although these works showed strong 
antibacterial ability of graphene/silver nanocomposites, to the best of our knowledge, 
there has no been investigation of the synergetic effect of AgNPs and photothermal 
effect of graphene on bacteria. By coupling these two antibacterial pathways, the 
graphene/silver nanocomposite might be more efficient under NIR irradiation. 
Therefore, in this work, we developed a facile, environmental friendly method to 
fabricate RGO/Ag nanocomposite using glucose as a reducing agent. Using 
Escherichia coli (E. coli) and Klebsiella pneumoniae (Kp) as the bacterial models, the 
antibacterial efficiency of RGO/Ag nanocomposite was investigated under NIR 
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irradiation. Furthermore, bacterial cell integrity and generation of ROS species with the 
treatment of RGO/Ag nanocomposite and NIR irradiation were demonstrated to 
uncover a possible mechanism of antibacterial activity of the RGO/Ag nanocomposite 
besides photothermal effect. 
2. Materials and Methods. 
2.1. Materials and Instruments.  
Graphene oxide was purchased from Cheap Tubes Inc., VT, which was 
synthesized according to Hummer’s method from graphite flakes. Glucose (≥99.5%, 
GC grade), silver nitrate (ACS reagent, ≥99.0 %) and ammonium hydroxide (ACS 
reagent, 28.0 %) were purchased from Sigma Aldrich Inc. Phosphate buffered saline 
tablets and fetal bovine serum were purchased from Fisher Scientific. Deionized (DI) 
water (Millipore Milli-Q grade) with resistivity of 18.2 MΩ•cm was used in all 
experiments. E. coli HB101 strain was obtained from American Tissue Culture 
Collection (ATCC). Kp Xen-39 (ATCC 93A 5370), a bioluminescent pathogenic 
bacterium strain expressing LUC bioluminescence was purchased from Caliper (Santa 
Clara, CA).  
A Hitachi SU8010 field emission scanning electron microscope was used to 
take the SEM and STEM images of the RGO/Ag nanocomposite. Elemental analysis 
for different RGO/metal nanocomposites was performed by an energy-dispersive X-ray 
spectroscope (EDS) (Oxford, X-Max) installed in the Hitachi SU8010 SEM. X-ray 
diffraction (XRD) profiles were obtained with a Bruker AXS D8 advanced powder X-
ray diffraction system using Cu Kα radiation. Fourier transform infrared (FTIR) spectra 
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were obtained with a FT-IR spectrometer (Spectrum 400, PekinElmer) and UV-vis 
absorption spectra were recorded with a Lambda 1050 UV/VIS/NIR spectrometer. The 
photothermal effect study was performed by a BWF1 series fiber-coupled diode laser 
system (750 mW at 808 nm) (B&W TEK Inc). Luminescence imaging was taken by 
Caliper’s Xenogen IVIS optical imaging system (Caliper, PerkinElmer, Santa Clara, 
CA). 
2.2. Preparation of RGO/Ag Nanocomposite.   
The RGO/Ag nanocomposites were prepared using a one-pot reaction. In brief, 
5 mg homogeneous GO solution was mixed with 160.0 mg glucose for 30 min. An 80 
µL aliquot of NH4OH (28.0 %) was added quickly to the solution and refluxed for 20 
min. During this time, the color of the solution changed from brown-yellow to dark 
black, indicating the formation of RGO from GO. Afterwards, 1.0 mL of 0.5 % AgNO3 
solution was added drop wise and the mixture was refluxed for 15 min. Finally, the 
cooled dispersed solution was filtered with 0.1 µm pore size membrane to separate the 
unattached silver nanoparticles from RGO/Ag nanocomposite. Finally, the RGO/Ag 
nanocomposite was redispersed into Milli-Q water with sonication for further use.  
2.3. Antibacterial Activity Tests.  
Bacteria were cultured in Lysogeny broth (LB) medium and shaken at 37 °C 
overnight before use. The next day, the bacterial cells were harvested by centrifuge and 
dispersed in PBS with an optical density at 600 nm (OD600) of 1.0. Then, the bacteria 
were diluted to 108 CFU mL-1 with sterile PBS. The samples of GO, RGO, AgNPs, and 
RGO/Ag nanocomposites in PBS were incubated with bacteria suspension, 
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respectively. The samples were incubated at 37 °C for 2 hours followed by the 
irradiation of 808 nm laser for another 10 min. Finally, 100 µL of the bacteria 
suspension was added into 900 µL LB medium for the growth in a shaking incubator at 
37 °C overnight. The concentration of bacteria was finally determined by measuring 
OD600. Meanwhile, the plate count method was used to compare the killing effect of 
RGO/Ag nanocomposite. Briefly, the bacteria suspension in LB medium treated with 
RGO/Ag nanocomposites was plated on LB-agar plates, and incubated at 37 °C 
overnight. The photographs were taken by commercial camera and the bioluminescence 
images were taken by IVIS optical imaging system. 
2.4. Cell Wall/Membrane Integrity Investigation.  
Log phase E. coli (108 CFU mL-1) cells were dispersed in 200 µL PBS with or 
without 15 µg/mL RGO/Ag nanocomposites. After growth for 2 h at 37 °C in the 
incubator, the 808 nm laser irradiation was followed for another 10 min to carry out the 
photothermal therapy. Then, the bacteria were stained with propidium iodide (PI, 1.25 
µg/mL) and 4’-6-diamidino-2-phenylindole (DAPI, 12.5 µg/mL) for 15 min in the dark, 
and then the cells were collected by centrifugation. The cells were then imaged using a 
Nikon Eclipse 80i (upright) fluorescent microscope. 
2.5. Cytotoxicity of RGO/Ag Nanocomposite to Mammalian Cells.  
SW620 cells and MH-S cells were cultured in 1640 medium supplemented 
with 10 % fetal bovine serum (FBS) at 37 °C overnight. Both cells were treated with 
various concentrations of RGO/Ag nanocomposites at 37 °C for 24 h. Then, each well 
was added 10.00 µL, 5 mg/mL MTT reagent. The cells were further incubated at 37 °C 
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for 4 h until the purple color developed. 100.00 µL DMSO solution was added into each 
well to stop reaction and dissolve the precipitant thoroughly. The absorbance of each 
well was recorded at 570 nm to determine the cell proliferation rate.   
2.6. Detection of Reactive Oxygen Species (ROS).  
The possibility of ROS production was evaluated by the 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA) assay. Briefly, a 50 µL aliquot of 
bacteria (108/mL) was added with 100 µL, 0.04 mM H2DCFDA PBS solution and 
incubated for 0.5 h. Then, 27 µL PBS or 0.1 mg/mL RGO/Ag nanocomposite (15 
µg/mL final) were added and incubated for 1 h. Then, the irradiation (0.30 W/cm2) was 
used to induce the photothermal treatment of E. coli for 10 min. After another 1 h 
incubation at 37 °C, the fluorescence intensity (Ex: 485 -495 nm; Em: 515 – 525 nm) 
was measured using microplate reader.  
3. Results and Discussion. 
3.1. Synthesis and Characterization of RGO/Ag Nanocomposite.  
Our goal was to develop a synergetic nanocomposite as an efficient 
antibacterial agent. Based on the antibacterial properties of silver nanoparticles and the 
photothermal effect of RGO, our hypothesis was that the combination of RGO and 
silver nanoparticles would generate the highly efficient antibacterial agent. As reported 
in our previous work, an environmentally friendly and facile method was used to 
prepare the RGO/Ag nanocomposite using glucose as the reducing agent and the 
resulted gluconic acid as the stabilizer. The silver nanoparticles were anchored on the 
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defects of the GO sheets. At the same time, the GO was reduced to form RGO with 
glucose.  
We characterized the formation of the RGO/Ag nanocomposite using several 
methods. As shown in Figure 48 A and B, The STEM and SEM images showed that 
silver nanoparticles were deposited on the surface of RGO sheet. From measuring more 
than fifty silver nanoparticles, the average diameter of silver nanoparticles on RGO 
sheet was determined to be 53.4 ± 0.9 nm. Then, the energy dispersive X-ray 
spectroscopy (EDS) was used to analyze the content of the nanocomposites. As shown 
in Figure 48C, the nanocomposite contained elements of carbon and oxygen, which 
indicated the presence of RGO, and silver for silver nanoparticles. The copper peak was 
associated with the TEM sample grid.  
Figure 48. STEM (A) and SEM (B), and EDS (C) of RGO/Ag nanocomposite.  
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Figure 49. Absorption spectra of GO, AgNPs, RGO, RGO/Ag nanocomposite.   
We further confirmed the formation of RGO/Ag nanocomposites using 
spectroscopic strategies. As shown in Figure 49, compared with the characteristic 
absorption peak of GO at 230 nm and pure silver nanoparticles at 400 nm, the RGO 
displayed a peak red shift to 260 nm. For RGO/Ag nanocoposites, the 260 nm 
absorption peak indicated the successful reduction of GO to RGO, and the 400 nm peak 
suggested that the silver nanoparticles were successfully deposited on the RGO sheets. 
During the reduction process, glucose was oxided to gluconic acid, which may act as a 
stabilizer on the surface of RGO to keep the nanocomposites from aggregating. As 
shown in the inset of Figure 49, even one year after the synthesis, the RGO/Ag 
nanocomposites exhibited excellent water-dispersibility. 
FTIR and XRD were used to further characterize the RGO/Ag 
nanocomposites. As shown in Figure 50A, compared with the curve of GO, the C=O 
stretching absorption band at 1725 cm-1 was dramatically decreased in RGO and 
RGO/Ag nanocomposites. Meanwhile, the C=C stretching peak at 1620 cm-1 increased. 
These changes indicated that the GO was successfully reduced during the synthesis 
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process. As shown in Figure 50B, the XRD pattern of RGO/Ag showed the peaks at 
38.1° 42.2°, 64.5°and 77.5°, which were the characteristic peaks of silver pattern.  
Figure 50. (A) FTIR of GO, RGO and RGO/Ag nanocomposite; (B) XRD pattern of 
RGO/Ag nanocomposite. 
3.2. Photothermal Effect of RGO/Ag Nanocomposite.  
Due to the increased absorption in the NIR region of RGO/Ag nanocomposite, 
the laser irradiation at 808 nm at a power density of 0.30 W/cm2 was used to study the 
photothermal effect of RGO/Ag nanocomposite in solution. Four controls were used 
including water, GO solution, AgNPs solution and RGO solution. As shown in Figure 
51, water, GO and AgNPs had virtually no change in temperature, whereas the RGO 
and RGO/Ag solution showed a rapid increase in temperature upon exposure to the 
laser in 10 min, and reached a plateau after 20 min of irradiation. With the same 
concentration of RGO (0.02 mg/mL), RGO/Ag nanocomposite showed a slightly higher 
temperature change than that of RGO solution. In addition, a larger temperature 
increase could be obtained by increasing the concentration of RGO/Ag nanocomposite. 
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These results demonstrated that the RGO/Ag nanocomposite can act as an efficient 
photothermal agent.  
Figure 51. Temperature evolution profile of H2O, AgNPs, GO, RGO and RGO/Ag 
nanocomposite upon NIR (808 nm, 0.3 W/cm2) irradiation. 
3.3. Synergistically Enhanced Antibacterial Activity of RGO/Ag Nanocomposite.  
In the above results, the RGO/Ag nanocomposite had efficient photothermal 
effect with the irradiation of 808 nm laser. Combined with the efficient antibacterial 
activity of silver nanoparticles, the RGO/Ag nanocomposite was expected to possess to 
an efficient antibacterial effect. Therefore, the synergistic antibacterial activity of 
RGO/Ag nanocomposite was investigated using E. coli and Kp. As shown in Figure 
52A, 15 µg/mL AgNPs decreased the viabilities of E. coli cells to about 85 %, which 
indicated the intrinsic antibacterial activity of AgNPs. In the other two control groups, 
including GO and RGO treatment, the E. coli cell viabilities did not dramatically 
decrease without irradiation, which illustrated that the GO and RGO did not have 
significant impact on bacteria without the irradiation. However, when the samples were 
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Figure 52. (A) Bacterial cell viability of E. coli after treatments with 15 µg/mL AgNPs, 
15 µg/mL pure GO, 15 µg/mL pure RGO and 15 µg/mL RGO/Ag nanocomposite with  
and without NIR irradiation (808 nm, 0.3 W/cm2). (B) Bacterial cell viability of Kp 
after treatments with 30µg/mL AgNPs, 30 µg/mL pure GO, 30 µg/mL pure RGO and 
30 µg/mL RGO/Ag nanocomposite with  and without NIR irradiation (808 nm, 0.3 
W/cm2). 
treated the NIR irradiation, the photothermal effect of RGO decreased the cell viability 
of E. coli to about 84 %. In contrast, the groups treated with AgNPs and GO did not 
cause cell viability decrease with the NIR irradiation due to their low photothermal 
effect (Figure 51). However, in the group treated with RGO/Ag, the cell viability of E. 
coli decreased to about 35 % without irradiation, and the cell viability of E. coli was 
1.8 % after 10 min irradiation. The extremely low cell viability of E. coli treated 
RGO/Ag was carried out by the combination of the intrinsic antibacterial activity of 
AgNPs and photothermal effect of RGO at low concentration. For the treatment of 
another bacterial, Kp, it was showed the similar results with that of E. coli. As shown 
in Figure 52B, with the same concentration at 30 µg/mL, only RGO/Ag nanocomposite 
killed the Kp cell to about 2.4 % after the irradiation. The synergistically enhanced 
antibacterial activity of RGO/Ag nanocomposite with NIR irradiation was clearly 
demonstrated.  
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Figure 53. (A) Bacterial cell viability of E. coli after treatments with different 
concentrations of RGO/Ag nanocomposite with and without NIR irradiation (808 nm, 
0.3 W/cm2). (B) Bacterial cell viability of Kp after treatments with different 
concentrations of RGO/Ag nanocomposite with and without NIR irradiation (808 nm, 
0.3 W/cm2). 
Then, we investigated the effect of the concentration of RGO/Ag 
nanocomposite on the antibacterial activity. As shown in Figure 53, with the increase 
of the concentration of RGO/Ag nanocomposite, the cell viability of E.coli and Kp both 
decreased no matter the irradiation was conducted. However, with the treatment of 
irradiation, the cell viability decreased faster. The IC50 was estimated at about 12 and 5 
µg/mL for E. coli without and with irradiation, respectively. Similarly, the IC50 for the 
treatment of Kp was estimated at about 35 and 15 µg/mL without and with irradiation, 
respectively. Apparently, RGO/Ag nanocomposite exhibited a higher antibacterial 
activity against E. coli than Kp, indicating that the Kp is a hard bacterial to be removed 
from the infection. Furthermore, CFU counting method was used to investigate the 
number of viable bacterial cells after the treatment of RGO/Ag nanocomposite and 
irradiation. As shown in Figure 54, for both E. coli and Kp cells, nearly no bacterial 
colony on the LB-agar plate was formed when RGO/Ag nanocomposite and irradiation 
0
10
20
30
40
50
60
70
80
90
100
110
120
0 25201510
S
u
r
v
ia
l 
r
a
te
 (
%
)
Concentration of RGO/Ag (g/mL)
 Without laser
 With laser 
0
20
40
60
80
100
120
0 3020105
S
u
r
v
ia
l 
r
a
te
 (
%
)
Concentration of RGO/Ag (g/mL)
 Without laser
 With laser 
A B 
 108 
 
were both treated. The groups treated with RGO/Ag nanocomposite only also decreased 
the colony counts, but not as low as that with irradiation at the same time. In contrast, 
the irradiation only has nearly no impact on the colony number.   
Figure 54. (A) Representing photographs of E. coli colonies treated with RGO/Ag 
nanocomposite formed on LB-agar plates. (a) control; (b) control with laser irradiation; 
(c) 15 µg/mL RGO/Ag nanocomposite; (d) 15 µg/mL RGO/Ag nanocomposite with 
laser irradiation. The laser irradiation was conducted under 808 nm with 0.3 W/cm2. 
Representing photographs (B) and luminescence images (C) of Kp colonies treated with 
RGO/Ag nanocomposite formed on LB-agar plates. (a) control; (b) control with laser 
irradiation; (c) 30 µg/mL RGO/Ag nanocomposite; (d) 30 µg/mL RGO/Ag 
nanocomposite with laser irradiation. The laser irradiation was conducted under 808 
nm with 0.3 W/cm2. 
3.4.  RGO/Ag Nanocomposite Caused Cell Integrity Disruption and ROS Generation 
with the Irradiation.  
To further explore the antibacterial mechanism of RGO/Ag with irradiation, 
two aspects, including cell integrity and ROS generation, were investigated using E. 
coli as a model. Two fluorescent nucleic acid dyes, DAPI and PI, were used to stain 
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Figure 55. Fluorescence images of live and dead E. coli cells after incubation with 15 
µg/mL of RGO/Ag nanocomposites for 2h: (A) E. coli with laser treatment; (B) E. coli 
with RGO/Ag nanocomposites; (C) E. coli treated with RGO/Ag nanocomposite and 
laser irradiation. Blue fluorescence shows bacterial quasi nuclear stained with DAPI, 
while red fluorescence shows dead bacteria stained with PI. The scale bar is 20 µm. 
the E.coli cells. DAPI labels all the cells, and PI can only stain the cells whose cell 
membranes are damages and lost the integrity. As shown in Figure 55A, the E. coli cells 
with only irradiation treatment had few dead cells. In the group treated with RGO/Ag 
nanocomposite only, a large number of cells were stained by PI, but a part of 
accumulated cells were still stained by DAPI only (white arrow in Figure 55B). 
However, in the group that was treated with RGO/Ag nanocomposite and irradiation, 
most of the E. coli cells were stained by both DAPI and PI, indicating disruption of cell 
walls and cell membranes. Therefore, the exposure to RGO/Ag nanocomposite 
with/without irradiation leads to the disruption of cell integrity. The damaged 
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membranes were more significant when the photothermal effect of RGO/Ag 
nanocomposite was introduced.  
Figure 56. ROS generation of E. coli by the treatment of RGO/Ag nanocomposite (15 
µg/mL) and 10 NIR irradiation. 
Furthermore, by using H2-DCF assay, we investigated the generation of ROS 
species when the RGO/Ag nanocomposite was used to treat E. coli with irradiation. As 
shown in Figure 56, compared with the control group, which the E. coli cells were 
treated with irradiation only, the fluorescent intensity significantly increased when the 
RGO/Ag nanocomposite was used to treat the bacteria. Moreover, when the irradiation 
was introduced with RGO/Ag nanocomposite, the fluorescent intentisy of H2-DCF was 
enhanced than that without irradiation. These results indicated that the treatment of 
RGO/Ag nanocomposite without/with irradiation both generated RGO species in the 
cells. Even though it was unclear that the generation of ROS species is direct or indirect 
production, the ROS species should be responsible for the antibacterial activity of 
RGO/Ag nanocomposite. If the ROS species was generated directly from the RGO/Ag 
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nanocomposite with the irradiation, the RGO/Ag nanocomposite would be potential 
photodynamic therapeutic agent both bacterial infection and other diseases like cancer.  
Figure 57. Relative cell viability of SW620 and MH-S after culturing with different 
concentrations of RGO/Ag nanocomposite varying from 0, 5, 10, 20, 30 to 40 µg/mL 
for 24 h at 37 °C. After the addition of MTT reagent and 4 h incubation at 37 °C, stop 
solution was added and followed by overnight incubation. The absorbance of each 
sample was recorded at 570 nm to determine the cell proliferation rate. 
3.5.  Cytotoxicity Investigation.  
To investigate the cytotoxicity of RGO/Ag nanocomposite toward mammalian 
cells, two cell lines, including a macrophage cell line (MH-S) and a colon cancer cell 
line (SW620), were used. The cell viabilities of these cell lines treated with different 
concentrations of RGO/Ag nanocomposite for 24 h were investigated using MTT assay. 
As shown in Figure 57, after treatment of RGO/Ag nanocomposite for 24 h at 20 
µg/mL, both MH-S cells and SW620 cells still have more than 75 % live cells. 
However, more than 98 % of E. coli and Kp were killed within 2 h followed by 10 min 
irradiation at the same concentration of 20 µg/mL. The viabilities of both cells retained 
above 60 % at higher concentrations, indicating that RGO/Ag nanocomposite may be a 
low cytotoxic, efficient antibacterial agent with irradiation.  
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4. Conclusions. 
In conclusion, a facile and environmentally friendly method was introduced to 
prepare RGO/Ag nanocomposite using glucose as a reducing agent. With intrinsic 
antibacterial activity of AgNPs and photothermal effect of RGO, the RGO/Ag 
nanocomposite was used to kill bacterial with high efficiency. The MIC of RGO/Ag 
nanocomposite coupled with irradiation against E. coli and Kp were 5 µg/mL and 10 
µg/mL, respectively. The results demonstrated the the RGO/Ag nanocomposite showed 
better performance of bactericidal effect against E. coli than that toward Kp. Besides 
the photothermal effect of RGO/Ag nanocomposite, cell disruption and generation of 
ROS species might be other reasons for the high efficient antibacterial activity. 
Moreover, the RGO/Ag nanocomposite showed low cytotoxicity at the low 
concentrations which are sufficient for killing bacteria. Overall, the results in this work 
combined the intrinsic antibacterial activity of AgNPs and photothermal effect of RGO 
to construct an enhanced synergetic antibacterial agent that has potential to be used in 
industry and clinic.
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CHAPTER VII 
LONG RANGE FLUORESCENCE QUENCHING OF GRAPHENE OXIDE WITH 
RIGID SILICA SHELL AS TUNABLE SPACER  
1. Introduction. 
Graphene, the novel two-dimensional carbon nanomaterial, has attracted 
tremendous research interest due to its excellent optical, electrical, thermal, and large 
surface properties.126, 202, 220 Using the modified Hummer’s method, graphene oxide 
(GO) can be easily produced and scaled up.221 GO possesses unique optical properties 
compared to the pristine graphene, due to the destruction of the sp2 carbon structure. 
The band-zero graphene generates adjustable band-gaps in GO, making them suitable 
for fluorescence imaging and construction of optical devices.222-224 In addition, oxygen-
containg groups, such as carboxyl and hydroxyl groups provide the high aqueous 
solubility and active sites for further modification.199 Furthermore, it has been reported 
that GO is also excellent quencher for fluorophores and quantum dots.100, 225-229 It has 
been widely used for the fabrication of fluorescent biosensors based on their quenching 
ability.127, 230, 231 Through π-π stacking, single-stranded DNA (ssDNA) modified with 
fluorophore can be absorbed onto the surface of GO, leading to the fluorescence 
quenching. When the ssDNA forms double-stranded DNA (dsDNA) or well-folded 
structures, the distance between the fluorophore and GO surface will be
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increased to restore fluorescence emission.203, 232 This strategy has been used for 
sensitive detection of nucleic acids, proteins, small molecules and metal ions.204, 233-237 
Therefore, sophisticated design of biosensors and bioimaging agents using GO would 
be dramatically improved by the fundamental investigation of the quenching ability of 
GO to fluorophores. However, the quenching mechanism of GO has been rarely 
reported. 
Theoretically, the energy transfer rate from fluorophore to GO was dependent 
on the distance between the donor and acceptor followed a d-4 dependency.238 In 
contrast to the traditional FRET process with d-6 dependency,239 the quenching ability 
of GO should be better than traditional quencher. Recently, Huang et al.240 and Piao et 
al.241 investigated the quenching ability of GO to fluorophores of FAM and Cy3.5, 
respectively. DNA strands were used to separate the fluorophores and GO in these two 
works with variations in the length of DNA strands and the formation of dsDNA 
strands. The Froster distance (d0), which was defined as the distance for 50 % 
quenching, was found as 7.5 ± 0.6 nm in Huang’s work.240 However, in these two 
works, DNA strands were chosen for the distance spacer, which led to a serious 
limitation. Due to the flexibility of DNA strands, even in the dsDNA format, they may 
have leaned at an angle to the surface of GO. The distance calculation through counting 
bases in DNA might cause the miscalculation because of the assumption that these 
DNA strands were perpendicular to the surface of GO. For instance, Piao et al. reported 
the quenching efficiency of GO increased after 13 bases, which implied the bended 
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structure of dsDNA. Therefore, a better model is necessary for more precious 
investigation of the quenching ability of GO to fluorophores.  
Herein, we demonstrated that a rigid spacer can be used to better understand 
the quenching ability of GO. As we reported before, silica is an inert rigid structure that 
can be used to separate the fluorophores and gold nanoparticles in the investigation of 
the metal-enhanced fluorescence.242, 243 Therefore, by coating different thicknesses of 
silica spacers on the fluorophores, the quenching ability of GO to fluorophores can be 
delicately measured in this model. 
2. Methods and Materials. 
2.1. Materials and Instruments.  
Single Layer Graphene oxide (GO) was purchased from Cheap Tubes Inc., 
VT. Tris(bipyridine)ruthenium(II) chloride (Rubpy), 1-Hexanol (99+ %), 
Tetraethylorthosilicate (TEOS, 98%), 3-ami-nopropyltriethoxysilane (APTES, 95%) 
were purchased from Sigma-Aldrich. Ammonium hydroxide (28.0% − 30.0%), cyclo-
hexane (HPLC grade), and ethanol were obtained from Fisher Scientific Co. 
Carboxytetramethylrhodamine-succinimidyl ester (TAMRA-SE) was purchased from 
Molecular Probes. Deionized (DI) water (Millipore Milli-Q grade) with resistivity of 
18.2 MΩ•cm was used in all experiments. 
A Hitachi SU8010 field emission scanning electron microscope was used to 
take the SEM images of the composite of silica nanoparticles and graphene oxide. A 
Hitachi 7500 transmission electron microscope (TEM) was used to take the images and 
measure the diameters of silica nanoparticles. UV-vis absorption spectra were recorded 
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with a Lambda 1050 UV/VIS/NIR spectrometer. A Jobin Yvon Horiba Fluorolog 
spectrofluorometer was employed for fluorescence intensity measurements. Zeta 
potential was detected using a Zetasizer (Marlwen, model of Nano-ZS). An Eppendorf 
5810 R centrifuge was used to wash silica nanoparticles. 
2.2. Synthesis of SiNPs@TAMRA.  
First, the SiNPs cores were synthesized using the reverse microemulsion 
method. Briefly, 7.5 mL cyclohexane, 1.6 mL 1-hexanol, 1.8 mL Triton X-100, and 
0.48 mL H2O were mixed with vigorous stirring.  After stirring for 15 min, 100 µL 
NH4OH was added followed by the addition of 400 µL TEOS to initiate the formation 
of silica nanoparticles. After 30 min, 80 µL APTES was injected to co-polymerize with 
the TEOS to provide amino groups on the surface of SiNPs. The reaction was allowed 
to proceed overnight and was followed up with ethanol and water washes. Finally, the 
formed SiNPs with amino groups were dispersed in 20 mL water with concentration of 
4 mg/mL. For conjugating TAMRA onto the surface of SiNPs, 20 mL of 4 mg/mL 
SiNPs was mixed with 0.5 mL TAMRA-SE and allowed to conjugate overnight. The 
SiNPs@TAMRA was then washed with water three times to obtain  4 mg/mL 
SiNPs@TAMRA dispersed in water.  
2.3. Formation of SiNPs@TAMRA@Si-NH2.  
To coat a layer of silica on the surface of SiNPs@TAMRA with different 
thicknesses, the modified Stӧber method was used. Briefly, 10 mL EtOH, 0.2 mL of 4 
mg/mL SiNPs@TAMRA prepared in the previous step, 0.18 mL water, 0.5 mL 
NH4OH, and different amounts of TEOS, ranging from 0.3, 0.6, 1.0, 2.0, 3.0, 4.0, 5.0, 
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7.5, and 10.0 µL, were stirred together for 2 hours. Then 0.15, 0.30, 0.50, 1.00, 1.50, 
2.00, 2.50, 3.25, and 7.5 µL APTES was added into the mixture to modify amino groups 
on the surface of silica shell. After 0.5 hour, EtOH and water were used to wash the 
SiNPs@TAMRA@Si-NH2 via centrifuge.  
2.4. Formation of SiNPs@Rubpy@Si-NH2.  
First, the SiNPs cores were synthesized using the reverse microemulsion 
method as previously mentioned. Then, a silica coating process coupled with Rubpy 
doping was carried out by the modified Stӧber method. Briefly, 10 mL EtOH, 2 mL of 
4 mg/mL SiNPs prepared in the previous step, 0.5 mL NH4OH, 1 mL 0.1 M Rupby 
solution and 20 µL TEOS were mixed to start the doping of Rubpy into the silica shell. 
Furthermore, to adjust the distance between the Rubpy and GO, different thicknesses 
of silica shell were generated by a similar process to section 2.3 of altering the amount 
of the TEOS and APTES during the coating process.  
2.5. Fluorescence Quenching Investigation.  
The experiment was carried out on a Jobin Yvon Horiba Fluorolog 
spectrofluorometer. Briefly, 100 µL, SiNPs@TAMRA@Si-NH2 (equi 0.1 nM 
TAMRA) solution was placed in a quartz cuvette for the fluorescence measurement. 
The excitation wavelength was set at 540 nm. The fluorescence spectrum was recorded 
from 560 nm to 650 nm. The slits for excitation and emission were set at 5 nm. After 
the recording of the origin fluorescence spectrum of SiNPs@TAMRA@Si-NH2, 1 µL 
of 5 mg/mL GO was added into the solution and mixed using pipette. The fluorescence 
spectrum was measured 2 min later to investigate the quenching ability.  
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2.6. Fluorescence Lifetime Measurement.  
100 µL of SiNPs@TAMRA@Si-NH2 (equi 0.1 nM TAMRA) solution was 
loaded into a quartz cuvette for lifetime measurement. The fluorescence lifetime was 
collected using a Jobin Yvon Horiba Fluorolog spectrofluorometer equipped with LED 
laser. The LED laser light source at 494 nm was used for the excitation. The emission 
data was collected at 575 nm with an 8 nm slit.   
3. Results and Discussion. 
3.1. Design of SiNPs@TAMRA@Si-NH2 Wrapped with GO.  
The fluorescence quenching ability of GO has been widely used for the 
fabrication of sensitive biosensors and bioimaging agents. However, the fundamental 
investigation of GO quenching ability was poorly elucidated by two recently works 
which used flexible DNA strands as the spacer. Herein, we designed a rigid spacer 
between GO and fluorophores, which would diminish the effect of inaccurate distance 
calculation with the DNA strands spacer. In our previous study, rigid silica shell was 
used to investigate the fluorescence enhancement effect of gold nanoparticles by 
adjusting the distance between gold nanoparticles and fluorophores. Therefore, we used 
the silica shell as a spacer between fluorophores and GO in this work to investigate the 
quenching ability of GO. Silica shell is used because of its inert nature, which does not 
change the interaction between the fluorophores and the investigated nanomaterials. As 
shown in Scheme 4, amino group modified silica nanoparticles (SiNPs) was 
synthesized firstly using the reverse micro-emulsion method. Then, a fluorophore, 
named TAMRA-SE was conjugated to the SiNPs through the interaction of amino 
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groups and succinimidyl ester group. Therefore, SiNPs@TAMRA was therefore 
formed without any silica shell coating. In order to adjust the distance between TAMRA 
and GO in the following steps, a silica shell was coated using the Stӧber method. In this 
coating process, APTES was added to co-polymerization with TEOS to form amino 
groups on the surface of final nanopartilces (SiNPs@TAMRA@Si-NH2). The thickness 
(d) of the silica shell was controlled by the amount of TEOS and APTES. With addition 
of GO to the solution of SiNPs@TAMRA@Si-NH2, GO would wrap the positively 
charged SiNPs@TAMRA@Si-NH2 through electrostatic interaction and thereby to 
quench the fluorescence of TAMRA with distance dependence.  
 
Scheme 4. Schematic of synthesis of SiNPs@TAMRA@Si-NH2 nanocomposite and 
investigation of fluorescence quenching ability of GO to TAMRA with distance (d) 
dependent.  
3.2. Characterization of GO.  
GO was purchased from the commercial company and dispersed into water 
through 2 hours ultrasonic treatment to obtain the stable solution (5 mg/mL). The SEM 
and STEM in Figure 58A and 58B show that the GO sheet size is in the micrometers 
range. As shown in Figure 58A, the wrinkles of GO were clearly observed from the 
SEM image. The large size and flexibility of GO sheet ensured the ability of the GO to 
wrap the silica nanoparticles through electrostatic binding force. Figure 58C 
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demonstrated the UV-vis absorption spectrum of GO solution. The strong peak at ca. 
230 nm was due to the π-plasmon of the sp2 carbon structure and the shoulder around 
300 nm was ascribed to the n to π* transitions.  
Figure 58. SEM (A), STEM (B) images and absorption spectrum (C) of GO.  
3.3. Fluorescence Quenching of GO to SiNPs@TAMRA@Si-NH2.  
Graphene oxide was reported to quench several fluorescent dyes, from visible 
to near-infrared region. Therefore, it is useful for the fabrication of fluorescent 
biosensors. We initially investigated the quenching ability of GO to the TAMRA 
conjugated on the surface of amino groups modified silica nanoparticles 
(SiNPs@TAMRA). As shown in Figure 59A, the shape of absorption spectra of 
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SiNPs@TAMRA before (curve a) and after (curve b) incubation with GO are similar 
to each other. The only difference was the intensity of the two curves, which resulted 
from the addition of GO. However, after the addition of GO to SiNPs@TAMRA, the 
fluorescence intensity of TAMRA was almost quenched (~ 93.4 %) (Figure 59B). To 
investigate the mechanism of the fluorescence quenching property of GO, the liftetimes 
of SiNPs@TAMRA before and after addition of GO were measured. As shown in 
Figure 59C, the lifetime of SiNPs@TAMRA decreased from 2.12 ± 0.02 ns to 0.20 ± 
0.02 ns. The quenching efficiency was found to be 90.6% calculated from the lifetime 
change using  𝑄 = 1 − 𝜏/𝜏0 , where τ0 and τ are the lifetimes of SiNPs@TAMRA 
without and with addition of GO, respectively. The close value of quenching 
efficiencies calculated from the total fluorescence intensity and lifetimes indicated that 
the main quenching mechanism of GO to TAMRA was dynamic quenching. 
Meanwhile, the similar absorption spectra pattern also supported this point. Due to the 
electrostatic interaction between the positive charged SiNPs@TAMRA and negative 
charged GO, GO should have adsorbed onto the surface of SiNPs@TAMRA once they 
were mixed together. Therefore, TEM and SEM images were used to demonstrate the 
interaction between GO and SiNPs@TAMRA. As shown in Figure 59D, the wrinkles 
on the edges of SiNPs@TAMRA (white arrow) clearly indicated the totally coverage 
of the GO on the SiNPs@TAMRA. The distance between TAMRA and GO was 
estimated as 0 nm because the TAMRA was covalently conjugated onto the surface 
SiNPs and the GO was compactly wrapped on the surface of SiNPs through amino 
groups.  
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Figure 59. Absorption (A) fluorescence (B) spectra of SiNPs@TAMRA without (a) and 
with (b) GO. λex = 540 nm. (C) Lifetime measurements of SiNPs@TAMRA without 
(b) and with (c) GO. Curve a is the reference. 492 nm LED laser was used in the lifetime 
measurement. (D) SEM image of SiNPs@TAMRA with GO. Inset is TEM image of 
SiNPs@TAMRA with GO, bar is 200 nm. The white arrows indicate the wrinkle of GO 
wrapped on the surface of nanoparticles.  
To find the maximum quenching efficiency of GO with SiNPs@TAMRA, we 
measured the fluorescence of SiNPs@TAMRA with different concentrations of GO. 
As shown in Figure 60, the fluorescence intensity of SiNPs@TAMRA decreased with 
the increase of the concentration of GO. The quenching efficiency reached a plateau 
after 10 µg/mL. Therefore, we chose 50 µg/mL GO for the following experiment to 
ensure that the quenching efficiency was only related to the distance between TAMRA 
and GO but not to the concentration of GO. 
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Figure 60. Fluorescence quenching of SiNPs@TAMRA with different concentration of 
GO. (A) Fluorescence spectra of SiNPs@TAMRA with different concentrations of GO. 
From top to bottom: 0, 1.0, 2.0, 3.0, 4.0, 5.0, 7.5, 10.0 and 20.0 µg/mL. (B) Quenching 
efficiency GO to SiNPs@TAMRA with different concentrations.  λex = 540 nm; λem 
= 575 nm. 
Afterward, the distance between TAMRA and GO was adjusted by the silica 
shell thickness. As shown in Figure 61, the different thicknesses of silica shell were 
coated on the surface of SiNPs@TAMRA using the Stӧber method through changing 
the amount of TESO and APTES. The sizes of the resulting nanoparticles were 
measured by TEM. The distance between TAMRA and GO was calculated by 
subtracting the radius of the SiNPs@TAMRA from SiNPs@TAMRA@Si-NH2. With 
the increase in the amount of TEOS, the distances were calculated as 0.3, 1.2, 6.5, 14.7, 
and 34.5 nm. Meanwhile, the amino group modified on the outside surface of the silica 
nanoparticles ensured the positive charge that can be adsorbed with GO. After 
introduction of 50 µg/mL GO, the fluorescence intensity of TAMRA in silica 
nanoparticles was quenched. With the increase of the thickness of the silica shell, the 
quenching efficiency decreased. As shown in Figure 62, the distance between TAMRA 
and GO was larger than 30 nm and the quenching efficiency of GO was still around 30 
%, which indicated the long-distance quenching ability of GO. 
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Figure 61. TEM images of SiNPs@TAMRA@Si-NH2 with different thickness of 0, 0.3, 
1.2, 6.5, 14.7, and 34.5 nm (A to F).  
According to the theoretical calculations of the quenching effect of graphene, 
it showed a relationship of  𝑄 = 1/[1 + (
𝑑
𝑑0
)4] , where d is the distance between 
graphene fluorophore and d0 was the characteristic distance. The d0 is reported different 
from each other regarding the various systems, ranging from ~ 5 to 8 nm.240, 244 By 
measuring the quenching efficiency of our TAMRA-GO system, the GO quenched the 
~ 50% of TAMRA fluorescence when the silica thickness was ~ 6.54 nm (Figure 62). 
This concluded that the d0 for TAMRA-GO system was about 6.54 nm.  
The quenching efficiency calculated from the steady-state fluorescence 
reflected the total quenching, including static and dynamic components. We then 
measured the lifetime of TAMRA when GO was presented to quench the fluorescence. 
The quenching efficiency was calculated by 𝑄 = 1 − 𝜏/𝜏0, where τ0  is the lifetime of 
TAMRA in the absence of GO, and τ is the lifetime of TAMRA in the presence of GO. 
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As shown in Figure 62B, the quenching efficiency calculated from lifetime was also 
plotted with the thickness of silica shell. As expected, it decreased with the increase of 
the thickness of silica shell. The quenching efficiencies obtained from these two 
methods were similar with each other, indicating that the main quenching mechanism 
was dynamic quenching.  
Figure 62. (A) Fluorescence spectra of SiNPs@TAMRA@Si-NH2 with GO. The 
distances between TAMRA and GO were 0, 0.3, 1.2, 6.5, 14.7, 34.5 nm (curve a to f). 
Curve g was SiNPs@TAMRA without addition of GO. (B) Quenching efficiency of 
the doped TAMRA as a function of the distance. The quenching efficiency was 
calculated based on average fluorescence lifetime (squares) and from steady-state 
fluorescence intensity (circles). The concentrations of nanoparticles were equi ca 0.1 
nM of TAMRA. λex = 540 nm; λem = 575 nm. 
3.4. Fluorescence Quenching of GO to SiNPs@Rubpy@Si-NH2.  
To investigate the universal quenching ability of GO, we changed the 
fluorophore from TAMRA to Rubpy, which is another useful dye with the emission of 
600 nm. Instead of the covalent conjugation between amino groups on silica 
nanoparticles and TAMRA, the Rubpy was doped into a thin layer of   
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Figure 63. TEM images of SiNPs (A), SiNPs@Rubpy (B), and SiNPs@Rubpy@Si-
NH2 with different thicknesses of 2.4, 3.0, 3.7, 4.8, 7.8, 10.1, and 15.6 nm (C to I). 
Figure 64. Fluorescence quenching of SiNPs@Rubpy with different concentrations of 
GO. (A) Fluorescence spectra of SiNPs@ RuBpy with different concentrations of GO. 
From top to bottom: 0, 10, 20, 30, 40 and 50 µg/mL. (B) Quenching efficiency GO to 
SiNPs@ RuBpy@Si-NH2 with different concentrations. λex = 460 nm; λem = 600 nm. 
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silica shell (SiNPs@Rubpy). Then, another layer of pure silica shell was coated on the 
surface of Rubpy-doped silica nanoparticles and followed with the modification of 
amino groups (SiNPs@Rubpy@Si-NH2). The distance between Rubpy and GO was 
calculated by subtracting the radius of SiNPs@Rubpy@Si-NH2 by the radius of 
SiNPs@Rubpy. The distances were obtained from 2.4, 3.0, 3.7, 4.8, 7.8, 10.1, to 15.6 
nm (Figure 63). We first investigated the quenching efficiency of GO to SiNPs@Rubpy 
with different concentrations (Figure 64). As the concentration of GO increased, the 
fluorescence intensity of Rubpy at 600 nm decreased and reached a plateau when the 
concentration of GO was 50 µg/mL. Therefore, we chose 50 µg/mL of GO for the 
following quenching efficiency investigation. As shown in Figure 65A, by increasing 
the distance between Rubpy and GO, the fluorescence intensity of Rubpy recovered 
from the quenching state. The quenching efficiency calculated from the steady-state 
fluorescence intensity was plot with the distance (Figure 65B). It followed the similar 
trends as that of the TAMRA nanoparticles. The characteristic distance was evaluated 
around 5.0 nm smaller than that of the TAMRA, when the quenching efficiency was 50 
%. The lifetime of Rubpy was dramatically decreased when it was doped into the thin 
layer of silica shell, which was out of our detection limit of the instrument. Therefore, 
the dynamic quenching mode was not investigated. Overall, the GO can quench the 
fluorescence of Rubpy with a distance-dependent manner.  
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Figure 65. (A) Fluorescence spectra of SiNPs@Rubpy (a) and SiNPs@Rubpy@Si-NH2 
with 50 µg/mL GO.  The distances between Rubpy and GO were separated by 2.4, 3.0, 
3.7, 4.8, 7.8, 10.1, and 15.6 nm silica space (curve b to h). (B) Quenching efficiency of 
the doped Rubpy as a function of the distance. The concentrations of nanoparticles were 
equi ca 0.1 nM of Rubpy. λex = 460 nm; λem = 600 nm. 
4. Conclusions. 
In conclusion, we have demonstrated the quenching ability of GO with two 
different fluorophores, TAMRA and Rubpy. The distance between the fluorophore and 
GO was adjusted by a rigid silica layer, which is more accurate than soft DNA strands. 
The quenching efficiency of GO to these two fluorophores followed a distance-
dependence with characteristic distance of 6.54 and 5.0 nm, respectively. By comparing 
the steady-state total quenching efficiency and dynamic quenching efficiency of GO to 
TAMRA, we found that the main quenching mechanism was dynamic quenching. 
Moreover, the quenching range of GO with these fluorophores was much greater than 
the traditional FRET distance (10 nm). By exposing the long-range quenching 
properties of GO to fluorophores, we further promoted applications of GO in analytical 
and biomedical probes design as a carrier and fluorescence quencher.
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CHAPTER VIII 
GRAPHENE OXIDE KILLS KLEBSIELLA PNEUMONIA BACTERIUM IN 
MACROPHAGES AND IN MICE 
1. Introduction 
Due to the excessive use of antibiotics in the last century, super bacteria which 
are resistant to those antibiotics can cause serious problems in the hospital.245 For 
instance, Klebsiella pneumoniae (Kp), which is a clinical pneumococcus, continuously 
acquires carbapenem-resistant properties due to the wide usage of carbon penicillin 
antibiotics in hospitals.246, 247 Further, Kp can easily infect patients who have pre-
conditions, including cystic fibrosis, asthma and emphysema.247 Therefore, it is urgent 
to develop effective new antibiotics and/or therapeutic agents to fight against the 
multiple-drug-resistant (MDR) bacteria.248 Recently, a variety of antibacterial 
nanomaterials have attracted attention.249-251 The antibacterial mechanisms of 
nanomaterials may be different from those of conventional antibiotics and can be used 
as auxiliary or alternative strategy to facilitate therapy of MDR bacterial infection.252, 
253 For example, silver nanoparticles have been reported to efficiently kill bacteria and 
have already entered the market.253-255 More recently, graphene, a 2-dimensional carbon 
nanomaterial, has shown great potential as an antibacterial agent.256-258  
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Graphene has been tested for several fields owing to its large surface area as 
well as excellent mechanical, electronic, and optical properties.199, 220 In biomedical 
fields, graphene-derivatives, including graphene oxide (GO), reduced graphene oxide 
(rGO), graphene quantum dots (GQDs) and graphene-based nanocomposites, have 
been widely examined for applicability in biosensors,233, 259 bioimaging,145, 205, 260 drug 
delivery,209, 215 and photothermal therapy.146, 201, 261 Meanwhile, graphene-derivatives 
can be used for killing bacteria. For example, graphene oxide and reduced graphene 
oxide showed toxicity to both Gram-positive and Gram-negative bacteria.256, 257 The 
contact of graphene derivatives with cell membrane caused direct damage to bacteria 
because of their extremely sharp edges.  Liu et al. compared the antibacterial 
properties of four different carbon materials, including graphite, graphite oxide, GO 
and rGO.191 They found that GO possessed the highest antibacterial activity while 
graphite oxide exhibited the lowest antibacterial activity. Meanwhile, a three-step 
antimicrobial mechanism was proposed for graphene-based materials, which are also 
applicable for carbon nanotubes. Moreover, the lateral size of GO affected the 
antibacterial activity.262 The larger GO sheets resulted in stronger antibacterial activity 
than that of the smaller one, as the larger GO sheets could effectively isolate bacterial 
from environment by wrapping the whole bacterium. Recently, the photothermal and 
photodynamic effects of graphene-based nanomaterials were also used to kill bacteria 
through different pathways. 193, 263  However, all these studies just conducted the 
antibacterial activity investigation at the bacterial level, which is based on the common 
bacteria such as Escherichia coli and Staphylococcus aureus by evaluating their 
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viability. The impact on infection ability of the bacteria treated by GO was not tested. 
Meanwhile, the clinical MDR bacteria were seldom used for evaluating the antibacterial 
activity of these nanomaterials.  
In this work, we used the MDR bacterium, Kp, as a model to investigate the 
antibacterial activity of GO. The invasive potency of Kp after treatment with GO was 
investigated in both cell culture and animal models. The results indicated that the Kp 
treated with GO was effectively killed and the infection ability was dramatically 
inhibited in cell culture and animals. To our knowledge, this is the first report studying 
the antibacterial property of GO in vivo with a MDR bacterium.  
 
2. Methods and Materials.  
2.1 Materials and Instruments.  
GO was purchased from Cheap Tubes Inc. (Grafton, VT). Phosphate buffered 
saline tablets and fetal bovine serum were purchased from Fisher Scientific (Waltham, 
MA). Deionized (DI) water (Millipore Milli-Q grade) with resistivity of 18.2 MΩ•cm 
was used in all experiments. C57BL/6J mice were purchased from Charles River (San 
Diego, CA). Kp Xen-39 (ATCC 93A 5370), a bioluminescent pathogenic bacterium 
strain expressing LUC bioluminescence was purchased from Caliper (Santa Clara, CA). 
Kp (ATCC 43816 serotype II) was obtained from Dr. Virginia Miller (University of 
North Carolina).  Kp Xen-39 (ATCC 93A 5370) was used in the bioluminescene 
imaging experiment and Kp (ATCC 43816 serotype II) was used for other infection of 
mice. Pseudomonas aeruginosa (Pa) WT PAO1 was a gift from S. Lory (Harvard 
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Medical School, Boston, MA). E. coli HB101 strain was obtained from American 
Tissue Culture Collection (ATCC). All of the animal experiments were approved by 
Institutional Animal Care and Use Committee (IACUC) at the University of North 
Dakota. 
A Hitachi SU8010 field emission scanning electron microscope was used to 
capture SEM and STEM images of GO. A Zetasizer (Marlwen, model of Nano-ZS, 
Westborough, MA) was used to measure the Zeta potential of GO. UV-vis absorption 
spectra were recorded with a Lambda 1050 UV/VIS/NIR spectrometer (PerkinElmer, 
Santa Clara, CA). Luminescence imaging was taken by Caliper’s Xenogen IVIS optical 
imaging system (Caliper, PerkinElmer, Santa Clara, CA). The OD value at 560 nm for 
3-(4,5-dimethyl-2-thiazolyl)-2,5- diphenyltetrazolium bromide (MTT) and nitroblue 
tetrazolium (NBT) assays was measured by a Multiskan spectrum spectrophotometer 
(Thermo Scientific, Waltham, MA). 
2.2.Antibacterial Activity Tests.  
Kp Xen-39 was cultured in Lysogeny broth (LB) medium with shaking at 37 
°C overnight before use.264 The next day, the bacterial cells were harvested by 
centrifugation and dispersed in PBS with an optical density at 600 nm (OD600) of 0.1 
for a concentration of 108 CFU mL-1.265 The samples of GO in PBS were incubated 
with bacteria suspension for 2 h at 37 °C. Finally, 100 µL of the bacteria suspension 
was added into 900 µL LB medium for the growth in a shaking incubator at 37 °C 
overnight. The concentration of bacteria was finally determined by measuring OD600 
and the bioluminescence image was taken by IVIS optical imaging system. Meanwhile, 
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the plate count method was used to demonstrate the killing effect of GO. Briefly, the 
bacteria suspension in LB medium treated with GO was plated on LB-agar plates, and 
incubated at 37 °C overnight. The antibacterial activity of GO to E. coli and Pa was 
investigated similarly with Kp by changing the bacteria. 
2.3.Cell Infection.  
The log-phase Kp bacteria (OD600 =1.0) was incubated with different 
concentrations of GO (Kp-GO) for 2 h in PBS at 37 °C. The same Kp bacteria without 
treatment of GO were used as a control. 0.1 mL Kp-GO and control Kp bacteria were 
both diluted with 0.9 mL LB medium for the incubation at 37 °C for overnight. Then, 
murine alveolar macrophage (MH-S) cells were infected with control Kp and Kp-GO 
for 8 h. MH-S cells were infected by Kp at MOI 10:1 bacteria-cell ratio and then washed 
three times with PBS to remove the floating bacteria. Bacteria on the surface of the cells 
were killed by adding 100 µL polymyxin B and left in incubation for another 1 h. The 
viability of MH-S cells after infection was determined by MTT assay.266 Briefly, 1 
µg/ml MTT was added into each well incubated with the infected cells and incubated 
at 37°C until color change.267 MTT was reduced to form a purple formazan product 
inside living cells. Afterward, stop solution was added to dissolve the formazan product, 
and the absorbance was quantified by measuring wavelength of 560 nm using a 
spectrometer plate reader.268  
2.4.Mouse Infection.  
First, the Kp bacteria (OD600 =0.1) were treated with 0.25 mg/mL GO for 2 h 
in PBS at 37 °C. The Kp bacteria without treatment of GO were used as a control. For 
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in vivo imaging of the bioluminescent Kp Xen-39 in mice, 50 µL GO treated and 
untreated Kp Xen-39 were intraperitoneally injected into two groups of mice after 
anesthesia with 40 mg/kg ketamine. The bioluminescence images were taken under 
IVIS optical imaging system at different time points from 0 to 24 h. The infection level 
was semiquantitively evaluated by the bioluminescence intensity determined by the 
ROI calculation using the IVIS software.264  
For further analysis of the antibacterial efficiency of GO in vivo, the mice 
anesthetized with 40 mg/kg ketamine were instilled with GO treated and untreated Kp 
by intranasal instillation, and sacrificed when they were moribund. Survival was 
determined using Kaplan–Meier curves. After bronchoalveolar lavage (BAL), the lung 
was excised for homogenization and fixed in 10% formalin for histological analysis. 
The formalin-fixed lung tissue was used for H&E staining to examine tissue damage 
post infection.  
The viability of alveolar macrophages (AM) was evaluated by MTT assay. 
Briefly, the AM cells were obtained from mice infected with GO treated and untreated 
Kp. The AM cells in each well were mixed with 1 µg/ml MTT and incubated at 37°C 
until color change as above.269 The superoxide anion in AM cell after infection of Kp 
was measured by NBT assay. AM cells were grown in serum-containing medium at 
37°C for 4 h and then mixed with 1 µg/ml NBT dye for another 1 h. 100 µl of stop 
solution (10% DMSO; 10% SDS in 50 mM HEPES buffer) was added into each well 
to terminate the reaction. The absorbance at 560 nm was measured using the plate 
reader after overnight incubation at 37°C.88 
 135 
 
To evaluate the infection severity of GO-treated Kp in mice, live Kp amounts 
in several organs, including the lung, liver, kidneys and spleen were analyzed. The 
organs were obtained from the different groups of mice at different time points. Then, 
the organs were grounded to determine the amount of intracellular bacteria through 
CFU. Briefly, the tissues were homogenized with PBS and spread on LB plates to 
enumerate level of bacteria. The plates were cultured in a 37°C incubator overnight, 
and colonies were counted. Meanwhile, the amounts of myeloperoxidase (MPO) 
released from the four different organs were analyzed by MPO assay. Briefly, the 100 
mg/ml tissue samples were homogenized in 50 mM hexadecyltrimethylammonium 
bromide, 50 mM KH2PO4, pH 6.0, 0.5 mM EDTA and centrifuged for 15 min at 12,000 
rpm at 4°C. Supernatants were decanted, and 100 µL of reaction buffer (0.167 mg/ml 
O-dianisidine, 50 mM KH2PO4, pH 6.0, 0.0005% mM H2O2) were added to 100 µL of 
sample. After 2 min, the absorbance was read at 460 nm using a spectrometer plate 
reader. 
2.5. Statistical Analysis.  
All experiments were performed in triplicate. Data were showed as mean ± SE 
(standard error) from the three independent experiments. All error bars stand for SE. 
Group means were compared using Student’s t-test or one-way ANOVA, using 
Graphpad Prism 5 software (La Jolla, CA).  
 
3. Results and Discussion. 
3.1. Characterization of GO.  
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GO was purchased from the commercial company (Cheap Tubes Inc.) and 
dispersed into water through ultrasonication to obtain a stable solution. Briefly, 100 
mL, 50 µg/mL GO was added with 40 mg NaOH under ultrasonic bath for 3 h to form 
stable GO. The resultant GO was purified with 0.1 µm filter. The STEM in Figure 66A 
shows that the GO sheet has the size of micrometers. Wrinkles and folds were clearly 
observed from the image. Then, the composite of GO was investigated by EDS (Figure 
66B), and the presence of carbon and oxygen was identified. The zeta potential of GO 
was -45 mV, indicating the presence of the oxygen-containing groups on the surface of 
GO (Figure 66C). The large negative charge of GO ensured the stability of GO solution. 
Then, UV-vis absorption spectrum was measured to characterize the GO solution. As 
shown in Figure 66D, the strong peak at ca. 230 nm was due to the π-plasmon of sp2 
carbon structure and the shoulder around 300 nm was ascribed to the n to π* transitions.  
Figure 66. Characterization of GO. (A) STEM image of GO. (B) EDS pattern of GO. 
(C) The zeta potential of GO. (D) The UV-vis spectrum of GO. 
 
 137 
 
3.2. Antibacterial Property of GO at the Level of Bacteria.  
The antibacterial activity of GO was firstly investigated at the bacterial level 
with GO concentrations from 0 to 500.0 µg/mL. The OD600 value and bioluminescence 
intensity were measured to determine the concentration of bacteria finally to evaluate 
the killing efficiency of GO. As shown in the inset of Figure 67A, the bioluminescence 
intensity of Kp (a Kp strain emitting bioluminescence from Caliper) in LB medium 
decreased with the increase of GO concentrations. Kp survival rates followed the same 
trend as those of the bioluminescence intensity. The survival rates decreased from 100% 
to 28.8%, 15.2%, 2.8% and 3.2% when the concentrations of GO increased from 0 to 
62.5, 125.0, 250.0 and 500.0 µg/mL, respectively. These results indicated that the 
antibacterial activity of GO is concentration-dependent. To further validate the results 
from the bioluminescence imaging and detection of OD600, we treated Kp bacteria with 
and without GO and determined bacterial colonies using LB-agar dishes. As shown in 
Figure 67B, the photographs (a and b) and bioluminescent images (c and d) both 
showed that the amounts of colonies drastically decreased treated with 250.0 µg/mL 
GO overnight. Collectively, GO exhibited excellent antibacterial activity to MDR Kp 
at the bacterial level. To evaluate whether antibacterial activity of GO is ubiquitous, we 
also investigated the bactericidal activity in another two bacteria E.coli and P. 
aeruginosa (Pa). As shown in Figure 67C and D, GO has the similar antibacterial 
activity to E. coli and Pa to Kp. With the increase of the concentration of GO, the 
survival rate of E. coli and Pa decreased. However, the survival rate of E. coli and Pa 
were 11.8 % and 11.9 % when treated with 250 µg/mL GO (Figure 67C and D), which 
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were higher than that to Kp (2.8 %). In order to minimize the effect of high 
concentration GO on the animals, Kp was chosen as our model bacterial to investigate 
the antibacterial activity of GO in vivo.  
Figure 67. Antibacterial property of GO with different concentration. (A) The Kp 
survival rate after treatment of different concentrations of GO. Inset: Bioluminescence 
images of Kp bacteria after incubation with different concentrations of GO. From left 
to right: 0, 62.5, 125.0, 250.0, and 500.0 µg/mL. (B) Representing photographs (a and 
b) and bioluminescence images (c and d) of Kp bacterial colonies treated with (a and c) 
and without (b and d) GO formed on LB-agar plates. (C) The E.coli survival rate after 
treatment of different concentration of GO. (D) The Pa survival rate after treatment of 
different concentration of GO. 
3.3. GO Increases Host Cells Resistance to Kp.  
After the treatment with GO, the infection ability of Kp was investigated in 
macrophage cells. MH-S cells were infected by Kp (8 h), which was treated with 
different concentrations GO from 0 to 500.0 µg/mL. As shown in Figure 68, using the 
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cell without any bacterial infection as the negative control, the cell viability increased 
when the concentration of GO increased and reached a plateau around 65 % when the 
concentration of GO was 250.0 µg/mL. These results indicated that GO can kill the 
bacteria to some extent and inhibit the infection potency of Kp. However, the cell 
viability has not recovered to the normal level compared to the cells without treatment. 
This might be due to two main reasons. First, GO might have not killed all the Kp 
bacteria that would still cause cell death after the infection. Second, GO might have 
cytotoxicity that would affect the cell viability at high concentrations. Before GO can 
be used in clinics as an antibacterial agent, the biocompatibility should be fully 
investigated.  
Figure 68. Relative viability of MH-S cells infected by Kp after treatment with different 
concentrations of GO (0.0, 62.5, 125.0, 250.0 and 500.0 µg/mL) at 37 °C through MTT 
assay. 
3.4. GO Increases Resistance to Kp in Mice.  
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We found that GO was able to kill Kp and inhibit its infection potency in cells. 
However, the antibacterial activity of GO in the animal level is unexplored. Using a 
mouse model, we investigated whether GO treatment can reduce the infection potency 
in Kp. To this end, we intraperitoneally injected mice with GO-treated Kp at 1 × 105 
CFU (in 50 µL PBS) per mouse. Then, the bioluminescence imaging was carried out 
using IVIS Lumina XR system to monitor the invasion and dissemination of Kp in mice. 
As shown in Figure 69A, the mouse injected with the Kp without GO treatment showed 
diffusing and intense bioluminescence. While bioluminescence stayed in the 
enterocoelia cavity in the early time, it extended to the thoracic cavity after 8 h post 
injection. However, the dissemination areas and intensity of bioluminescence in mice 
infected by GO-treated Kp were more constrained (GO at 250.0 µg/mL). Even after 24 
h post injection, the translocation of Kp to thoracic cavity was limited when GO was 
used to treat Kp. Then, we semiquantitively measured the bioluminescence intensity in 
these two groups (Figure 69B). The bioluminescence intensity of control Kp-infected 
mice was almost twice higher (1.6 - 2.0) than that of the mice infected by GO-treated 
Kp. This proved that GO was able to kill Kp and inhibit its infection potency in vivo.  
Since Kp is a common cause of respiratory infection, we intranasally instilled 
Kp in to mouse lungs to investigate whether GO impacts the infection potency. As 
shown in Figure 70A, 50% mice died within 48 h with sham- treated Kp, and all the 
mice had died at 72 h. In contrast, 80% the mice infected by GO-treated Kp remained 
alive during the whole period. The results demonstrated that GO could greatly inhibit 
the infection potency of Kp, decreasing the mortality and prolonging the survival of 
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infected-mice. After infection via intranasal instillation, the damage of the lung tissue 
was also investigated using H&E staining. As shown in Figure 70B, the morphology 
was altered, including signs of inflammatory response, tissue damage, and severe 
pneumonia in the mice treated Kp without GO incubation. However, GO-treated Kp 
caused subdued inflammatory features, reduced polymorphonuclear neutrophil (PMN) 
penetration and decreased tissue damage. Therefore, GO can significantly alleviate the 
damage of lung tissue by reducing Kp infection ability.  
Figure 69. GO decreased infection severity in mice. (A) Bioluminescent images were 
obtained using IVIS Lumina XR system at different time points and the mice 
intraperitoneally injected with GO-treated Kp and untreated Kp. (B) Semiquantitively 
bioluminescence intensity of the two groups in (A).  
Figure 70. GO decreased mortality rates and tissue damage. (A) Kaplan-Meier survival 
curves were obtained by infecting mice with GO-treated and untreated Kp, respectively 
(n=5 mice per group). (B) Morphological evidence of lung injury and inflammatory 
responses as assessed by H & E staining histological analysis (20×, scale bar = 50 µm).  
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To further delve into the antibacterial mechanism of GO in vivo, the viability 
of alveolar macrophages (AM) isolated from the infected mice was evaluated because 
AM are a key immune cell in fighting against Gram-negative bacterial infection. The 
viability of AM reflects the health state of the bacterial infection. As shown in Figure 
71A, the survival of AM in GO-treated Kp infected mice increased by approximately 
1.4- and 3.1-fold compared to that of the sham-Kp group at 24 h and 48 h post infection, 
respectively. Meanwhile, the phagocyte-derived reactive oxygen species (ROS) is 
considered another factor reflecting the extent of bacterial infection. Severe infection 
will lead to excessive generation of ROS species (Figure 71B). At 8 h and 24 h post 
injection, GO-treatment significantly decreased the generation of ROS in AM, 
indicating reduced infection extent. Furthermore, the quantity of PMN in BAL and 
blood of the infected mice were also measured to gauge inflammatory response. As 
shown in Figure 71C and D, PMN penetration in both BAL fluid and blood of  GO 
treated-Kp group was lower than that of sham-Kp group at 8 h and 24 h post infection. 
Collectively, these data of AM cell viability, ROS species, and PMN penetration 
indicated that the infection potency of Kp after GO treatment was greatly dampened in 
vivo against the controls.  
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Figure 71. (A) Cell viability of AM after bacterial infection by MTT assay. (B) ROS 
production in AM cells detected using an NBT assay. (C and D) PMN infiltration in the 
BAL and blood was counted by HEMA staining (Thermofisher). ***p < 0.001; RLU: 
relative LUC units. 
Bacterial spread to various organs is another mortiferous factor during sepsis. 
Septicemia and ultimately sepsis might be caused by bacterial dissemination during the 
diseases progression. Therefore, we investigated Kp dissemination after intranasal 
instillation by determining bacterial burdens in the lung, liver, spleen, and kidneys. As 
shown in Figure 72, the lung (A) had the highest bacterial loads, followed by the spleen 
(C), kidney (D) and liver (B). However, in all the organs, bacterial CFUs from the mice 
infected with GO-treated Kp were significantly lower than those from sham-treated 
group at 8 h and 24 h post infection. To validate this observation, we detected the 
activity of tissue injury, MPO, in all of the organs as MPO is released from PMN in 
response to various pulmonary infections. As shown in Figure 73, in all the four organs, 
the activity of MPO followed the same trends as that of the bacterial CFUs in Figure 
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72. At 8 h and 24 h post infection, the MPO activity of GO-treated Kp group was 
significant lower than that from sham-treated Kp group, indicating lessened infection.  
Figure 72. The lung (A), liver (B), spleen (C), and kidneys (D) showed significantly 
decreased bacterial burdens in GO-Kp infected mice (Mann Whitney U test). **p < 
0.01; ***p < 0.001. 
Figure 73. Decreased MPO activity in the lung (A), liver (B), spleen (C), and kidney 
(D) of GO-Kp treated mice at 8 h and 24 h. Data are shown as mean + SEM of n = 3 
mice per group and are representative of three independent experiments. **p < 0.01; 
***p < 0.001; one-way ANOVA (Tukey’s post hoc). RLU: relative LUC units.  
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4. Conclusions. 
In conclusion, the antibacterial activity of GO to Kp was investigated at the 
bacterial, mammalian cell and animal levels in this work. At the bacterial level, GO can 
kill Kp in a concentration-dependent manner. More than 95% Kp was killed when the 
concentration of GO was at 250.0 µg/mL. After treatment with GO, Kp also showed 
reduced infectivity to macrophage MH-S cells, thus increased cell viability. More 
importantly, antibacterial activity of GO was investigated in animal models. Similarly, 
GO can significantly inhibit the infection potency of Kp after peritoneal injection and 
intranasal instillation, respectively. The mortality of mice with Kp infection was 
decreased when GO was used. Meanwhile, the inflammatory responses in the lung, liver, 
spleen and kidney were also decreased after infected with GO-treated Kp. Taken 
together, these findings indicate that GO might be a potential therapeutic agent for Kp, 
which may also be used to control other MDR bacteria that cause severe disease in 
clinics. 
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